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Abstract 
Background and aims 
 Social anxiety is common in people with psychosis.  Recent evidence suggests 
that cognitive behavioural interventions can be used with this population to reduce 
distress and increase functioning.  Imagery rescripting is effective for a range of 
psychological problems including social anxiety.  This study aimed to investigate 
whether imagery rescripting is effective for social anxiety in people with psychosis.   
 
Method 
 A single case series, multiple baseline design was used.  Ten participants were 
recruited from Early Intervention in Psychosis (EIP) and Integrated Delivery Team 
(IDT) services in Norfolk and Suffolk.  The intervention was replicated from previous 
work in the social anxiety field (Wild et al., 2008; Wild & Clark, 2011).  Throughout 
the study participants completed measures related to social anxiety, beliefs, memory and 
imagery, psychotic symptoms, depression, social functioning and quality of life.  Each 
participant attended seven sessions including a one month follow-up assessment.  Data 
were analysed using visual inspection and the calculation of reliable and clinical 
change.  Exploratory group statistics and effect sizes were also calculated. 
 
Results 
 Five participants achieved reliable and clinical change in social anxiety and were 
classified as ‘recovered’ (Wise, 2004).  Improvements in belief, memory and imagery 
ratings were observed for most participants following imagery rescripting.  Psychotic 
symptoms, depression, social functioning and quality of life remained largely stable.  
Those who didn’t recover had more complex needs or comorbid difficulties.  Group 
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analyses revealed significant improvements and medium to large effect sizes.  However, 
this should be interpreted with caution due to the small sample size.   
 
Conclusion 
 The study offers some support for the use of imagery rescripting for social 
anxiety in people with psychosis.  Those with less complex presentations are likely to 
benefit most and it may offer a brief yet effective intervention for these individuals.   
Those with complex difficulties may require longer and more intensive input.  
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CHAPTER ONE 
1. Introduction 
1.1 Overview 
This thesis aims to investigate whether imagery rescripting is effective for social 
anxiety in people with psychosis.  This chapter will provide definitions of terms and 
explanations of psychological theories and models for psychosis, social anxiety and 
social anxiety in people with psychosis.  The role of imagery in these populations will 
be discussed, followed by a description of imagery rescripting, theories regarding 
mechanisms of change and an outline of the evidence base.  The evidence base for the 
use of cognitive behavioural interventions for anxiety in people with psychosis will be 
considered, presented as a systematic review of the literature.  Finally, a rationale for 
the study will be provided together with research hypotheses and questions. 
1.2 Psychosis 
1.2.1 Definition of psychosis 
The term 'psychosis' refers to disorders characterised by impairment in 
perception, thinking, mood and behaviour (National Institute for Health and Care 
Excellence [NICE], 2014).  It involves positive symptoms, such as hallucinations and 
delusions, and negative symptoms including diminished emotional expression, a lack of 
desire to initiate goals (avolition), poverty of speech (alogia), a decrease in the ability to 
experience pleasure (anhedonia) and reduced interest in social interaction (asociality; 
American Psychiatric Association [APA], 2013).  Psychotic disorders include 
schizophrenia, bipolar disorder and schizoaffective disorder, which affect around 1%, 
2% and 0.5% of the population, respectively.  When other conditions are included (e.g. 
psychotic depression, delusional disorder) psychosis affects over two million people in 
the United Kingdom (Morrison, Renton, French & Bentall, 2008).    
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The symptoms and the potential for recovery from psychosis vary.  Some will 
recover well whereas others will experience repeated episodes (NICE, 2014).  The onset 
of psychosis begins with a pre-morbid period followed by a 'prodomal' stage where an 
individual displays a reduction in functioning.  This is followed by a 'first-episode' 
(Yung & Jackson, 1999).  Psychotic experiences can be precipitated by stress and are 
associated with comorbid issues such as anxiety and depression (British Psychological 
Society [BPS], 2014).  The ‘Early Intervention in Psychosis’ (EIP) movement is based 
on the idea that providing support during the early stages of psychosis can reduce long-
term impairment and distress (Department of Health [DH], 2000). 
1.2.2 Models of psychosis 
1.2.2.1 Vulnerability-stress models 
Vulnerability-stress models suggest that a number of factors are involved in the 
development of psychosis (Garety, Bebbington, Fowler, Freeman & Kuipers, 2007).  
The role of genetics, socioeconomic status, urbanicity, adversity (e.g. abuse, neglect, 
trauma) and drug use has been highlighted (e.g. Binbay et al., 2012; Varese et al., 
2012).  Traumatic brain injury, migration, psychosocial stress, impaired social 
functioning and being male are also associated (Cornblatt et al., 2012; Molloy, Conroy, 
Cottor & Cannon, 2011; O’Donoghugh et al., 2015; Pruessner, Iyer, Faridi, Joober, & 
Malla, 2011; van Os, Linscott, Myin-Germeys, Delespaul & Krabbendam, 2009).   
1.2.2.2 Cognitive-behavioural models 
Whilst vulnerability-stress models go some way to explain the onset of 
psychosis, cognitive-behavioural models propose that cognitive and emotional factors 
are important to consider in the development and maintenance of symptoms.  Garety, 
Kuipers, Fowler, Freeman, & Bebbington (2001) hypothesise that people with 
psychosis experience cognitive disturbance.  This leads to anomalous experiences (e.g. 
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thoughts interpreted as voices, heightened perception) which the individual then 
attempts to explain.  From this, additional cognitive factors may maintain psychosis.  
This might include biased reasoning processes (e.g. ‘jumping to conclusions’; Freeman, 
Garety & Philips, 2000), external attributions about others’ behaviour, and 
dysfunctional beliefs about the self, others and the world.  Core beliefs are likely to be 
negative and associated with difficult or traumatic experiences.  For instance, paranoia 
is often associated with self-beliefs about being weak or vulnerable and beliefs about 
others being threatening or bad (Fowler et al., 2006; Smith et al., 2006).   
Garety et al. (2001) also highlight the role of emotion, explaining that the 
processes observed in anxiety may also apply to psychosis.  For example, biases in 
information processing (e.g. attentional bias; Freeman et al., 2000) may provide 
evidence for a psychotic belief, safety behaviours may prevent an individual from 
obtaining evidence contrary to a belief (Freeman & Garety, 2000) and meta-cognitive 
beliefs (e.g. thought uncontrollability) may increase anxiety (Freeman & Garety, 1999), 
leading to further interpretations that are based on threat. 
Morrison (2001) highlights the similarity between psychosis and anxiety.  In 
particular, Morrison’s model considers the role of intrusions into awareness (i.e. 
hallucinations, delusions) and suggests the interpretation of these intrusions causes 
distress.  As with anxiety, misinterpretations in psychosis are likely to be influenced by 
cognitive processing, emotional and physiological states and safety behaviours.  The 
interpretations are likely to be based on dysfunctional knowledge about the self and 
others, associated with experiences such as trauma and significant life events. 
1.2.3 Summary of psychosis section 
People with psychosis experience symptoms that can cause significant 
functional impairment.  A number of psychological theories have been proposed for the 
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development and maintenance of psychosis including vulnerability-stress and cognitive 
behavioural models (e.g. Garety et al., 2001; Morrison, 2001).  The role of anxiety is 
highlighted and this has the potential to perpetuate symptoms over time.  Given its 
potentially disabling nature, research investigating interventions for people with 
psychosis is warranted.  This will be considered in greater detail below.      
1.3 Social anxiety 
1.3.1 Definition of social anxiety disorder 
Social anxiety involves "marked fear or anxiety about one or more social 
situations in which the individual is exposed to possible scrutiny by others…The 
individual fears that he or she will act in a way or show anxiety symptoms that will be 
negatively evaluated” (APA, 2013, p. 202).  It is the most common type of anxiety 
disorder, affecting 12% of the population (Kessler et al., 2005).   
The terms social phobia and social anxiety disorder tend to be used 
interchangeably and it is argued that social anxiety is likely to be distributed within the 
general population on a continuum, from more mild forms (that still affect functioning) 
to diagnosable social phobia (Rapee & Spence, 2004).  Both terms will be used 
throughout this study as it involves those with social phobia and those with significant 
levels of social anxiety but who may not have a diagnosis of social phobia.  
1.3.2 Models of social anxiety 
1.3.2.1 The development of social anxiety 
Social anxiety is likely to arise from a combination of factors including 
biological, psychological and environmental elements (Rapee & Spence, 2004).  The 
role of genetics has been highlighted (e.g. Fyer, Mannuzza, Chapman, Martin & Klein, 
1995; Lieb et al., 2000; Nelson et al., 2000; Stein, Jang & Livesley, 2002), together with 
physical or sexual abuse, bereavement, parental conflict and divorce, socio-economic 
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difficulties, bullying, criticism and rejection (Hackmann, Clark & McManus, 2000; 
Kimbrel, 2008; Rapee & Spence, 2004).   
1.3.2.2. Cognitive-behavioural models 
Clark and Wells (1995) suggest that individuals with social phobia fear social 
situations because they are concerned that they will behave unacceptably leading to 
rejection.  Central to the model is the idea that when an individual with social phobia 
enters a social situation they experience a shift in attention towards themselves.  This 
increases awareness of their anxiety making it difficult for them to process the situation 
correctly.  This results in negative cognitions, an increase in anxiety and the use of 
safety behaviours, creating a vicious cycle of fear and response. 
Rapee and Heimberg (1997) suggest that in social situations individuals with 
social phobia form a mental representation of how they believe they appear to others.  
This is based on negative information from both internal sources (e.g. blushing, 
sweating) and external sources (e.g. verbal and non-verbal information from others).  
Attention is directed towards this representation and any perceived threats in the 
environment, preventing the individual from gaining accurate information about 
performance.  They are also likely to predict how others expect them to act.  This is 
contrasted with how the person assumes they come across, leading to an estimate of 
how others will perceive their social performance.  Anxiety follows, including physical 
(e.g. shaking), cognitive (e.g. negative thoughts) and behavioural (e.g. reduced eye 
contact) elements.  Performance suffers as a result of this anxiety and the negative 
representation is reinforced.  The model is shown in Figure 1.1.   
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Figure 1.1. Rapee and Heimberg’s (1997) cognitive-behavioural model of social phobia 
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1.3.3 Summary of social anxiety section 
 Social anxiety is the most common anxiety disorder (Kessler et al., 2005) and it 
can have a significant impact on functioning.  Theories regarding development have 
been proposed and cognitive behavioural models (e.g. Clark & Wells, 1995; Rapee & 
Heimberg, 1997) highlight the role of cognitive and affective elements.  The following 
section will consider the nature of social anxiety in people with psychosis.  
1.4 Psychosis and social anxiety 
1.4.1 Prevalence and nature of social anxiety in psychosis 
Social anxiety is found in people with psychosis more than any other comorbid 
problem (Cassano, Pini, Saettoni, Rucci and Dell’Osso, 1998).  Sixty percent of those 
with first-episode psychosis are likely to experience social anxiety, with 31% meeting 
criteria for social phobia (Voges and Addington, 2005).  Romm, Melle, Thoresen, 
Andreassen and Rossberg (2012) found that those with first-episode psychosis and 
severe social anxiety demonstrated impairment in social functioning, premorbid 
adjustment, self-esteem and quality of life.  Social anxiety has also been found to 
increase the risk of depression in those with psychosis (Voges & Addington, 2005).  
This is clearly an important issue that warrants further investigation. 
1.4.2 Models of psychosis and social anxiety 
1.4.2.1 Michail and Birchwood’s (2009) pathways model  
Michail and Birchwood (2009) hypothesise that there are three pathways in the 
development of social anxiety and psychosis.  Firstly social anxiety might develop 
before persecutory beliefs, precipitating and maintaining such thinking styles in those 
with psychosis.  The second pathway suggests that social anxiety and persecutory 
beliefs develop at the same time during the early stages of psychosis.  The final pathway 
in the model suggests that paranoid thinking styles might lead to the development of 
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social anxiety in those with psychosis.  For example, delusions may lead to social 
anxiety through a ‘jumping to conclusions’ bias.  An individual might interpret 
ambiguous social situations as threatening, leading them to make negative attributions 
about others’ behaviour (Freeman et al., 2000).  
1.4.2.2 Birchwood et al’s (2007) stigma processing model 
Birchwood et al. (2007) describe a stigma processing model of psychosis and 
social anxiety (See Fig. 1.2).  They suggest that those with psychosis are aware of a pre-
existing societal stigma leading them to feel devalued.  They experience anxiety about 
others judging and rejecting them (also known as other-to-self focus).  As a result the 
individual focuses their attention on an image of themselves related to how they might 
appear to others (also known as self-to-self focus).  For instance, an individual may 
have thoughts about looking ‘weird’ because they feel tense and shaky.  This leads to a 
‘catastrophic shaming belief’ that others will regard them as mentally unwell.  In 
response to anger and anxiety, safety behaviours such as hostility and avoidance are 
used.  Unfortunately this causes the individual to withdraw from social contact, leading 
to reinforcement of their negative beliefs about social performance.    
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Figure 1.2. Birchwood et al’s (2007) stigma processing model of psychosis and social 
anxiety 
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events) are included, with an emphasis on how these factors influence self-impression in 
relation to others.  Self-processing as a response to perceptions of interpersonal threat 
are central to the model, with a focus on beliefs about being inadequate, inferior and 
having an increased level of self-consciousness.  This processing can occur in verbal or 
imaginal form and involves an individual concluding that cognitions, images and other 
internal experiences are accurate and based in reality.  This leads to changes in 
cognition, affect, physiology and behaviour.  For instance, an individual may display 
worry, rumination and behavioural avoidance (see Fig. 1.3).   
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Figure 1.3. Newman-Taylor and Stopa’s (2013) model of paranoia 
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1.4.3 Summary of psychosis and social anxiety section 
 The prevalence of social anxiety in people with psychosis is high (Cassano et al., 
1998; Voges & Addington, 2005) and it has the potential to negatively impact 
functioning and quality of life (Romm et al., 2012).  A number of theories related to 
social anxiety and psychosis have been proposed.  Michail and Birchwood (2009) 
suggest that there are a number of pathways to social anxiety in psychosis.  Birchwood 
et al. (2007) highlight the role of social anxiety in the maintenance of psychotic 
experiences, focusing on the role of stigma and loss of social status.  Newman-Taylor 
and Stopa (2013) suggest that both social anxiety and paranoia involve a fear of others 
and they present a model focussed on self-processing in response to perception of 
interpersonal threat.  The role of social anxiety in people with psychosis is clearly an 
important issue that warrants further investigation.   
Birchwood et al. (2007) note that people with psychosis who also experience 
social anxiety hold an image of how they might appear to others.  This appears to be 
related to the ‘intrusions into awareness’ suggested by Morrison (2001) in relation to 
psychotic symptoms and anxiety, or the ‘mental representation’ referred to by Rapee 
and Heimberg (1997) in their model of social phobia.  Due to the overlap between these 
models the role of imagery in people with psychosis and social anxiety may be an 
important area of investigation.  This is considered in more detail below.     
1.5 Imagery  
1.5.1 Definition of imagery 
Mental images are “cognitive representations of perceptual information that are 
not in the product of current external sensory input.” (Hirsch and Clark, 2007, pp. 448).  
They involve visual information but can also involve auditory, olfactory and 
kinaesthetic elements (Kossyln, Ganis & Thompson, 2001) and lead to greater 
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emotional arousal than verbal material (Holmes, Arntz & Smucker, 2007).  As a result 
negative imagery can maintain psychological problems (Serruya & Grant, 2009).   
1.5.2 Imagery in psychosis 
Morrison et al. (2002) found that 69% of people with psychosis reported 
recurrent images related to paranoia, past trauma and auditory hallucinations.  In 
support, Schulze, Freeman, Green & Kuipers (2013) investigated mental imagery in 
participants with persecutory delusions and found that 72.5% reported images related to 
paranoia.  Sixty percent of the sample were able to identify negative autobiographical 
events that were related to paranoid images.  Morrison et al. (2002) note that imagery 
may maintain psychosis and that it should therefore be a focus of intervention.   
1.5.3 Imagery in social anxiety 
Imagery has also been found to be important in the context of social anxiety 
(Clark & Wells, 1995, Wells, 1997).  Using a semi-structured interview, Hackmann, 
Surawy and Clarke (1998) found that 77% of participants with social phobia reported 
imagery.  The images commonly represented fears about performance in social 
situations (e.g. blushing, sweating or shaking).  Wells & Papageorgiou (1999) note that 
images in social anxiety usually occur from the perspective of an ‘observer’ with the 
individual seeing themselves from another’s point of view.  This encourages an 
inaccurate impression of actual performance based on subjective and introspective 
information (Clark and Wells, 1995).  As with psychosis, self-imagery in social phobia 
is often based on memories of difficult experiences (Hirsch, Clark & Mathews., 2006).  
This can maintain social phobia as the individual focusses on their symptoms and 
ignores evidence likely to refute their beliefs (Clark & Wells, 1995).   
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1.5.4 Imagery in psychosis and social anxiety 
Lockett et al. (2012) used the semi-structured interview developed by Hackmann 
et al. (1998) to investigate imagery in participants with psychosis and social anxiety.  
Although similar themes were identified between people with psychosis and social 
anxiety and those with social phobia without psychosis (e.g. fear of negative evaluation, 
lost social status) there were also differences.  Rather than using an observer 
perspective, individuals with psychosis often observed an ‘other’ from a field 
perspective who was exaggerated and threatening (e.g. imagining others staring at 
them).  Furthermore, imagery was more likely to be characterised by fear and paranoia 
rather than social anxiety.  For example, some participants described feeling intimidated 
by others.  As with psychosis and social anxiety alone, negative imagery might maintain 
social anxiety in those with psychosis.  Research investigating interventions for 
distressing imagery in this population may therefore be warranted.      
1.5.5 Summary of imagery section 
Negative imagery has the potential to maintain psychological problems (Serruya 
& Grant, 2009), including psychosis (Morrison et al., 2002) and social anxiety (Clark & 
Wells, 1995).  An investigation into imagery in those with psychosis and social anxiety 
highlighted similar themes as those experienced in social phobia but also differences 
(e.g. feeling threatened, paranoia; Lockett et al., 2012).  This suggests that although 
there is overlap between psychosis and social anxiety those experiencing both 
conditions are a distinct population.  In their work on the processes underlying social 
anxiety and paranoia, Newman-Taylor and Stopa (2013) argue that imaginal experience 
is under investigated in people with psychosis.  Given the potential for imagery to 
maintain psychological distress, further investigation is warranted.   
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1.6 Imagery rescripting 
1.6.1 Definition of imagery rescripting 
Imagery rescripting is a psychological intervention designed to change the 
meaning of images and associated memories and reduce emotional distress (Holmes et 
al., 2007).  It involves asking an individual to think about an image or memory and 
imagine the content changing in a way that is helpful (Arntz, 2012).  Holmes et al. 
(2007) explain that “if the image were a painting, we would be working directly on the 
canvas interacting with the image itself in some way – such as examining the picture, 
re-painting parts of it, and so on” (pp. 301).  This allows an individual to challenge 
beliefs about being powerless or hopeless and encourages mastery, control and self-
compassion (Gilbert & Irons, 2004; Rusch, Grunert, Mendelson and Smucker, 2000).   
1.6.2 Arntz and Weertman’s (1999) imagery rescripting procedure 
Arntz and Weertman (1999) provide a description of an imagery rescripting 
procedure that focuses on rescripting traumatic memories.  Although their work 
involves the treatment of childhood sexual abuse they suggest that the procedure can be 
used with memories associated with a range of psychological problems.   
Arntz and Weertman’s (1999) procedure is divided into three stages.  First, the 
individual is asked to imagine and describe a past event (in as much detail as possible) 
as if they were their younger self.  They are then asked to imagine the event as their 
adult self (i.e. as a bystander) and describe their thoughts, feelings and behaviours at the 
time of the event.  At this point the adult self is invited to intervene in any way that is 
helpful.  The final stage involves asking the individual to describe the event as their 
younger self whilst having the opportunity to receive further intervention from their 
adult self.  The younger self is able to ask the adult self to provide anything else that 
they feel is needed at the time (e.g. comfort or reassurance).  This allows new 
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information to be introduced to the younger representation as there is similarity between 
this perspective and the developmental level of the original event (see Arntz & 
Weertman (1999) for a more detailed account of the procedure).  Further theories 
regarding the mechanisms of change for imagery rescripting are discussed below.   
1.6.3 Theories related to imagery rescripting 
1.6.3.1 Foa and Kozak’s (1986) emotional processing theory 
Foa and Kozak (1986) suggest that emotional processing is required in order to 
modify memory.  This works on the basis that prolonged exposure to feared stimuli 
activates the fear memory and offers opportunity for new and corrective information to 
be introduced.  Increased physiological arousal and habituation to anxiety-inducing 
stimuli allows the fear network to be modified, leading to a reduction in emotional 
distress.  As imagery rescripting has an element of imaginal exposure it arguably 
encourages emotional processing in this way (Krakow et al., 2001).   
1.6.3.2 Teasdale and Barnard’s (1993) interacting cognitive subsystems theory 
Teasdale and Barnard (1993) highlight the role of propositional (i.e. explicit 
“knowing” meaning) and implicational (i.e. implicit “feeling” meaning) subsystems.  
When information moves from the propositional to the implicational system there is a 
change in meaning.  Imagery rescripting has the potential to activate the implicational 
subsystem through the elicitation of memories and emotion.  Introducing new 
information to memory allows the event to be re-appraised and given new meaning.   
1.6.3.3 Learning theory 
Arntz (2012) suggests that memories related to distressing events, also known as 
representations of the unconditioned stimulus (US), are re-activated in different 
situations.  This leads to concerns that the event will occur again.  Arntz (2012) suggests 
that imagery rescripting may involve changing the meaning of an event through a 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
17 
 
process of US revaluation.  It can be used to activate the representation of the US and 
modify its underlying meaning so that it no longer leads to a fear response.  The 
modification of the US representation through imagery rescripting allows generalisation 
to other contexts (Arntz, 2011).  This is more likely to induce change than extinction 
which requires repeated learning over different contexts so that the conditioned 
response (CR) and the US are not associated.  Furthermore, if a positive image is paired 
with the original image systematically the memory will be focussed on the positive 
image leading to a reduction in distress (Arntz, 2012). 
1.6.3.4 Brewin’s (2006) retrieval competition hypothesis 
 Brewin (2006) suggests that there are multiple representations of self including 
real life and imagined representations.  In a situation an individual uses a representation 
of self based on different factors including environmental cues and the frequency, 
distinctiveness and valance of past representations.  There is competition for 
representations of the self and positive representations are increased by allowing them 
to become stronger than negative representations.  Imagery rescripting attempts to 
achieve this, not by replacing memories but updating them with new information. 
1.6.4 Imagery rescripting for psychosis 
Imagery interventions appear to be beneficial for people with psychosis.  
Morrison (2004) presents a case study of a man experiencing a recurrent image of being 
put into a van and being assaulted by an armed gang.  The man pretended the image was 
a video so that fast forwarding and rewinding could be used.  He also introduced a 
‘rescuer’, used humour through the use of a cartoon character and developed a ‘safe’ 
image of being somewhere comfortable (i.e. at home).  Reductions in belief and distress 
ratings were observed over the course of treatment.   
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Serruya & Grant (2009) describe a man who experienced images related to fears 
that the Central Intelligence Agency (CIA) and the devil were out to get him.  They 
encouraged the patient to rescript the images allowing him to gain control over his 
delusions and reduce his anxiety.  More recently, Ison, Medoro, Keen and Kuipers 
(2014) used imagery rescripting with four people who were hearing voices.  In three 
participants the intervention led to significant reductions in distress, negative affect, the 
conviction of beliefs and control over a memory associated with the negative imagery.   
1.6.5 Imagery rescripting for social anxiety 
A number of studies support the use of imagery rescripting with people with 
social anxiety.  Wild, Hackmann and Clark (2007) used 45 minutes of imagery 
rescripting with 14 participants with social phobia.  Prior to rescripting, a semi-
structured interview (Hackmann et al., 2000) was used to identify an image of a social 
situation.  A distressing memory associated with the image was also identified.  The 
meaning of the image and memory was summarised into one or two sentences and 
referred to as an ‘encapsulated belief’.  Intervention to rescript the memory led to 
improvements in beliefs, memory distress, imagery distress and vividness and social 
anxiety.  Although their procedure was based on Arntz and Weertman’s (1999) 
protocol, Wild et al. (2007) made some changes.  All three stages of the rescripting 
were delivered at once rather than taking breaks in between.  Also, immediately before 
the rescripting, the memory was updated using 30 minutes of cognitive restructuring.  
This allowed the encapsulated belief to be challenged (Wild & Clark, 2011).   
Wild, Hackmann and Clark (2008) used imagery rescripting with 11 participants 
with social phobia.  This differed from the intervention provided by Wild et al. (2007) 
in that two sessions were used one week apart; a control session that involved 
discussing the participant’s image and memory without attempting to change them, and 
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an experimental session that included cognitive restructuring and the rescripting of the 
memory.  Following the control session no significant change in negative beliefs, 
memory distress or social anxiety was observed.  However, following the experimental 
session and at a follow-up assessment, there were significant reductions on each of 
these measures and measures of imagery distress, vividness and frequency.   
More recently, Nilsson, Lundh and Viborg (2012) found that imagery rescripting 
led to reductions in distress, fear of social interaction, negative evaluation from others 
and negative self-perceptions in participants with social anxiety.  Lee and Kwon (2013) 
demonstrated that imagery rescripting led to greater improvements in social anxiety 
when compared to a control group.  Frets, Kevenaar and van der Heiden (2014) used a 
single case series design to investigate imagery rescripting for social phobia in six 
participants.  All participants demonstrated improvements in social anxiety and fear of 
negative evaluation following intervention.   
1.6.6 Summary of imagery rescripting section 
Imagery rescripting involves changing the meaning of imagery and memory to 
reduce emotional distress (Holmes et al., 2007).  A number of theories have been 
hypothesised for this including similarity between a younger perspective and the 
developmental level of the original event (Arntz & Weertman, 1999); modification of 
the fear network through the introduction of new information (Foa & Kozak, 1986); 
changes in the meaning of information through re-appraisal (Teasdale & Barnard, 
1993); US revaluation (Arntz, 2012); and increasing the strength of positive 
representations of self by introducing new information (Brewin, 2006). 
Imagery interventions appear to be useful for people with psychosis (Ison et al., 2013; 
Morrison, 2004; Serruya & Grant, 2009) and for people with social anxiety (e.g. Frets et 
al., 2008; Lee & Kwon, 2013; Nilsson et al., 2012; Wild et al., 2007; Wild et al., 2008).  
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To the author’s knowledge, no research has been conducted investigating whether 
imagery rescripting is effective for social anxiety in people with psychosis.  Considering 
that social anxiety has the potential to cause significant distress and impairment in those 
with psychosis this could be worthwhile.  Existing cognitive behavioural interventions 
for anxiety in the context of psychosis are considered below.   
1.7 Cognitive behavioural interventions  
1.7.1 Cognitive Behavioural Therapy (CBT) for anxiety in people with 
psychosis 
 It is clear that research investigating suitable interventions for social anxiety in 
people with psychosis is justified.  A systematic review is presented below, offering 
information about the efficacy of CBT for anxiety in people with psychosis.  Whilst 
including CBT for social anxiety, the review investigates whether CBT is an effective 
treatment for ‘anxiety’ in people with psychosis.  This allows for a more comprehensive 
search of the literature, highlighting whether anxiety is a suitable target of intervention 
for those with psychosis.  It also allows for an investigation into whether CBT for 
anxiety for people without psychosis is effective and feasible for those with psychosis.  
In 2013, Braga, Reynolds and Siris published a review of the epidemiology, 
course and treatment of anxiety in participants with schizophrenia spectrum disorders 
(e.g. schizophrenia, schizoaffective disorder).  The anxiety disorders included were 
social phobia, obsessive compulsive disorder (OCD), generalised anxiety disorder 
(GAD), panic disorder, specific phobia, post-traumatic stress disorder (PTSD) and acute 
stress disorder.  Although there was no restriction on the type of intervention most 
studies reported the use of medication or CBT.  The authors conclude that although 
there is some support for the use of these treatments further research is required.   
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Although this review is worthwhile it has some limitations.  First, only one 
database was used meaning that some studies are likely to have been missed.  The 
review searched for studies published up until July 2012 and additional studies have 
been published since this time.  In addition to the specified anxiety disorders the only 
search term used was ‘schizophrenia’.  Given that the literature often uses a 
transdiagnostic approach, studies referring to ’psychosis’ might have also been 
excluded.  Perhaps most importantly, effect sizes were not presented.  This makes it 
difficult to fully evaluate the efficacy of CBT for anxiety in this population.  With these 
limitations in mind, it was deemed appropriate to conduct an updated review.    
1.7.2 CBT for anxiety in people without psychosis 
Throughout the review, effect sizes for CBT for anxiety in people without 
psychosis will be compared with studies using CBT for anxiety with psychosis 
populations.  Wolitzky-Taylor, Horowitz, Powers and Telch (2008) conducted a meta-
analysis of CBT for specific phobia, reporting effect sizes of 1.05, 0.98 and 0.57 for 
CBT with exposure, CBT without exposure and placebo treatments, respectively.  Mean 
effect sizes of 0.77 and 0.95 for post-test and follow-up are reported for CBT for social 
phobia (Gil, Carrillo & Meca, 2001).  An effect size of 0.64 has been found for both 
panic disorder and GAD (Haby, Donnelly, Corry & Vos, 2005) and an effect size of 
1.26 has been found for OCD (Eddy, Dutra, Bradley and Westen, 2004).  For PTSD, 
Bradley, Greene, Russ, Dutra & Westen (2005) note effect sizes of 1.65 and 1.26 for pre 
versus post-treatment and treatment versus wait-list control, respectively.  Cohen (1988) 
referred to effect sizes as ‘small’ (d=0.2), ‘medium’ (d=0.5) and ‘large’ (d=0.8) and this 
will be used throughout the review to evaluate treatment efficacy.   
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1.7.3 Systematic review of CBT for anxiety in people with psychosis 
 1.7.3.1 Search strategy  
A search was performed using the PsycINFO, MEDLINE (EBSCO) and Web of 
Science databases on 21st June 2014.  All years were searched using three groups of 
terms; one relating to CBT, one relating to psychosis and one relating to anxiety.   
The search terms used were: CBT OR "cognitive behavio* therap*" OR "cognitive 
therap*" AND psychosis OR psychotic OR schizo* OR hallucination* OR delusion* 
AND anxi* OR "anxiety disorder*" OR OCD OR "obsessive compulsive" OR 
obsession* OR compulsion* OR panic OR agoraphobia OR PTSD OR "post-trauma*" 
OR "posttrauma*" OR "acute stress" OR GAD OR "generali?ed anxiety" OR worr* OR 
phobi* OR "social* anxi*" OR "social* phobi*". 
Titles, abstracts and methodologies were scrutinised to select 20 papers for 
review.  To ensure studies published since the search date were included, automatic 
alerts were set up for all databases used.  Two studies (Foster, Startup, Potts & 
Freeman, 2010; Tundo et al., 2014) were found using this method.  In total, 22 studies 
were reviewed.  The ancestry method was used to investigate articles missed by the 
electronic search but none were found. 
 1.7.3.2 Inclusion and exclusion criteria 
  Studies were included if they were written in English and reported on a sample 
with psychosis and anxiety and the use of CBT.  Studies that included participants with 
a diagnosis of ‘psychosis’, ‘schizophrenia’ (any type) and ‘schizoaffective disorder’ 
were included.  Studies were also included if they made reference to any of the anxiety 
disorders or symptoms specified in the terms above and if they used CBT, regardless of 
the format of intervention.  Studies with all ages were used, including those that 
recruited children and adolescents.          
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Only full articles were included so that the methodological quality of the studies 
could be assessed.  Letters, review articles and non-peer reviewed results such as books, 
conference abstracts and posters were excluded.  Studies that did not include 
participants with psychosis or those with ‘mixed’ groups of participants with severe 
mental illness that did not report specifically on those with psychosis (e.g. those that 
included mood or personality disorders without psychosis) were also excluded.  Studies 
that did not use CBT and stand-alone experimental studies such as Cognitive-Bias 
Modification (CBM) and Virtual Reality (VR) were excluded.  Studies were also 
excluded if anxiety was not the primary outcome, if anxiety was not present in the 
sample or if anxiety was not measured using psychometric instruments.  See Figure 1.4 
for information about the number of studies excluded at each stage.   
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Figure 1.4. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) diagram (Liberati et al., 2009) 
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1.7.3.3 Type of studies included 
Twelve of the studies were single or multiple case study or small N 
methodology designs (Callcott, Standart & Turkington, 2004; Dudley, Dixon & 
Turkington, 2005; Ekers, Carman & Schlich, 2004; Good, 2002; Gruber, Dordević, 
Biočina-Martić & Agius, 2006; Hagen, Solem & Hansen, 2014; Hofmann, Bufka, 
Brady, Du Rand & Goff, 2000; Kevan, Gumley & Coletta, 2007; Kobori, Sato, 
Katsukura & Harada, 2008; Marcello, Hilton-Lerro & Mueser, 2009; Nakamura, 
Schiffman, Lam, Becker & Chorpita, 2006; Tully & Edwards, 2009), six were open 
trials (Arlow, Moran, Bermanzohn, Stronger & Siris, 1997; Frueh, et al., 2009; Gega, 
White, Clark, Turner & Fowler, 2013; Trappler & Newville, 2007; Tundo et al., 2014; 
Welfare-Wilson & Newman, 2013) and four were randomised controlled trials (RCTs; 
Foster et al., 2010; Freeman et al., 2015; Halperin, Nathan, Drummond & Castle, 2000; 
Kingsep, Nathan & Castle, 2003).   
In terms of diagnosis, one study focused on ‘anxiety’ (Welfare-Wilson & 
Newman, 2013), four focused on OCD (Ekers et al., 2004; Hagen et al., 2014; Kobori et 
al., 2008; Tundo et al., 2014), three focused on panic disorder with or without 
agoraphobia (Arlow et al., 1997; Gruber et al., 2006; Hofmann et al., 2000), five 
focused on PTSD (Callcott et al., 2004, Frueh et al., 2009; Kevan et al., 2007; Marcello 
et al., 2009; Trappler & Newville, 2007), two focused on ‘worry’ (Foster et al., 2010; 
Freeman et al., 2015), two focused on specific phobia (Dudley et al., 2005; Nakamura et 
al., 2006) and five focused on social phobia/anxiety (Gega et al., 2013; Good, 2002; 
Halperin et al., 2000; Kingsep et al., 2003; Tully & Edwards, 2009). 
1.7.3.4 Evaluation of literature 
 Details of the 20 papers included in the final review are displayed in Table 1.1.  
Fifteen of these studies (Callcott et al., 2004; Dudley et al., 2005; Ekers et al., 2004; 
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Freeman et al., 2015; Foster et al., 2010; Gega et al., 2013; Good, 2002; Gruber et al., 
2006; Hagen et al., 2014; Kevan et al., 2007; Marcello et al., 2009; Nakamura et al., 
2006; Tully & Edwards, 2009; Tundo et al., 2014; Welfare-Wilson & Newman, 2013)  
were not included in the review conducted by Braga et al. (2013).  This review therefore 
adds to the current literature.     
As suggested by Crombie (1996), studies were evaluated in reference to the use 
of adequate sample size, reliable and valid measures, baseline assessments and follow-
up periods, randomization, blinding and appropriate data analyses.  They were also 
scrutinised for their consideration of confounding factors, treatment fidelity and 
potential clinical implications.  Where possible, effect sizes were calculated and 
reviewed using Cohen’s (1988) criteria.     
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Table 1.1  
Studies investigating CBT for anxiety in psychosis, presented alphabetically by author         
 
Author 
 
Study 
design 
 
N/Gender 
 
Diagnosis 
(psychosis) 
 
Diagnosis 
(anxiety) 
 
Mean 
age 
(SD) 
 
Therapy (Length) 
 
Outcome 
 
Effect size (d, r) 
 
Arlow et al. 
(1997) 
 
Open trial 
 
2F 
6M 
 
Schizophrenia 
Schizoaffective  
disorder 
 
Panic disorder 
 
38 (*) 
 
CBGT (16 
weeks) 
 
Significant 
improvement 
 
Baseline to post-
treatment; WASPA 
(d=0.68) 
Callcott et al. 
(2004) 
Multiple 
case report 
2F Psychosis PTSD 39.5 (*) CBT (*) Improvement * 
Dudley et al. 
(2005) 
Case study 1M Paranoid 
schizophrenia 
Specific 
phobia 
38 (*) CBT: Systematic 
desensitisation 
(38 sessions) 
Improvement * 
Ekers et al. 
(2004) 
Case report 1M Schizophrenia OCD 31 (*) CBT: ERP 
 (20 hours) 
Clinically 
significant 
change 
* 
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Author 
 
Study 
design 
 
N/Gender 
 
Diagnosis 
(psychosis) 
 
Diagnosis 
(anxiety) 
 
Mean 
age 
(SD) 
 
Therapy (Length) 
 
Outcome 
 
Effect size (d, r) 
Foster et al. 
(2010) 
RCT 14M 
10F 
Schizophrenia 
Schizoaffective 
disorder 
Delusional 
disorder 
Worry 39.60 
(*) 
CBT (Four 
sessions) 
Significant 
improvement 
Post-treatment PSWQ, 
treatment vs. TAU; 
baseline to post-
treatment (d=0.56), 
two-month follow-up 
(d=0.74)  
Freeman et al. 
(2015) 
RCT 86M 
64F 
Schizophrenia 
Schizoaffective 
disorder 
Delusional 
disorder 
Worry 40(*) CBT (Six hour-
long sessions) 
Significant 
improvement 
Post-treatment PSWQ, 
treatment vs. standard 
care (d=0.47) 
Frueh et al. 
(2009) 
Open trial 5M 
15F 
Schizophrenia 
Schizoaffective 
disorder 
PTSD 42.30 
(8.40) 
CBT: Exposure-
based (11 weeks) 
Significant 
improvement 
Pre to post-treatment; 
CAPS (d=0.54), PCL 
(d=0.54) 
Pre-treatment to three 
month follow-up; 
CAPS (d=0.84), PCL 
(d=0.78) 
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Author 
 
Study 
design 
 
N/Gender 
 
Diagnosis 
(psychosis) 
 
Diagnosis 
(anxiety) 
 
Mean 
age 
(SD) 
 
Therapy (Length) 
 
Outcome 
 
Effect size (d, r) 
Gega et al. 
2013) 
Open trial 6M Psychosis Social phobia *(*) CBT (12 weeks) Significant 
improvement 
(24-week 
follow-up) 
SIAS; pre to post-
treatment (d=0.73), 
post-treatment to 
follow-up (d=1.02), 
pre-treatment to follow-
up (d=0.87) 
Good (2002) Case study 1M Schizophrenia Social phobia *(*) CBT (24 weeks) Improvement * 
Gruber et al. 
(2006) 
Case report 1M Psychosis Panic disorder 
with 
agoraphobia 
*(*) CBT (19 
sessions) 
Clinically 
significant 
change 
* 
Hagen et al. 
(2014) 
Case study 1M Paranoid 
schizophrenia 
OCD *(*) CBT including 
ERP (9 hour-long 
sessions) 
Clinically 
significant 
change 
* 
Halperin et al. 
(2000) 
RCT 13M 
3F 
Schizophrenia Social anxiety 39.6 (*) BGT (8 two-hour 
sessions) 
Significant 
improvement 
Post-treatment, 
treatment vs. control; 
SIAS (d=0.30), BSPS 
(d=0.11) 
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Author Study 
design 
N/Gender Diagnosis 
(psychosis) 
Diagnosis 
(anxiety) 
Mean 
age 
(SD) 
Therapy (Length) Outcome Effect size (d, r) 
Hofmann et al. 
(2000) 
Multiple 
case study 
3M 
1F 
Schizophrenia Panic disorder 38 (*) CBT (15-17 
sessions) 
Improvement * 
Kevan et al. 
(2007) 
Single N  1F Schizophrenia PTSD 31 (*) Trauma 
elaboration and 
cognitive 
restructuring (9 
one-hour 
sessions) 
Improvement * 
Kingsep et al. 
(2003) 
RCT 23M 
10F 
Schizophrenia Social anxiety *(*) CBGT (12 one-
hour sessions 
plus one follow-
up session) 
Significant 
improvement 
Mean for all measures 
(d=0.64), SIAS 
(d=0.69), BSPS 
(d=0.17), BFNE 
(d=1.05) 
Kobori et al. 
(2008) 
Case report 1M Schizophrenia OCD 26(*) CBT (18 
sessions) 
Improvement * 
Marcello et al.  
(2009) 
Case study 1M Schizoaffective 
disorder 
PTSD *(*) CBT: Cognitive 
restructuring (16 
one-hour 
sessions) 
Clinically 
significant 
change 
* 
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Author Study 
design 
N/Gender Diagnosis 
(psychosis) 
Diagnosis 
(anxiety) 
Mean 
age 
(SD) 
Therapy (Length) Outcome Effect size (d, r) 
Nakamura et 
al. (2006) 
Multiple 
baseline 
single case 
1M Schizophrenia 
(Disorganised 
type) 
Specific 
phobia 
14(*) CBT (22 weeks) Improvement * 
Trappler & 
Newville 
(2007) 
Open trial 24* Schizophrenia 
Schizoaffective 
disorder 
PTSD *(*) CBGT (12 
weeks) 
Significant 
improvement 
IES; CBT (r=0.71), 
supportive group 
therapy (r=0.02) 
Tully and 
Edwards 
(2009) 
Case report 1M Paranoid 
schizophrenia 
Social anxiety 45(*) CBT (11 
sessions) 
Improvement 
(diagnosis) 
No 
improvement 
(ratings) 
* 
Tundo et al. 
(2014) 
Open trial 13M 
8F 
Schizophrenia 
Schizoaffective 
disorder 
OCD 29(*) CBT and ERP Significant 
improvement 
d=0.80 (Y-BOCS 
Total) 
Welfare-
Wilson and 
Newman 
(2013) 
Open trial 4M 
3F 
Psychosis Anxiety 25(*) CBGT Significant 
improvement 
Baseline to three month 
follow-up; Anxiety 
subscale of DASS-21 
(d=1.26) 
 
 
Note.  BFNE = Brief Fear of Negative Evaluation Scale; BSPS = Brief Social Phobia Scale; CAPS = Clinician-Administered PTSD Scale; CBT = 
Cognitive-behavioural therapy, CBGT = Cognitive-behavioural group therapy, DASS-21 = Depression, Anxiety Stress Scale, Short Form; ERP = 
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Exposure and response prevention, IES = Impact of Events Scale; OCD = obsessive-compulsive disorder, PCL = Post-traumatic Stress Disorder 
(PTSD) Checklist; PSWQ = Penn State Worry Questionnaire; PTSD = post-traumatic stress disorder, RCT = randomised controlled trial; SIAS = 
Social Interaction Anxiety Scale; TAU = treatment as usual; WASPA = Westergaard Assessment Scale for Panic Attacks; Y-BOCS = Yale-Brown 
Obsessive Compulsive Scale; * = not reported/not-applicable. 
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1.7.3.5 Case study and small N methodology designs 
Callcott et al. (2004) describe two patients with psychosis and PTSD who were 
treated with CBT.  On the Impact of Events scale (IES; Horowitz, Wilner & Alvarez, 
1979) scores for one patient reduced from 41 to 10, moving from the ‘high’ (>19) to 
‘medium’ (8.6-19) range (Horowitz, 1982).  This patient also experienced a reduction in 
negative symptoms.  Unfortunately data for the other patient were not reported.  
Dudley et al. (2005) describe a 38 year-old man with schizophrenia and dog 
phobia who received 38 sessions of CBT with systematic desensitisation.  
Improvements were observed on the Mobility Inventory for Agoraphobia (Chambless, 
Caputo, Jasin, Gracely & Williams, 1985) after treatment and at six-month follow-up.  
Improvements were also observed on the Psychotic Symptoms Rating Scales 
(PSYRATS; Haddock, McCarron, Tarrier & Faragher, 1999).  However, indirect 
treatment for psychosis was provided making it difficult to observe the true effect. 
Ekers et al. (2004) treated a 31 year-old man with schizophrenia and OCD with 
20 hours of Exposure and Response Prevention (ERP).  A reduction in OCD was 
observed using a self-report version of the Yale-Brown Obsessive Compulsive Scale 
(Y-BOCS; Steketee, Frost & Bogart, 1996), with scores reducing from 31 pre-treatment 
to 16 at discharge and 9 at six-month follow-up.  Based on a cut-off score of 16, 
(Steketee et al., 1996) the client achieved clinical change.  Although the authors claim 
that psychotic symptoms remained stable, this was based on clinical judgment only. 
Good (2002) discusses a man with schizophrenia and social phobia who was 
treated with 24 weeks of CBT.  The Modified Fear Questionnaire (Marks & Mathews, 
1979) was used to demonstrate a reduction in social anxiety and the Krawiecka-
Goldberg-Vaughan (KGV) scale (Krawiecka, Goldberg & Vaughan, 1977) was used to 
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demonstrate a reduction in psychosis.  From this it is suggested that anxiety can increase 
psychotic symptoms. 
Gruber et al. (2006) describe a man with psychosis and panic disorder with 
agoraphobia who was treated with 19 sessions of CBT.  The Beck Anxiety Inventory 
(BAI; Beck & Steer, 1990) demonstrated a reduction in scores from 40 at baseline to 17 
post-treatment and 10 at three-month follow-up.  Based on a suggested cut-off score of 
14 (Eack, Singer & Greeno, 2008), clinically significant change was observed.   
Hagen et al. (2014) used 9 hour-long sessions of manualised CBT (including 
ERP) with a man who had schizophrenia and OCD.  Reductions in OCD symptoms 
were observed using the self-report version of the Y-BOCS (Steketee et al., 1996) and 
the Obsessive Compulsive Inventory-Revised (OCI-R; Huppert et al., 2007).  Scores on 
the Y-BOCS reduced from 24 at pre-treatment to five at six-month follow-up.  Based on 
the suggested cut-off score of 16 (Steketee et al., 1996), the client achieved clinically 
significant change.  On the OCI-R, scores reduced from 38 to 10, which is below the 
recommended clinical cut-off score of 21 (Foa et al., 2002).   
Hofmann et al. (2000) conducted 15-17 sessions of CBT with four patients with 
schizophrenia and panic disorder.  Diagnostic assessments and severity ratings showed 
improvements in panic symptoms in all four patients.  Reductions were also observed in 
ratings related to the intensity of paranoia and delusions, leading the authors to conclude 
that treating panic may also improve symptoms of psychosis. 
Kevan et al. (2007) used single N methodology to investigate trauma elaboration 
and cognitive restructuring in a 31 year-old female with schizophrenia and PTSD.   A 
battery of measures demonstrated a reduction in PTSD from pre-treatment to discharge.  
However, the patient was diagnosed with schizophrenia two years before the study and 
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no symptoms were observed at assessment.  The findings may therefore not be 
applicable to those with active psychosis.     
Kobori et al. (2008) used CBT to treat OCD in a 26 year-old man with 
schizophrenia.  The Y-BOCS was used to demonstrate symptom improvement over the 
course of treatment, with scores reducing from 31 to 18.  Unfortunately the client did 
not achieve clinical change (<16; Steketee et al., 1996).  However, a follow-up 
assessment after two years indicated no relapse.  Despite reporting that there was no 
deterioration in psychosis over time, this was not explicitly measured.  
Marcello et al. (2009) describe a man with schizoaffective disorder and PTSD 
who was treated with 16 one-hour sessions of cognitive restructuring.  A clinically 
significant reduction in PTSD was observed using the stressor specific version of the 
PTSD Checklist (PCL; Weathers, Litz, Herman, Huska & Keane, 1993), with scores 
reducing from 57 in the first session to 30 at session 16 (whereby scores greater than 45 
indicate ‘severe’ PTSD; Blanchard, Jones-Alexander, Buckley, & Forneris, 1996).  
However, the patient experienced ‘cognitive deficits’ and modifications were made to 
the treatment protocol.  This means that the findings may not be applicable to those 
without cognitive impairments. 
Nakamura et al. (2006) describe a 14 year-old with schizophrenia with a specific 
phobia of water.  Over 22 weeks of CBT reductions were observed in parent and patient 
fear ratings.  Strengths of this study include the use of a multiple baseline design and 
parent and patient blinding.  However, due to age-related modifications to treatment it is 
possible that the results are not applicable to adults with psychosis. 
Tully and Edwards (2009) present a 45 year-old man with paranoid 
schizophrenia and social anxiety.  Following 11 sessions of CBT the man no longer met 
diagnostic criteria for social anxiety.  However, no improvement was observed on the 
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Social Phobia Rating Scale (SPRS; Wells, 1997).  Although the authors make reference 
to the potential association between psychosis and social anxiety no measure of 
psychotic symptoms was used.  
1.7.3.6 Summary of case study and small N methodology designs 
The case studies and small N methodology designs have allowed various 
treatment protocols to be investigated in detail and clinically significant effects have 
been found.  However, weaknesses were identified, including a lack of extended 
baselines (e.g. Gruber et al., 2006; Kobori et al., 2008), no follow-up assessments (e.g. 
Callcott et al., 2004; Ekers et al., 2004; Nakamura et al., 2006) and no assessor blinding 
(e.g. Hofmann et al., 2000).  In some studies (Gruber et al., 2006; Hagen et al., 2014) 
treatment was delivered intensively or protocols were modified with little explanation of 
the approach used (e.g. Hofmann et al., 2000; Marcello et al., 2009).  Although some 
studies claimed that CBT for anxiety could also improve symptoms of psychosis (e.g. 
Ekers et al., 2004; Kobori et al., 2008; Tully & Edwards, 2009), measures of psychosis 
were not used.  
1.7.3.7 Open trials 
 Arlow et al. (1997) conducted an open trial of group CBT with eight patients 
with schizophrenia or schizoaffective disorder and panic disorder.  Paired t-tests 
indicated that scores on the Westergaard Assessment Scale for Panic Attacks (WASPA; 
Westergaard, Block & DuBoff, 1994) improved over treatment (t=2.47, p=0.043).  
Based on this the calculated Cohen’s d effect size for the baseline and post-treatment 
mean scores is 0.68.  However, the sample included seven Caucasians, six of whom 
were men.  This may mean that the findings do not generalise to the larger population.  
Frueh et al. (2009) conducted an open trial of exposure-based CBT with 20 
adults with schizophrenia or schizoaffective disorder and PTSD.  Following 22 sessions 
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participants demonstrated significant symptom improvement on the Clinician-
Administered PTSD Scale (CAPS); Blake et al., 1990) and the PCL.  Cohen’s d effect 
size for pre to post-treatment is 0.54 for both the CAPS and the PCL.  From pre-
treatment to three month follow-up, Cohen’s d effect sizes are 0.84 for the CAPS and 
0.78 for the PCL.  A manualised treatment package was used and treatment fidelity was 
measured by taping and rating sessions.  The authors note that PTSD can perpetuate 
psychosis.  However, psychotic symptoms were not measured.   
Gega et al. (2013) report on the use of 12 weeks of CBT for six clients with 
psychosis and social phobia.  Significant reductions in social anxiety and paranoia were 
observed at 24-week follow-up, as measured by the Social Interaction Anxiety Scale 
(SIAS; Mattick & Clarke, 1998) and the Green et al. Paranoid Thought Scales (GPTS; 
Green et al., 2008).  Effect sizes for improvement on the SIAS are as follows; pre-post 
treatment (d=0.73), post-treatment to follow-up (d=1.02) and pre-treatment to follow-up 
(d=0.87).  Significant improvements were not found post-treatment (at 12-week 
assessment).  This suggests that other factors (e.g. spontaneous recovery, delayed 
benefit) might have been involved in the participants’ improvement at follow-up.  
Trappler and Newville (2007) used 12 weeks of group-based CBT with 24 
patients with schizophrenia or schizoaffective disorder and PTSD.  Progress was 
compared to an age-matched group provided with supportive group therapy.  Wilcoxon-
signed rank tests were used to demonstrate improvements on the IES in the CBT group 
(z=-3.47, p=0.001) but not the supportive therapy group (z=-0.008, p=NS).  
Improvements were also observed on the Brief Psychiatric Rating Scale (BPRS; Overall 
& Gorham, 1988) for the CBT group (z=-4.20, p<0.001) but not the supportive therapy 
group (z=-0.01, p=NS).  Effect sizes for the IES were as follows; CBT (r=0.71) and 
supportive group therapy (r=0.02).  Unfortunately a follow-up period was not used. 
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Tundo et al. (2014) provided CBT for OCD in 21 patients with schizophrenia 
and schizoaffective disorder.  The Y-BOCS was used to demonstrate significant 
improvements in OCD at six months (p<0.001) and 12 months (p=0.017).  Cohen’s d 
effect size for the total Y-BOCS score was 0.80 (A. Tundo, personal communication, 
January 12, 2015).  However, the CBT was adapted and treatment frequency, 
medication and follow-up visits varied between patients.  This makes replication in 
clinical practice difficult.   
Welfare-Wilson and Newman (2013) report on the use of a 12-week CBT group 
programme for 11 clients with psychosis and anxiety.  The Depression, Anxiety and 
Stress Scale, Short-Form (DASS-21; Lovibond & Lovibond, 2004) was used to 
demonstrate significant improvement in anxiety at three-month follow-up (t(7)=4.285, 
two-tailed p=.005).  The Cohen’s d effect size for the anxiety subscale of the DASS-21 
from baseline to three month follow-up is 1.26.  Unfortunately the authors did not 
specify the type of anxiety experienced by the participants making it difficult to 
ascertain whether the intervention was beneficial for those with specific disorders or 
anxiety generally.  
1.7.3.8 Summary of open trials 
Despite some positive findings most of the open trials used limited outcome 
measures (e.g. Arlow et al., 1997; Welfare-Wilson & Newman, 2013) or did not use 
assessment blinding (e.g. Frueh et al., 2009; Tundo et al., 2014).  Power analyses were 
not used to calculate sample size resulting in small numbers of participants.  
Furthermore, the lack of randomisation or control groups make it difficult to ascertain 
whether the interventions led to the improvements observed or whether there were other 
factors involved (e.g. spontaneous recovery; Gega et al., 2013).     
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Effect sizes for the open trials range from 0.54 to 1.26 (‘medium’ to ‘large’).  
Although most studies provide effect sizes comparable to those found for CBT for 
anxiety in people without psychosis, some do not.  Specifically, CBT for OCD in people 
with psychosis (Tundo et al., 2014) demonstrated a ‘medium’ effect (0.80), whereas a 
study for people without psychosis found a ‘large’ effect (1.26; Eddy et al., 2004).  
Although one study investigating CBT for PTSD in people with psychosis found a 
‘large’ pre-treatment to three-month follow-up effect size of 0.84 (Freuh et al., 2009), a 
study with people without psychosis found a greater pre-post effect size of 1.65 
(Bradley et al., 2005).  This might highlight the complexity of providing effective 
treatment for these conditions in people with psychosis. 
1.7.3.9 Randomised controlled trials (RCTs) 
Foster et al. (2010) used an RCT to investigate CBT for worry in 24 participants 
with persecutory delusions.  The participants were allocated to a four session 
intervention or treatment as usual (TAU).  Compared to TAU a significant reduction in 
worry was observed in the CBT group using the Penn State Worry Questionnaire 
(PSWQ; Meyer, Miller, Metzger & Borkovec, 1990).  This was maintained at two 
month follow-up.  A significant reduction in delusional distress was also observed using 
the PSYRATS.  Based on data provided for the PSWQ, Cohen’s d effect size is 0.56 
post-treatment and 0.74 at two month follow-up. 
Strengths of this study include the use of a randomisation procedure and a power 
analysis to calculate the sample size.  However, the final sample was small and four 
participants were not included in the follow-up analysis.  It is therefore difficult to 
generalise the findings to a larger population.  Baseline levels of worry were higher in 
the CBT group than the TAU group and assessor blinding and measures of treatment 
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fidelity were not used (Foster et al., 2010).  This makes it difficult to observe the true 
effect of the intervention. 
Freeman et al. (2015) conducted a RCT investigating a six session CBT 
intervention for worry in 150 participants with persecutory delusions.  The participants 
were assigned to a CBT group or to standard care, which included regular input from a 
psychiatrist and a mental health worker.  The PSWQ was used to demonstrate a 
significant reduction in worry in the CBT group compared to standard care.  A 
significant reduction was also found in persecutory delusions using the PSYRATS.  
These findings were maintained at 24 week follow-up.  Based on the group difference, 
the authors report a Cohen’s d effect size of 0.47 for the PSWQ.    
The study has a number of strengths including the use of power analysis, 
measurement of treatment fidelity and intention-to-treat analysis.  However, the 
treatment was delivered by three therapists, meaning therapeutic style is likely to have 
varied between participants.  This makes it difficult to generalise the findings to the 
wider population.  In turn, the authors note the absence of a control condition 
investigating therapist contact.  Finally, despite being a single-blind study the assessors 
were ‘unmasked’ in six assessments.     
Halperin et al. (2000) conducted a pilot RCT of group CBT in 16 patients with 
schizophrenia and social anxiety.  Treatment was provided over eight weeks and the 
Brief Social Phobia Scale (BSPS; Davidson et al., 1997) and the SIAS were used to 
demonstrate improvement in social anxiety at post-treatment and six week follow-up.   
Although the randomised nature of this trial is a strength, Halperin et al. (2000) 
do not describe the randomisation procedure or blinding.  The Brief Symptom Inventory 
(BSI; Derogatis & Melisaratos, 1983) was used to measure psychosis and although 
score reduction was observed, the authors note that this did not measure psychosis fully.  
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No power or intention-to-treat analyses were reported meaning that the results may not 
be applicable to a larger population.  Cohen’s d effect size based on the post-treatment 
data for the treatment and control groups is 0.30 for the SIAS and 0.11 for the BSPS. 
Kingsep et al. (2003) used an RCT consisting of 12 sessions of group CBT with 
33 patients with schizophrenia and social anxiety.  Significant improvements were 
observed using the BSPS, the SIAS and the Brief Fear of Negative Evaluation Scale 
(BFNE; Leary, 1983).  Treatment was manualised, fidelity was measured and 
assessment blinding was used.   A post-treatment mean effect size of 0.64 is quoted for 
all of the social anxiety measures used.  For the SIAS, BSPS and BFNE the effect sizes 
are 0.69, 0.17 and 1.05, respectively.   
This study did not use a power analysis to calculate sample size and as with 
Halperin et al’s (2000) study, the BSI was used to assess psychosis.   Participants 
attended a rehabilitation programme during treatment and follow-up data were 
unavailable for the control group.  This makes it difficult to ascertain the true effect of 
the intervention.   
 1.7.3.10 Summary of RCTs 
 Although the RCTs have value there are a number of limitations.  For those 
investigating CBT for social anxiety (Halperin et al., 2000; Kingsep et al., 2003), power 
analyses were omitted and a generalised measure of psychopathology was used to 
investigate psychotic symptoms.  The sample sizes were generally small (Halperin et 
al., 2000; Kingsep et al., 2003; Foster et al., 2010) and assessor blinding was omitted or 
not fully adhered to (Foster et al., 2010; Freeman et al., 2015; Halperin et al., 2000).  
There were also issues with treatment, including treatment being offered in addition to 
CBT (Kingsep et al., 2003) and the omission of intention-to-treat analysis (Foster et al., 
2010; Halperin et al., 2000; Kingsep et al., 2003).  
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 The ‘medium’ effect sizes of 0.56 and 0.74 found by Foster et al. (2010) for 
CBT for ‘worry’ are similar to the ‘medium’ effect size of 0.64 found for GAD (Haby, 
Donnelly, Corry and Vos, 2005).  However, Freeman et al. (2015) only found a ‘small’ 
effect size of 0.47 for CBT for worry.  The ‘medium’ effect size of 0.64 quoted by 
Kingsep et al. (2003) is compared to a ‘large’ follow-up effect size of 0.95 found for 
CBT for social anxiety in people without psychosis (Gil et al., 2001).   However, when 
the BFNE was used a ‘large’ effect size of 1.05 was found (Kingsep et al., 2003).  The 
effect sizes for the two RCTs for social anxiety vary depending on the study and 
measure used, with ‘small’ effect sizes for the BSPS and ‘medium’ effect sizes for the 
SIAS.  This highlights the need for adequate measures when investigating the 
effectiveness of CBT for anxiety in people with psychosis.   
 1.7.3.11 Discussion 
All of the studies outlined in this review demonstrated improvement in anxiety 
following treatment.  Based on Cohen’s (1988) criteria, the majority of effect sizes are 
within the ‘medium’ to ‘large’ range, suggesting that CBT is an effective treatment for 
anxiety in people with psychosis.  However, five studies (Freeman et al., 2015; Freuh et 
al., 2009; Halperin et al., 2000; Trappler & Newville, 2007; Tundo et al., 2014) out of 
ten demonstrated smaller effect sizes than those presented for CBT for anxiety in people 
without psychosis.  Although methodological limitations should be taken into account, 
this may highlight the complexity of treating anxiety in people with psychosis.  
1.7.3.11.1 Research quality  
Most studies used reliable and valid measures and in some cases measures of 
treatment fidelity (e.g. Arlow et al., 2007; Freeman et al., 2015; Kingsep et al., 2003) 
and follow-up sessions were used (e.g. Ekers et al., 2004; Foster et al., 2010; Freeman et 
al., 2015; Good, 2002; Gruber et al., 2006; Halperin et al., 2000; Kobori et al., 2008).  
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However, extended baseline periods, follow-up assessments and blinding were often 
omitted and randomisation was not used.  This makes it difficult to observe the effect of 
the intervention accurately.   
The majority of studies investigated the use of CBT for PTSD, social anxiety 
and OCD.  However, variation was found in treatment content and process.  This makes 
it difficult to observe whether CBT is beneficial for one type of anxiety over another.  It 
also makes it difficult to ascertain whether CBT is effective for anxiety in psychosis in 
general or whether different components work with particular anxiety disorders.  
Although most studies provided descriptions of the intervention, some made 
modifications (e.g. Freeman et al., 2015; Hofmann et al., 2000; Marcello et al., 2009; 
Tundo et al., 2014) or provided treatment over short time periods (e.g. Freeman et al., 
2015; Foster et al., 2010; Gruber et al., 2006; Hagen et al., 2014).  This makes 
replication difficult. 
There was also variation in research design across the studies and each of the 
anxiety disorders.  Eighteen studies used a case study, small N methodology or open 
trial design.  Four studies were RCTs and these focused on the treatment of social 
phobia and ‘worry’ only.  It could therefore be argued that the most robust evidence 
supports the use of CBT for these particular types of anxiety.  However, the RCTs had 
clear limitations and the findings should be interpreted with these in mind. 
1.7.3.11.2 Considerations for future research 
The number of studies available for each of the anxiety disorders was sparse.  
Although there are more studies focusing on PTSD, social anxiety and OCD, variation 
in study design and methodology makes it difficult to conclude whether CBT is more 
effective for one type of anxiety over another.  More studies should be conducted, 
including RCTs that consider the limitations identified in this review.   
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In addition to focusing on the limitations identified, and improving the 
methodological rigour of the evidence base, future research should focus on the 
theoretical assumptions regarding anxiety and psychosis.  Studies should ensure that 
they measure psychotic symptoms in addition to anxiety with a focus on symptom 
severity and reliable and valid measures.  This will demonstrate whether CBT is 
effective for anxiety and psychosis or whether it is more effective for anxiety alone.   
1.7.3.11.3 Conclusion  
The systematic review suggests that CBT is an effective intervention for anxiety 
in people with psychosis.  Although differences were found in effect sizes, the majority 
were in the ‘medium’ to ‘large’ range.  Methodological limitations and complexity in 
treating anxiety in people with psychosis may account for differences in effect size 
between the studies reviewed and the literature for the use of CBT for people with 
anxiety who do not have psychosis.  None of the studies included in the review 
examined imagery interventions for anxiety in people with psychosis.  Considering that 
social anxiety is prevalent in psychosis and imagery rescripting is effective for social 
anxiety in people without psychosis, this warrants further investigation. 
1.8 Summary of literature and rationale for study 
 It is clear from the theoretical models presented that anxiety has an important 
role in psychosis (e.g. Garety et al., 2001; Morrison, 2001).  In particular, there is a high 
prevalence of social anxiety in people with psychosis and this can have a significant 
impact on functioning and quality of life.  Models of psychosis and social anxiety 
highlight an association between the two conditions (e.g. stigma, loss of social status; 
Birchwood et al., 2007; fear of others; Newman-Taylor & Stopa, 2013) and suggest that 
they can precipitate and develop alongside one another (Michail & Birchwood, 2009).  
Therefore treating social anxiety in people with psychosis may be beneficial.   
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 Negative imagery and memories have the potential to maintain social anxiety 
and imagery rescripting has been shown to be an effective intervention for people with 
social anxiety that do not have psychosis.  A systematic review of CBT interventions for 
anxiety in psychosis revealed there are currently no studies that have investigated 
whether imagery rescripting is effective for social anxiety in people with psychosis.  
This study will investigate whether an existing imagery rescripting approach (Wild et 
al., 2008; Wild & Clark, 2011) is efficacious for rescripting traumatic memories 
associated with social anxiety in people with psychosis.  This is an important issue as 
treating social anxiety in those with psychosis has the potential to reduce distress, 
increase functioning and ease pressure on the health service.   
Existing research supports the use of cognitive behavioural interventions for 
anxiety in people with psychosis, including social anxiety.  However, there are only a 
small number of studies and these have various methodological issues.  This study will 
contribute to the evidence base by providing initial data on the efficacy and feasibility 
of imagery rescripting for social anxiety in people with psychosis.  It will also highlight 
adaptations that should be considered for future research or clinical practice. 
1.9 Research hypotheses 
1.9.1 Primary hypotheses 
1. There will be a reduction in social anxiety scores following imagery 
rescripting, measured one month after imagery rescripting 
2. There will be a reduction in visual analogue scale ratings related to anxiety 
following imagery rescripting 
3. There will be a reduction in encapsulated belief and memory distress ratings 
related to negative imagery following imagery rescripting 
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4. There will be a reduction in distress, vividness and frequency ratings related 
to negative imagery following imagery rescripting 
1.9.2 Research questions 
1. What is the effect of imagery rescripting on psychotic symptoms and 
paranoia in people with psychosis and social anxiety? 
2. What is the effect of imagery rescripting on depression in people with 
psychosis and social anxiety? 
3. What is the effect of imagery rescripting on social functioning and quality of 
life in people with psychosis and social anxiety?  
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CHAPTER TWO 
2.  Method 
2.1 Overview 
This chapter outlines the design and methodology for the study.  A single case 
series multiple baseline approach was used and this is described together with the 
randomisation procedure.  Participant inclusion and exclusion criteria, the recruitment 
strategy and information about the final sample is presented.  The intervention and a 
treatment fidelity procedure are described, followed by an outline of the measures used 
to investigate the primary hypotheses and research questions.  Ethical issues are 
considered and the study procedure and plan for data analysis are provided.           
2.2 Design 
A small scale feasibility and piloting approach is appropriate for investigations 
of novel interventions (Craig et al., 2013).  This study used a single case series multiple 
baseline design.  Continuous assessment was used to provide a baseline and track 
change before, during and after the introduction of the intervention.  This investigated 
whether the participants’ presentation was stable before the intervention and whether 
any change followed its introduction.  This approach increased internal validity, 
allowing any changes to be attributed to the intervention rather than other factors (e.g. 
natural improvement in symptoms, other events; Kazdin, 2010).   
The use of a multiple baseline approach allowed the feasibility of the 
intervention to be investigated by looking at change within and between participants.  In 
line with guidance for multiple baseline designs (Anderson & Kim, 2003) the 
participants were randomised into blocks of varying length (one, two or three weeks; 
see Fig. 2.1).  The intervention consisted of two sessions, separated by one week.  Each 
participant was asked to complete measures related to social anxiety, psychosis, mood, 
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functioning and quality of life before, during and after the baseline period, before and 
after the intervention sessions and at one week and one month follow-up periods.  This 
allowed individual progress to be monitored over the course of the study and allowed 
any change as a result of introducing the intervention to be observed.   
 
Figure 2.1. Multiple baseline design for the current study 
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Note.  The blue boxes indicate baseline periods, the yellow boxes indicate the intervention sessions, the 
orange boxes indicate the one week break (between intervention sessions) and the green boxes indicate 
follow-ups.    
 
2.3 Randomisation 
Participants were randomly allocated to one of the three blocks using sealed 
envelopes.  The Chief Investigator was not involved in the design of the randomisation 
system and was only given the envelopes once sealed.   
2.4 Participants 
 Participants were recruited from Early Intervention in Psychosis (EIP) and 
Integrated Delivery Team (IDT) services within Norfolk and Suffolk Foundation Trust 
(NSFT).  In line with previous research investigating social anxiety in psychosis (e.g. 
Birchwood et al., 2007; Romm et al., 2012) all participants had experienced at least one 
episode of psychosis. 
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2.4.1 Inclusion criteria 
Participants were included if they had a diagnosis of psychosis (e.g. 
schizophrenia, schizoaffective disorder, delusional disorder).  A measure of social 
anxiety, the Social Interaction Anxiety Scale (SIAS; Mattick & Clark, 1998), was used 
to ensure that participants had clinically significant levels of social phobia, indicated by 
a score of 37 and above (Peters, 2000).  To ensure that those recruited were able to 
provide informed consent, only individuals aged 18 years and over were approached.  In 
line with EIP policy (Mental Health Network NHS Confederation, 2011) the maximum 
age of those included was 35 years.  
2.4.2 Exclusion criteria 
 Those experiencing florid psychosis and those without the capacity to consent to 
take part were not approached.  Individuals were excluded if they were not experiencing 
clinically significant levels of social anxiety (i.e. ≤36 on the SIAS).  Individuals were 
also excluded if they scored above four on any of the positive items on the Positive and 
Negative Syndrome Scale (PANSS: Kay, Fiszbein & Opler, 1987), indicating more than 
‘moderate’ impairment.  Individuals scoring above this are likely to have found it too 
distressing or challenging to take part in the intervention.  Individuals not fluent in 
English and those receiving other psychological interventions were not included to 
ensure that the true effect of the intervention could be investigated.  
2.4.3 Recruitment 
Following ethical approval the Chief Investigator presented the study to EIP and 
IDT teams in NSFT.  Recruitment started in Norwich and was followed by Great 
Yarmouth and Bury St. Edmunds.  The teams were provided with recruitment packs, 
including covering letters, participant information sheets and consent forms (see 
Appendices A-C).  Case managers were asked to identify clients likely to be suitable.  
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They were then asked to provide them with a recruitment pack.  Once a client had 
provided verbal consent to be contacted the Chief Investigator telephoned them to 
arrange an appointment. 
2.4.4 Sample 
As a single case series involves testing an intervention for feasibility it was not 
necessary to conduct a power analysis to calculate sample size.  Wild et al. (2007) used 
14 participants in their study investigating imagery rescripting for social phobia.  Wild 
et al. (2008) used 11 participants.  Based on this, 13 participants were recruited for the 
current study.  This is appropriate for a single case series (Kazdin, 2010).   
Three of the 13 participants did not complete the study.  One participant (one 
week baseline) completed the baseline period and the first session of the intervention 
but withdrew due to becoming unwell.  Another participant (three week baseline) was 
excluded before completing the baseline period due to starting another intervention.  
One participant (two week baseline) completed the baseline period but experienced a 
bereavement before the intervention was introduced.  Although this participant restarted 
the study at a later date some sessions were missed and he was subsequently excluded.   
Further information regarding participant recruitment is included in Figure 2.2.  
Of the five participants who were excluded due to non-eligibility, two individuals did 
not meet the criteria for social anxiety (a score of ≤36 on the SIAS; Peters, 2000) and 
one individual scored above four points on positive scale items on the PANSS.  One 
individual had a learning disability and another did not speak fluent English.  It was 
assumed that these individuals would have found it too difficult to take part.           
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Figure 2.2. Consolidated Standard of Reporting Trials (CONSORT) diagram (Schulze, 
Altman & Moher, 2010) 
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2.5 Measures 
Demographic information was obtained for each of the participants from their 
clinical notes including gender, age, ethnicity and diagnoses.  Details of the measures 
used in the study, including the available psychometric properties, are presented below.  
All non-copyright measures are included in Appendix D.      
2.5.1 Screening measures 
2.5.1.1 Social Anxiety Interaction Scale (SIAS; Mattick & Clarke, 1998) 
The SIAS is a self-report questionnaire that measures anxiety during social 
interaction (i.e. in the presence of other people).  It was used to identify those 
appropriate for inclusion.  The SIAS takes around five minutes to complete.   
The SIAS has 20 items corresponding to a diagnostic description of social 
phobia (American Psychiatric Association [APA], 1987).  Each item is scored on a five-
point Likert scale from ‘Not at all characteristic of me’ to ‘Extremely characteristic of 
me’ (Mattick & Clarke, 1998).  The SIAS has a maximum score of 80 and scores of 37 
points or more are representative of social phobia (sensitivity = 0.93, specificity = 0.60, 
positive predictive value = 0.84, negative predictive value = 0.78; Peters, 2000).  It has 
high internal consistency (social phobia sample, α=0.93) and test-retest reliability 
(α=0.92).  Discriminant validity has been demonstrated by differences between 
participants with social phobia, agoraphobia and simple phobia and clinical and non-
clinical samples.  Construct validity has also been found (Mattick & Clarke, 1998).   
2.5.1.2 Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) 
The PANSS is a semi-structured interview that assesses psychotic symptoms.  
The PANSS was used as a screening tool to ensure that participants were well enough to 
take part.  The PANSS has 30 items divided into three subscales and takes around 45-50 
minutes to complete.  Seven items constitute a positive syndrome scale and seven 
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constitute a negative scale.  Sixteen items are included in a general psychopathology 
scale.  Each item is scored on a 7-point scale, from ‘Absent’ to ‘Extreme’.   
The PANSS has internal consistency with alpha coefficients of 0.73, 0.83 and 
0.79 for the positive, negative and general psychopathology subscales, respectively.  
Test-retest reliability has been found for the positive (r=.80, p<.001), negative (r=.68, 
p<.01) and general psychopathology (r=.60, p<.02) scales.  The PANSS has criterion 
and construct validity (Kay, Opler & Lindenmayer, 1987) and interrater reliability 
(ICC=0.74, 0.69 and 0.64 for the positive, negative and general psychopathology scales, 
respectively; Bell, Milstein, Beam-Goulet, Lysaker & Cicchetti, 1994).    
 2.5.2 Semi-structured interview (Hackmann et al., 1998; Hackmann, et al., 
2000, as cited in Cooke, 2012) 
A semi-structured interview (Hackman et al., 1998; Hackmann et al., 2000, as 
cited in Cooke, 2012) was used to gain information about the images and memories 
participants experienced in relation to social events.  This approach was adopted from 
previous work in the social anxiety field (Wild et al., 2007, Wild et al., 2008).  The 
interview includes 22 questions and takes approximately 30 minutes to complete.  A 
scale of -3 (field perspective) to +3 (observer perspective) is also used to gain 
information about the focus of the memory (Hackman et al., 1998; Hackmann et al., 
2000, as cited in Cooke, 2012).  As with Wild et al. (2007, 2008) participants were 
asked to provide one or two sentences to reflect the meaning of the image and memory 
(the ‘encapsulated belief’). 
2.5.3 Primary outcome measures 
In addition to being used as a screening measure, the SIAS (Mattick & Clarke, 
1998) was used to investigate the hypothesis that there would be a reduction in social 
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anxiety following imagery rescripting, measured one month after imagery rescripting.  
The other primary outcome measures used in the study are described below.       
2.5.3.1  Visual analogue scale for anxiety (VAS-A) 
The VAS-A requires the participant to place a mark on a scale to indicate their 
level of anxiety.  A 100mm scale ranging from zero (‘Not anxious’) to one (‘Anxious’) 
is used, allowing a score to be assigned to the mark provided (e.g. 0.50, 0.75).  The 
VAS-A was used to investigate the hypothesis that there would be a reduction in ratings 
of anxiety following imagery rescripting.  The VAS-A was also used to collect data 
during the baseline period to measure anxiety before the introduction of the 
intervention.  The VAS-A takes approximately 30 seconds to complete.   
2.5.3.2 Idiographic ratings (Wild et al., 2008) 
Wild et al. (2008) asked participants to rate the ‘encapsulated belief’ from zero 
(not at all) to 100 (extremely).  This scale was also used to rate ‘memory distress’ and 
the distress and vividness of the imagery.  Image frequency was rated for the past week.  
The scales were used to investigate the hypotheses that that would be a reduction in 
encapsulated belief, memory and imagery ratings following imagery rescripting.  The 
ideographic ratings take approximately two minutes to complete.   
2.5.4 Secondary outcome measures 
2.5.4.1 Schizotypal Symptoms Inventory (SSI; Hodgekins et al., 2012) 
 The SSI is a self-report questionnaire designed to measure schizotypal 
experiences that might also be classified as subthreshold psychotic experiences.  It is 
more sensitive at detecting these experiences than the PANSS, which focusses on the 
presence of frank psychotic symptoms (Hodgekins et al., 2012).  It was therefore 
deemed a more appropriate measure to use to investigate the effect of the imagery 
rescripting on psychotic symptoms.    
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 The SSI consists of 20 items divided into three subscales; social anxiety (six 
items), paranoia (six items) and anomalous experiences (eight items).  It measures 
symptom frequency over two weeks and items are scored on a five-point Likert scale 
from ‘Not at all’ to ‘All of the time’.  There is a maximum score of 80 and higher scores 
indicate more symptoms.  It takes approximately five minutes to complete.   
High internal consistency has been found for the total scale (α=0.92) and for the 
social anxiety (α=0.89), paranoia (α=0.90) and anomalous experiences (α=0.83) 
subscales.  Test-retest reliability has been demonstrated for the total scale (ICC = 0.85, 
p<.001) and individual subscales (0.60-0.84, p<.001).  Correlations with PANSS 
positive symptom scores has been found on the total (r=0.59, p<.001), social anxiety 
(r=0.35, p<.001), paranoia (r=0.55, p<.001) and anomalous experiences (r=0.60, 
p<.001) scales (Hodgekins et al., 2012).   
2.5.4.2  Visual analogue scale for paranoia (VAS-P) 
The VAS-P is a self-report scale 100mm in length ranging from zero (‘Not 
paranoid’) to one (‘Paranoid’), allowing a score to be assigned to the mark provided 
(e.g. 0.50, 0.75).  The VAS-P was used to investigate whether the imagery rescripting 
had an effect on paranoia.  The VAS-P was also used to collect data during the baseline 
period to measure paranoia before the intervention.  The VAS-P takes approximately 30 
seconds to complete.   
2.5.4.3 Depression subscale of the Depression Anxiety and Stress Scale – Short 
Form (DASS-21; DASS-D; Lovibond & Lovibond, 1995) 
The DASS-21 is a self-report questionnaire that measures depression, anxiety 
and stress over a one week period.  The DASS-D was used in the current study to 
examine the effect of the imagery rescripting on mood.  The DASS-D takes 
approximately two minutes to complete.   
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The DASS-D consists of seven items.  Each item is scored on a four-point Likert 
scale from ‘Did not apply to me at all’ to ‘Applied to me very much, or most of the 
time’ (Osman et al., 2012).  It has a maximum score of 21 and higher scores indicate 
more symptoms.  The DASS-D has high internal consistency (α=0.94).  In addition, it 
has good concurrent validity (Antony, Bieling, Cox, Enns & Swinson, 1998) and 
convergent and discriminant validity (Henry & Crawford, 2005). 
2.5.4.4 Time Use Survey (TUS; Hodgekins et al., 2015; Short, 2006) 
The TUS is a clinician administered semi-structured interview that measures 
functioning.  It was designed by the Office for National Statistics (Short, 2006) for 
measuring how people spend their time.  However, it has been used with people with 
psychosis (Fowler et al., 2009; Hodgekins et al., 2015) and was therefore deemed 
appropriate to examine the effects of the intervention on social functioning.   
The TUS obtains information related to time spent in employment, education 
and training, voluntary work, leisure activities, sports activities and hobbies, socialising, 
childcare and housework and chores over one month.  It takes approximately 20-30 
minutes to complete.  ‘Structured Activity’ is calculated based on the number of hours 
per week over the month spent on each domain (Fowler et al., 2009).  A higher 
frequency of hours spent in activity on the TUS indicates a higher level of functioning. 
From a study comparing time use in people with psychosis and a non-clinical 
group, Hodgekins et al. (2015) suggest that less than 45 hours of structured activity per 
week is in the clinical range, less than 30 hours per week is in the social disability range 
and less than 15 hours per week is in the severe social disability range.  These cut-off 
scores will be adopted in the current study to assess social functioning. 
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2.5.4.5 EuroQOL-5 Dimensions-5 Levels Visual Analogue Scale (EQ-5D-5L 
VAS; Herdman et al., 2011)  
 The EQ-5D-5L VAS is a self-report visual analogue scale that measures health 
status.  It is also regarded as an index for quality of life.  Respondents rate their current 
health status on a 20-cm vertical visual analogue scale from 0 (worst imaginable health 
state) to 100 (best imaginable health state; van Hout et al., 2012).  It was used in the 
current study to examine the impact of the intervention on quality of life.  The EQ-5D-
5L VAS takes approximately 30 seconds to complete. 
2.6 Intervention 
 The intervention used by Wild et al. (2008) was replicated in the current study.  
It consisted of two sessions with a one week break in-between.   
2.6.1 Control session 
 The control session was designed to examine whether it is the imagery 
rescripting procedure (provided in the second intervention session) which leads to 
therapeutic change rather than just discussing the image and the memory (Wild et al., 
2008).  The control session lasted for 90 minutes and the aim was to listen to the 
participant and empathise and reflect on the image and memory elicited by the semi-
structured interview (Hackmann et al., 1998, Hackmann et al., 2000).  No attempt was 
made to change the memory at this stage (Wild et al., 2008).   
2.6.2 Imagery rescripting session 
 The aim of the imagery rescripting session was to update the memory and place 
it in context.  This session included 45 minutes of cognitive restructuring followed by 
30-45 minutes of imagery rescripting.  The cognitive restructuring involved challenging 
the meaning of the memory and how it related to the participant’s current beliefs and 
experiences (e.g. alternative ways of thinking about the event, examples that 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
58 
 
counteracted the memory; Wild et al., 2008).  This was used in the imagery rescripting 
section (Wild et al., 2008).  Wild & Clark (2011) describe an imagery rescripting 
procedure and this was used to create a script for the current study (see Appendix E).   
2.6.3 Treatment fidelity 
  In 2004 the Behavior Change Consortium published guidelines for ensuring 
treatment fidelity in intervention studies (Bellg et al., 2004).  In addition to using a 
script to deliver the imagery rescripting a rating scale was devised to monitor content 
(See Appendix F).  A Clinical Psychologist provided training on how to use imagery 
rescripting and regular supervision was held to reduce ‘drift’.  With participant consent, 
sessions were audio recorded and rated by a Clinical Psychologist to measure adherence 
to the script.  The control sessions were also recorded to ensure that no attempts were 
made to update the memory before the imagery rescripting session.   
2.7 Ethical considerations 
2.7.1 Ethical approval and guidance 
Ethical approval was granted by London-Brent Research Ethics Committee and 
Research and Development (R&D) at NSFT (see Appendix G).  British Psychological 
Society (2010) guidelines for research conduct were followed at all times.   
2.7.2 Informed consent 
Potential participants were provided with a recruitment pack by a member of 
their clinical team.  The Participant Information Sheet outlined the study rationale and a 
discussion of confidentiality and risk issues.  It also informed potential participants of 
their right to withdraw from the study at any point.  Individuals were not approached by 
the research team until they had provided verbal consent for this to occur.  
All participants were required to provide informed consent before entering the 
study.  Potential participants were encouraged to discuss the study with their case 
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manager, family members or friends before making a decision.  They were given at least 
48 hours to read the information sheet and consent form and consider whether they 
wanted to take part.    
Before providing consent potential participants were informed that they would 
not be able to take part if they did not meet the study criteria.  If an individual was not 
eligible they were provided with an explanation and given the opportunity to ask 
questions.  Their case manager was also informed.  If suitable, participants were asked 
to provide consent for a letter to be written to their General Practitioner (GP; See 
Appendix H) outlining their involvement in the study. 
2.7.3 Data storage and confidentiality 
The Data Protection Act (Gov.uk, 2015) was followed, ensuring that data were 
used fairly and stored securely.  Data anonymisation was ensured through the use of 
coding by allocating a number to completed measures instead of participants’ names.  
Copies of signed consent forms were stored separately to the anonymised measures.  
Raw data were stored in locked filing cabinets at the relevant service for the duration of 
the study.  Following study completion, raw data were stored at the University of East 
Anglia (UEA) in a locked filing cabinet.  The data will be held at the UEA for 10 years 
following study completion, after which it will be destroyed. 
An encrypted memory stick was used to transfer electronic data between 
computers.  Data were only stored on NHS and university computers and these were 
protected with passcodes.  A Dictaphone was used to record the intervention sessions 
(to assess treatment fidelity).  Participant details were not included in the recordings and 
following the session they were uploaded to an NHS computer and erased from the 
device.  Participant addresses and telephone numbers were stored on a mobile phone 
which was protected with a passcode.  Following participation these data were erased.  
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
60 
 
Although participants were offered confidentiality the limits of this were outlined (i.e. if 
they disclosed any information that suggested they or others are were at risk).   
2.7.4 Risks and benefits of participation 
It was considered that the participants might experience distress when talking 
about negative images and memories.  It was also considered that some participants 
might experience paranoia and fear of scrutiny from the Chief Investigator.  Participants 
were informed about the potential for these issues before providing consent.  They were 
also offered the opportunity to terminate sessions or withdraw from the study at any 
point.  A debrief was provided at the end of each intervention session and at the end of 
the study and the participants were offered the opportunity to discuss any concerns.  No 
significant ethical issues arose during the course of the study.  
In an attempt to reduce burden participants were offered the opportunity to 
divide the intervention sessions or take regular breaks.  Where possible, participants 
were seen at the service they were in contact with.  When participants asked to be seen 
at their home address the service and university lone worker policies were followed.  
Following each appointment or contact with a participant an entry was made in the 
clinical notes and a research log.   
The participants were informed that completion of the study might have led to 
improvements in social anxiety, psychosis, mood, functioning and quality of life, but 
this could not be guaranteed.  They were offered a £15 shopping voucher for taking 
part.  This was given to them on completion of the study.   
2.8 Procedure 
The measures administered at each stage of the study process are outlined in 
Table 2.1.  Once a participant had provided verbal consent to be contacted, the Chief 
Investigator contacted them by telephone to discuss the study.  An appointment was 
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made to meet the potential participant, complete the consent form and administer the 
SIAS and the PANSS (Time point 1).   
 
Table 2.1 
Time points and approximate completion time for measures  
 
 
 
 
 
 
 
 
 
 
 
 Time point 
Measure 1 2 3 4 5 6 7 8 9 
SIAS 
PANSS 
SSInt 
VAS-A 
Ratings 
SSInv 
VAS-P 
DASS-D 
TUS 
EQ-5D-5L 
VAS 
X 
X 
 
 
 
 
 
 
 
X 
 
X 
X 
X 
X 
 
 
 
 
 
X 
X 
 
 
X 
 
X 
X 
X 
X 
 
 
 
 
 
X 
 
 
X 
X 
X 
 
X 
 
 
 
 
 
 
X 
X 
 
X 
 
 
 
X 
X 
 
X 
 
 
 
X 
X 
 
X 
X 
 
 
X 
X 
X 
X 
X 
X 
 
 
 
 
X 
X 
 
 
X 
X 
X 
X 
X 
X 
 
 
 
 
X 
Approx. 
time taken 
to 
complete 
measures  
55 
mins 
40 
mins 
45 
mins 
35 
mins 
5  
mins 
5 
mins 
5  
mins 
 
 
 
 
 
 
 
45 
mins 
 
 
 
 
 
 
 
45 
mins 
 
 
 
 
Note. Time points: 1 = Screening; 2 = Baseline; 3 = End of baseline; 4 = Before control session; 5 = After 
control session; 6 = Before imagery rescripting session; 7= After imagery rescripting session; 8 = One 
week follow-up; 9 = One month follow-up.  Abbreviations: SIAS = Social Interaction Anxiety Scale; 
PANSS = Positive and Negative Syndrome Scale; SSInt = Semi-structured interview; VAS-A = Visual 
analogue scale for anxiety; Ratings = Ideographic ratings; SSInv = Schizotypal Symptoms Inventory; 
VAS-P = Visual analogue scale for paranoia; DASS-D = Depression subscale of the Depression Anxiety 
and Stress Scale, Short Form (DASS-21); TUS = Time Use Survey; EQ-5D-5L VAS = EuroQOL-5-
Dimensions-5-Levels Visual Analogue Scale.  
 
If the participant was eligible and consented to participate an envelope was 
chosen to randomly allocate them to one of the three blocks.  The participant was 
informed of the block that they had been allocated to and an appointment was arranged 
to complete the baseline measures (Time point 2).  During the baseline period the 
participants were asked to complete the VAS-A and the VAS-P on a daily basis.  
Participants in the two-week and three-week baseline conditions were also asked to 
complete the DASS-D and the EQ-5D-5L VAS on a weekly basis.  
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Following the appropriate baseline period an appointment was arranged to 
complete the end of baseline measures (Time point 3).  The participant was then invited 
to attend the control session.  At the beginning of this session participants were asked to 
complete the semi-structured interview, the VAS-A, the ideographic ratings and the 
VAS-P (Time point 4).  Following the session they were asked to complete the VAS-A, 
the ideographic ratings and the VAS-P (Time point 5).   
The imagery rescripting session was held one week after the control session.  In 
addition to the 75-90 minutes allocated for the intervention, time was provided for 
participants to discuss any concerns that they had following the imagery rescripting.  
Before and after the imagery rescripting session participants were asked to complete the 
VAS-A, the ideographic ratings and the VAS-P (Time points 6 and 7).  Within one 
week of the imagery rescripting session an appointment was made to complete the 
measures again (Time point 8).  A final set of measures was administered one month 
after the imagery rescripting session (Time point 9).   
At the final appointment participants were debriefed and given the £15 voucher.  
Throughout the study participants were asked to attend seven sessions lasting 
approximately eight hours in total.  The study process is outlined in Figure 2.3.      
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Figure 2.3. Flowchart describing study process 
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2.9 Data preparation and analysis 
2.9.1 Data entry 
Data were entered into Microsoft Excel and line graphs were created for each 
measure for each participant.  For exploratory statistical analyses the Statistical Package 
for the Social Sciences (SPSS) for Windows (Version 22) was used.   
2.9.2 Missing data 
As suggested by Arnold and Kronmal (2002), values for missing data were 
computed using the average score from the data obtained for a measure.  Only five 
pieces of visual analogue scale data were missing for the study.   
2.9.3 Individual analyses 
2.9.3.1 Data presentation  
For the SIAS, SSI, DASS-D, TUS and the EQ-5D-5L VAS the graphs were 
divided into three phases.  For the VAS-A, the ideographic ratings and the VAS-P the 
graphs were divided into six phases.  See Tables 2.2 and 2.3 for more information.   
 
Table 2.2   
Description of the phases for the SIAS, SSI, DASS-D, TUS and EQ-5D-5L VAS 
 
Phase 
 
Time points 
 
Baseline 
 
Baseline to end of baseline scores 
Cont/ImRs End of baseline to one week follow-up scores 
Follow-up One week to one month follow-up scores  
 
Note. Cont/ImRs = Control/imagery rescripting.   
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Table 2.3   
Description of the phases for the VAS-A, ideographic ratings and VAS-P 
 
Phase 
 
Time points 
 
Baseline 
 
Baseline to pre-control session scores 
Control session Pre to post-control session scores 
Break Post-control to pre-imagery rescripting scores 
Imagery rescripting Pre to post-imagery rescripting scores 
One week follow-up Post-imagery rescripting to one week follow-up scores 
One month follow-up One week to one month follow-up scores 
 
 
 
 
 
Note. For the ideographic ratings baseline data were not available and are not included in analysis. 
 
2.9.3.2 Visual inspection of data  
Kazdin (2010) suggests using visual inspection of graphs to investigate the 
effect of an intervention at different time points.  If a change in data is observed 
following the intervention then it can be attributed to this.  Kazdin’s (2010) criteria for 
visual inspection relevant to the current study are outlined in Table 2.4.  
 
Table 2.4 
Kazdin’s (2010) criteria for visual inspection of case-series data  
 
Criterion 
 
Meaning 
 
Changes in mean 
 
Change in the mean score between different phases.  
Investigates whether means increase or decrease over phases. 
Change in level Change in shift from one phase to another.  Investigates 
whether data shift up or down quickly from the end of one 
phase to the start of another.  
Change in trend 
 
 
Change in direction as a new phase is introduced.  Investigates 
whether data show systematic increases or decreases over 
different phases. 
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In the current study change in level was quantified using the increase or decrease 
in scores from the preceding data point (e.g. a shift up of +2 points or shift down of -2 
points).  Change in trend was categorised as an ‘increase’, ‘decrease’ or ‘no trend’ in the 
slope of the line.  Visual inspection is presented individually for each participant.  See 
Appendix I for detailed visual inspection of the data for the research questions. 
2.9.3.3 Kendall’s tau   
Kendall’s tau (1970) was used to investigate whether the data obtained over the 
baseline period were stable.  A significant trend suggested data instability.  Kendall’s 
tau was calculated for the VAS-A and the VAS-P for all participants and for the DASS-
D and EQ-5D-5L VAS for participants in the two and three week baseline conditions. 
2.9.3.4 Reliable change 
Reliable change is achieved when a change in score is larger than the likely 
variation posed by a measure (Evans, Margison & Barkham, 1998).  Reliable change of 
greater or less than 1.96 (p<.05) is unlikely without real change (Jacobson and Truax, 
1991).  The Reliable Change Index (RCI) was calculated using the standard error of the 
difference between measures taken before and after an intervention (whereby SD1 = 
standard deviation of matched sample; r = test-retest reliability of the measure): 
  
1.96*SD1*√2*√(1-r) 
 
 Reliable change values are displayed for the SIAS (using data from Mattick & 
Clarke, 1998) and SSI (using data from Hodgekins et al., 2012) in Table 2.5.  Reliable 
change over the baseline period was calculated from the first baseline score.  Reliable 
change for the rest of the study phases was calculated from the mean baseline score.  
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Test-retest data for the VAS-A, ideographic ratings, VAS-P, DASS-D, TUS and EQ-
5D-5L VAS were not available and reliable change could not be calculated.   
 
Table 2.5 
Reliable change data for the SIAS and the SSI 
 
Measure 
 
Matched 
sample mean 
 
Matched 
sample SD 
 
Test-retest 
reliability 
 
Reliable 
change value 
 
SIAS 
 
34.6 
 
16.4 
 
.92 
 
13 
 
SSI 
 
18.67 
 
15.70 
 
.85 
 
17 
Note. SD = standard deviation; reliable change value is rounded to the nearest whole number. 
 
2.9.3.5 Clinical change 
To achieve clinically significant change an individual is required to move from 
the dysfunctional range to the functional range (Jacobson, Follette & Revenstorf, 1984).  
Jacobson & Truax (1991) suggest a number of criteria for calculating clinical change.  
Where normative data are available and the distributions overlap they suggest the use of 
criterion c.  This investigates whether performance following the intervention is closer 
to the mean of a functional rather than a dysfunctional population.  The formula 
provided for calculating this is shown below (Evans et al., 1998): 
 
(meanclin) x (SDnorm) + (meannorm x SDclin) / SDnorm + SDclin 
 
This formula was used to calculate clinical change values for the SSI (using data 
from Hodgekins et al., 2012) and the DASS-D (using data from Antony et al., 1998) and 
these are displayed in Table 2.6.  Pre-existing cut-off scores were used to assess clinical 
change for the SIAS (≤36; Peters, 2000) and the TUS (≥45 hours = non-clinical range; 
≤30 hours = social disability; ≤15 hours = severe social disability; Hodgekins et al., 
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2015).  Clinical change was evaluated at the end of baseline and one week and one 
month follow-up.  Normative data were not available for the VAS-A, ideographic 
ratings, VAS-P and EQ-5D-5L VAS and clinical change could not be calculated.   
 
Table 2.6 
Clinical change data for the SSI and the DASS-D 
 
  
 
Measure 
 
 
Data 
 
 
SSI 
 
 
DASS-D 
 
Clinical sample mean 
 
18.67 
 
13.19 
Clinical sample SD 15.70 9.28 
Normative sample mean 9.54 2.12 
Normative sample SD 9.22 3.64 
 
 
 
Clinically significant change value 
 
 
 
16 
 
 
 
5 
 
 
Note. SSI = Schizotypal Symptoms Inventory; DASS-D = Depression subscale of the Depression Anxiety 
Stress Scale – Short Form (DASS-21); SD = standard deviation; clinically significant change value is 
rounded to the nearest whole number. 
 
Wise (2004) suggests using reliable and clinical change to categorise individuals 
following intervention.  Those who achieve reliable and clinical change have 
‘recovered’. Those who achieve reliable change have ‘improved’.  Those who do not 
achieve either are ‘unchanged’ and those who achieve reliable change in the negative 
direction have ‘deteriorated’.  This was used for SIAS scores at one month follow-up.   
2.9.4 Group analyses 
Kazdin (2010) notes that statistical analyses can be used in addition to visual 
inspection and this was adopted in the current study.  Due to the small sample size any 
statistical analyses were strictly exploratory and this should be considered.     
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2.9.4.1 Statistical analyses 
Friedman’s ANOVA was used on an exploratory basis to investigate change 
over time for each of the measures (further information is included in the results chapter 
under the relevant hypotheses).  Following Wild et al. (2008), difference scores between 
the control and imagery rescripting sessions were compared for the VAS-A, the 
ideographic ratings and the VAS-P.  Wilcoxon tests were used to investigate whether 
the imagery rescripting session achieved significant change in scores compared to any 
change observed in the control session.  
2.9.4.2 Effect size 
Morris and DeShon (2002, as cited in Lakens, 2013) report an appropriate effect 
size calculation for repeated measures designs.  This was used in the current study and 
is presented below (whereby Cohen’s drm = Cohen’s d repeated measures, Mdiff = Mean 
difference, SDdiff = SD of difference scores, r = correlation between measures):   
  
Cohen’s drm= Mdiff / Sdiff x √ 2(1-r) 
 
Whereby Sdiff  = √ SD12 + SD22 – 2 x r x SD1 x SD2 
 
 Effect sizes were calculated for each measure using data for the whole sample.  
For all measures, effect sizes were calculated for post-imagery rescripting and one 
month follow-up from the mean baseline value (or the pre-control value for the 
ideographic ratings).  For the SIAS, SSI, DASS-D, TUS and EQ-5D-5L VAS the one 
week follow-up assessment was used as the post-imagery rescripting time point.  For 
the VAS-A, ideographic ratings and VAS-P, effect sizes were also calculated for post-
control from the mean baseline or pre-control value.  Unfortunately a post-control effect 
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size could not be calculated for the SIAS, SSI, DASS-D, TUS and EQ-5D-5L as the 
required data were not available.  The effect sizes for each measure were categorised as 
‘small’ (d=0.2), ‘medium’ (d=0.5) or ‘large’ (d=0.8; Cohen, 1988). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
71 
 
CHAPTER THREE 
3. Results 
3.1 Overview 
 This chapter outlines the study findings.  Descriptive statistics and information 
about each participant’s image, image perspective, memory and encapsulated belief are 
outlined.  Kazdin’s (2010) guidelines for visual inspection of case series data were 
followed and data investigating the primary hypotheses and research questions are 
presented for each participant in graphs.  Individual participant analyses are followed by 
group analyses of each hypothesis including a consideration of reliable and clinical 
change, exploratory non-parametric testing and the calculation of Cohen’s d repeated 
measures effect sizes.  Information related to treatment fidelity is also included.   
3.2 Participant information   
 Table 3.1 includes descriptive statistics for all participants.  Table 3.2 includes 
information about the image, the perspective of the image (as rated during the semi-
structured interview; Hackman et al., 1998; Hackmann et al., 2000, as cited in Cooke, 
2012), the memory and the encapsulated belief for each participant.      
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Table 3.1 
Descriptive statistics for all participants  
 
 
Characteristic 
 
Value 
 
Range 
 
 
Mean age (SD) 
 
 
24.90 (6.74) 
 
 
19-35 
 
 
Gender (Male/Female) 
 
 
6/4 
 
 
Ethnicity 
White British 
Czech 
 
 
 
 
 
 
 
9 
1 
 
 
Diagnosis 
Brief psychotic disorder 
Bipolar affective disorder 
Psychosis NOS 
Psychotic disorder caused by multiple drug use 
Paranoid schizophrenia 
Severe depression with psychotic symptoms 
Unknown* 
 
 
 
 
3 
1 
1 
1 
2 
1 
1 
 
 
 
Mean (SD) SIAS at screening  
1 
 
59.10 (6.10) 
 
 
47-66 
 
 
Mean (SD) SIAS at follow-up 
 
 
42.50 (17.48) 
 
 
24-76 
 
 
Mean (SD) PANSS Positive Scale 
 
 
10.90 (3.18) 
 
 
7-18 
 
 
Mean (SD) PANSS Negative Scale 
 
 
10.20 (2.78) 
 
 
7-15 
 
 
Mean (SD) PANSS General Scale 
 
 
29.50 (2.99) 
 
 
27-37 
 
 
 
Note. NOS = Not otherwise specified; PANSS = Positive and Negative Syndrome Scale; SIAS = Social 
Interaction Anxiety Scale; * = Client was receiving ongoing assessment for psychotic symptoms. 
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Table 3.2 
Image, image perspective, memory and encapsulated belief data for each participant 
 
 
Participant 
 
 
 
 
Image 
 
 
 
 
Image 
perspective  
 
 
 
 
 
 
 
Memory 
 
 
 
Encapsulated 
belief 
 
 
1 
 
 
 
Doing something 
embarrassing in 
a group and 
being laughed at 
 
 
 
 
 
Field 
 
 
 
 
Ex-girlfriend 
saying “You have 
a nice body but 
not a nice face” 
 
 
 
 
“I’m not very 
handsome and 
people can be 
brutally honest” 
 
 
2 
 
 
Getting off the 
bus and people 
laughing and 
saying horrible 
things 
 
 
 
 
 
 
Field 
 
 
Girl at high 
school put 
chewing gum in 
hair and it had to 
be cut out 
 
 
“I am weak, a 
victim and others 
are hostile, nasty 
and intimidating” 
 
 
 
3 
 
 
Saying the 
wrong thing in 
groups or public 
and people 
laughing at me 
 
 
 
Field 
 
 
Struggling to get 
money out of 
purse in front of 
cashier in shop 
 
 
“I am a bad, 
horrible person 
likely to make a 
fool of myself” 
 
 
4 
 
 
Being in groups 
and looking 
quiet or saying 
something 
inappropriate 
 
 
 
 
 
 
Field 
Observer 
 
 
Father shouting at 
grandmother and 
not standing up 
for her 
 
 
“I am anxious, I 
find it hard to talk 
and others are 
better than me” 
 
 
5 
 
 
Being in 
supermarket and 
having people 
stare at me and 
talk about me 
 
 
 
 
Observer 
 
 
Having a panic 
attack in town 
centre during a 
busy shopping 
day 
 
 
“I am pathetic 
and disgusting 
and others will 
treat me like 
crap” 
 
 
6 
 
 
Talking to 
people and 
looking untidy or 
appearing 
unusual/rude 
 
 
 
 
 
Field 
 
 
Friend saying that 
they saw my 
girlfriend and she 
looked nice 
 
 
“I am a freak, 
failure, smelly 
and others 
measure me up” 
 
 
7 
 
 
Feeling nervous 
in public, 
concerned that 
situation is 
unmanageable 
 
 
 
 
 
Field 
 
 
Waiting in queue, 
feeling anxious 
and listening to 
music 
 
 
“Everything is 
too much, I will 
breakdown and 
lose control” 
 
 
8 
 
 
Having a 
conversation and 
anxiety causes 
me to sweat and 
wet myself 
 
 
 
 
 
Field 
 
 
Taking drugs with 
friends and 
feeling that I have 
wet myself  
 
 
“I am pathetic, an 
embarrassment 
and others are up 
to no good” 
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9 Looking nervous 
in public and 
having people 
stare at me 
Field Cashier in Fish 
and Chip shop 
was rude to me in 
front of customers 
“I look nervous, 
agitated, fidgety 
and others will 
make me look 
like a dick” 
 
 
10 
 
 
Being beaten up, 
seeing myself 
with bruises and 
scars on face  
 
 
 
 
 
 
 
 
 
 
Observer 
 
 
Being approached 
by past ‘bully’ 
and he asks if I 
am who he thinks 
I am 
 
 
“I am the one and 
only (in a bad 
way) and others 
are against me” 
 
 
Note. Participant 4 rated ‘image perspective’ as ‘half field’ and ‘half observer’. 
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3.3 Individual analyses 
3.3.1 Participant 1   
Participant 1 is a 20 year-old white British male who experienced a brief 
psychotic episode when he was 14 years old.  He continues to experience hallucinations 
but understands these as psychosis.  He lives with his family and girlfriend and reported 
high levels of social anxiety daily, especially when out in public. 
 
3.3.1.1 Social anxiety data 
Figure 3.1. Scores on the SIAS for Participant 1 
  
Figure 3.2. Scores on the VAS-A for Participant 1 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
   Baseline           Cont/ImRs          Follow-up 
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Interpretation of the SIAS and VAS-A data is displayed in Tables 3.3 and 3.4.  
Kendall’s tau indicated that VAS-A data were stable over the baseline period (tau = 
.145, p>.05).   
 
Table 3.3 
Visual inspection of SIAS data displayed in Figure 3.1. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
45 
 
-4 
 
No trend 
 
N 
 
N 
Cont/ImRs 37 -12 Decrease Y Y 
Follow-up 32 +1 No trend Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.4 
Visual inspection of VAS-A data displayed in Figure 3.2. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.57 
 
+0.02 
 
No trend 
Control 0.61 -0.01 No trend 
Break 0.49 -0.22 Decrease 
ImRs 0.36 -0.05  No trend 
One Wk FU 0.46 +0.25 Increase 
One Mnth FU 0.46 -0.24 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Reliable and clinical change in social anxiety were observed following the 
control/imagery rescripting phase and at one month follow-up.  For the VAS-A, no 
trend was observed over baseline or the control session.  A decrease in scores was 
observed following the control session.  A tape recording indicated that Participant 1 
received cognitive restructuring during this session and this should be considered. 
 
3.3.1.2 Encapsulated belief, imagery and memory data 
Figure 3.3. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 1 
 
  
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
Most scores decreased before imagery rescripting and the premature use of 
cognitive restructuring in the control session may have influenced this.  Encapsulated 
belief and memory and imagery distress reduced over the course of the study (although 
there was a small increase in encapsulated belief at follow-up).  There was little change 
in imagery vividness and frequency (although imagery frequency remained low and 
stable).  Detailed visual inspection of the ratings is included in Appendix J. 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
78 
 
 
 
3.3.1.3 Psychotic symptom and paranoia data 
Figure 3.4. Scores on the SSI for Participant 1 
 
Figure 3.5. Scores on the VAS-P for Participant 1 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They remained 
stable and reliable and clinical change were not found.  Kendall’s tau indicated that 
VAS-P data were stable over baseline (tau = .141, p>.05).  Mean paranoia scores 
deceased from baseline and remained stable over the course of the study. 
 
                    Baseline             Cont/ImRs           Follow-up 
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3.3.1.4 Depression data 
Figure 3.6. Scores on the DASS-D for Participant 1 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
 Depression was in the clinical range at baseline.  There was a slight observed 
decrease in depression over the control/imagery rescripting phase but this was not 
clinically significant.  There was a small increase in scores over follow-up.   
 
3.3.1.5 Social functioning data 
Figure 3.7. Scores on the TUS for Participant 1 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                   Baseline           Cont/ImRs            Follow-up 
                Baseline             Cont/ImRs           Follow-up 
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Social functioning was in the clinical range at baseline and it remained largely 
stable throughout the study.  Although there was a decrease in scores over follow-up the 
participant did not move into the ‘social disability’ range. 
 
3.3.1.6 Quality of life data 
Figure 3.8. Scores on the EQ-5D-5L VAS for Participant 1 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
 There was an increase in quality of life following the control/imagery rescripting 
phase and this was maintained at follow-up.  However, quality of life was rated as high 
throughout.    
 
3.3.1.7 Participant summary 
 Reliable and clinical change in social anxiety were achieved after the 
control/imagery rescripting phase and at one month follow-up.  Visual analogue scale 
scores indicate that there was a decrease in anxiety between the control and imagery 
rescripting sessions and after imagery rescripting.  A tape recording highlighted that 
cognitive restructuring was provided during the control session.  This might explain the 
                             Baseline           Cont/ImRs          Follow-up 
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change in scores following this session.  Ideographic ratings decreased before imagery 
rescripting suggesting that the control session had an effect.  There were reductions in 
encapsulated belief and memory and imagery distress ratings over the study.  Although 
there was little change in imagery frequency, scores remained low and stable. 
There was little change in psychotic symptoms and reliable and clinical change 
were not found.  Paranoia decreased from baseline and remained stable.  Depression and 
social functioning also remained stable and clinical change was not found.  Quality of 
life increased following the control/imagery rescripting phase but this was high 
throughout the study.      
Participant 1 reported finding the intervention helpful as it allowed him to think 
about his positive attributes and gain control over the chosen image and memory.  He 
suggested that the comments made by his ex-girlfriend were unkind and that it was “her 
issue” rather than something he needed to be concerned about in future relationships.     
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3.3.2 Participant 2 
 Participant 2 is a 19 year-old white British female who experienced a brief 
psychotic episode when she was 17 years old.  She lives alone, has few friends and little 
contact with her family.  She has recently completed some part-time courses and is 
looking for employment.  She reported experiencing high levels of social anxiety. 
 
3.3.2.1 Social anxiety data 
Figure 3.9. Scores on the SIAS for Participant 2 
  
Figure 3.10. Scores on the VAS-A for Participant 2 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
    Baseline            Cont/ImRs            Follow-up 
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Table 3.5 
Visual inspection of SIAS data displayed in Figure 3.9. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
51.5 
 
-21 
 
Decrease 
 
Y 
 
N 
Cont/ImRs 41.5 +1 No trend N N 
Follow-up 35.5 -13 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.6 
Visual inspection of VAS-A data displayed in Figure 3.10. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.48 
 
-0.16 
 
No trend 
Control 0.21 +0.10 Increase 
Break 0.29 +0.06 Increase 
ImRs 0.35 +0.05  Increase 
One Wk FU 0.42 +0.09 Increase 
One Mnth FU 0.44 -0.04 No trend 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Reliable and clinical change in social anxiety were observed at follow-up 
suggesting the intervention had an effect with time.  However, reliable change was also 
observed over baseline and there was no trend over the control/imagery rescripting 
phase.  This makes it difficult to attribute change to the intervention rather than natural 
improvement.   
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VAS-A data were stable over baseline (tau = .036, p>.05).  Mean scores 
increased from the control phase through to follow-up.  However, scores appear to 
stabilise slightly following the baseline phase.  
 
3.3.2.2 Encapsulated belief, memory and imagery data 
Figure 3.11. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 2 
  
          
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
Although there was a small reduction in imagery distress, overall there was little 
change in scores over the control session suggesting that this did not have an effect.  
Encapsulated belief and memory and imagery distress ratings decreased following 
imagery rescripting.  Encapsulated belief showed the greatest improvement.  Although a 
reduction in imagery vividness ratings was also observed, scores remained high.  
Imagery frequency remained low and stable throughout the study.  More detailed visual 
inspection of the ideographic ratings is included in Appendix J.  
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3.3.2.3 Psychotic symptom and paranoia data 
Figure 3.12. Scores on the SSI for Participant 2  
 
Figure 3.13. Scores on the VAS-P for Participant 2 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Despite a decrease in psychotic symptoms over the baseline phase, scores 
remained in the clinical range.  Scores remained stable throughout the control/imagery 
rescripting and follow-up phases and reliable and clinical change were not found.  VAS-
P data were stable over baseline (tau = .044, p>.05).  Mean scores decreased from the 
                           Baseline             Cont/ImRs            Follow-up 
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control to the imagery rescripting phase but increased over the follow-up period.  
However, there was large variation in scores over the study.  
 
3.3.2.4 Depression data 
Figure 3.14. Scores on the DASS-D for Participant 2 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = .548, p>.05) and in the clinical 
range.  Although it decreased over the control/imagery rescripting phase clinical change 
was not found.  
 
 
 
 
 
 
 
 
 
                                      Baseline                            Cont/ImRs      Follow-up 
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3.3.2.5 Social functioning data 
Figure 3.15. Scores on the TUS for Participant 2 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
  
Social functioning was in the ‘social disability’ range at baseline.  Scores moved 
to the ‘severe social disability’ range following the control/imagery rescripting phase.  
Participant 2 completed some courses over baseline and this should be considered. 
 
3.3.2.6 Quality of life data 
Figure 3.16. Scores on the EQ-5D-5L VAS for Participant 2 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                     Baseline            Cont/ImRs          Follow-up 
               Baseline                           Cont/ImRs      Follow-up 
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 Although there was variation in scores, quality of life was stable over baseline 
(tau = .183, p>.05).  Scores remained stable and high throughout the study.   
 
3.3.2.7 Participant summary 
 Reliable and clinical change were observed in social anxiety at follow-up.  
However, reliable change was also observed over baseline and there was no trend over 
the control/imagery rescripting phase.  This makes it difficult to attribute change to the 
intervention rather than natural improvement.  Mean visual analogue scale scores for 
anxiety increased from the control phase to follow-up and returned to baseline level.  
However, scores appear to stabilise slightly following the baseline phase.  For the 
ideographic ratings, encapsulated belief and memory and imagery distress ratings 
decreased following imagery rescripting.  Encapsulated belief showed the greatest 
improvement.  Although there was a small reduction in imagery distress, there was little 
change in ideographic ratings over the control session suggesting it had minimal effect.  
Psychotic symptoms reduced over baseline and remained stable, but reliable and 
clinical change were not found.  Mean paranoia scores decreased from the control to the 
imagery rescripting phase but increased through to follow-up.  Depression decreased 
over the control/imagery rescripting phase but clinical change was not found.  Social 
functioning moved to the ‘severe social disability’ range following the control/imagery 
rescripting phase.  The participant was completing some courses over the baseline phase 
and this should be considered.  Quality of life remained stable throughout the study.   
Participant 2 reported that the intervention helped her to feel less victimised and 
more confident.  She also stated that she realised people were there for her and that she 
did not have to cope alone.  She was keen to continue with psychological input for her 
anxiety and explained that the imagery work had given her the confidence to do so.     
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3.3.3 Participant 3 
 Participant 3 is a 34 year-old white British female with paranoid schizophrenia.  
She lives with, and is employed by her mother and experiences ongoing psychosis 
which is treated using depot medication.  She reported high levels of social anxiety and 
presented as quiet, only speaking when questions were asked.    
 
3.3.3.1 Social anxiety data 
Figure 3.17. Scores on the SIAS for Participant 3 
  
Figure 3.18. Scores on the VAS-A for Participant 3 
   
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 Baseline            Cont/ImRs            Follow-up 
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Table 3.7 
Visual inspection of SIAS data displayed in Figure 3.17. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
53.5 
 
-9 
 
Decrease 
 
N 
 
N 
Cont/ImRs 47.5 -3 No trend N N 
Follow-up 47.5 +3 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table 3.8 
Visual inspection of VAS-A data displayed in Figure 3.18. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.56 
 
-0.07 
 
No trend 
Control 0.58 -0.10 Decrease 
Break 0.52 -0.03 No trend 
ImRs 0.51 +0.01  No trend 
One Wk FU 0.49 -0.04 No trend 
One Mnth FU 0.39 -0.17 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Reliable and clinical change in social anxiety were not observed.  VAS-A data 
were stable over baseline (tau = -.197, p>.05).  There was a decrease in scores over the 
control session suggesting that this had an effect.  Scores remained stable but decreased 
at follow-up.  Although this suggests that the intervention may have had an effect with 
time, other factors may have been involved and this should be considered. 
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3.3.3.2 Encapsulated belief, memory and imagery data 
Figure 3.19. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 3 
  
                                
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
Excluding imagery frequency (which remained low and stable throughout the 
study), all ratings decreased after imagery rescripting and further reductions were 
observed at one week and one month follow-up.  However, reductions in encapsulated 
belief and memory distress ratings over the control session suggests that it may have 
had an effect.  More detailed visual inspection is included in Appendix J.    
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3.3.3.3 Psychotic symptom and paranoia data 
Figure 3.20. Scores on the SSI for Participant 3  
 
Figure 3.21. Scores on the VAS-P for Participant 3 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They were stable for 
the duration of the study and reliable and clinical change were not found.  VAS-P data 
were stable over baseline (tau = -.333, p>.05).  Mean scores increased over the control 
phase and remained high.  This suggests that the intervention did not have a positive 
effect on paranoia for this participant.       
                    Baseline             Cont/ImRs            Follow-up 
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3.3.3.4 Depression data 
Figure 3.22. Scores on the DASS-D for Participant 3 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
 Depression was in the clinical range at baseline.  An increase in trend was 
observed at follow-up.  There was no trend over the control/imagery rescripting phase 
suggesting that other factors may have been involved (e.g. a natural decline in mood).  
 
3.3.3.5 Social functioning data 
Figure 3.23. Scores on the TUS for Participant 3 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                Baseline             Cont/ImRs          Follow-up 
              Baseline            Cont/ImRs         Follow-up 
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 At the second baseline assessment social functioning was in the ‘social 
disability’ range.  There was an increase in social functioning following the 
control/imagery rescripting phase and this remained stable over follow-up.  However, 
this was not clinically significant.   
 
3.3.3.6 Quality of life data 
Figure 3.24. Scores on the EQ-5D-5L VAS for Participant 3 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
There was a small increase in quality of life following the control/imagery 
rescripting phase and this remained stable.  However, there was also an increase over 
baseline making it difficult to attribute change to the intervention rather than natural 
improvement. 
 
3.3.3.7 Participant summary 
 Reliable and clinical change were not found for social anxiety.  Visual analogue 
scale scores for anxiety decreased following the control session suggesting an effect.  
Scores decreased at follow-up suggesting the intervention had an effect with time.  
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However, other factors may have been involved and this should be considered.  
Excluding imagery frequency (which was low and stable), all ideographic ratings 
reduced following imagery rescripting.  Further reductions were observed at follow-up.  
Encapsulated belief and memory distress ratings decreased over the control session 
suggesting that this might have had an effect.    
Psychotic symptoms remained stable and reliable and clinical change were not 
found.  There was an increase in paranoia scores over the control phase and mean scores 
remained high.  Depression was in the clinical range and this increased at follow-up.  
However, no trend was observed over the control/imagery rescripting phases suggesting 
other factors (e.g. a natural decline in mood) may have been involved.  Social 
functioning increased over the control/imagery rescripting phase and remained stable 
but this was not clinically significant.  A small increase was observed in quality of life, 
but an increasing trend over baseline makes it difficult to attribute this to the 
intervention rather than natural improvement.  
Participant 3 reported that the intervention helped her to feel more comfortable 
in public and realise that people would not laugh at her for making mistakes.  She was 
less concerned about talking to shop assistants and more confident about paying for 
items.  However, Participant 3 remained anxious about many different social situations. 
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3.3.4 Participant 4 
 Participant 4 is a 32 year-old white female from the Czech Republic with severe 
depression with psychotic symptoms.  She moved to England to pursue employment but 
recently left her job as it was too demanding on her mental health.  She experiences a 
high level of social anxiety and finds it difficult to socialise with friends. 
 
3.3.4.1 Social anxiety data 
Figure 3.25. Scores on the SIAS for Participant 4 
  
Figure 3.26. Scores on the VAS-A for Participant 4 
   
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                   
                            Baseline             Cont/ImRs            Follow-up 
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Table 3.9 
Visual inspection of SIAS data displayed in Figure 3.25. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
57 
 
+2 
 
No trend 
 
N 
 
N 
Cont/ImRs 47 -22 Decrease Y Y 
Follow-up 30 -12 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.10 
Visual inspection of VAS-A data displayed in Figure 3.26. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.59 
 
+0.17 
 
No trend 
Control 0.73 -0.03 No trend 
Break 0.69 -0.04 No trend 
ImRs 0.53 -0.29  Decrease 
One Wk FU 0.37 -0.03 No trend 
One Mnth FU 0.24 -0.23 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Reliable and clinical change in social anxiety were observed following the 
control/imagery rescripting phase and at follow-up.  VAS-A data were stable over 
baseline (tau = .170, p>.05).  Scores were stable over the control phase and reduction in 
mean scores and decreasing trend was observed over the imagery rescripting and 
follow-up phases.  
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3.3.4.2 Encapsulated belief, memory and imagery data 
Figure 3.27. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 4 
  
                                          
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
All ratings decreased following imagery rescripting and scores were low at 
follow-up.  Although encapsulated belief increased at one week follow-up this reduced 
at one month follow-up.  There was no change in the ratings over the control session 
suggesting that it did not have an effect.  See Appendix J for detailed visual inspection 
of the ratings.   
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3.3.4.3 Psychotic symptom and paranoia data 
Figure 3.28. Scores on the SSI for Participant 4  
 
Figure 3.29. Scores on the VAS-P for Participant 4 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms increased over baseline and they were in the clinical range.  
Clinical change was observed following the control/imagery rescripting phase and this 
was maintained at follow-up.  However, reliable change was not found.  The participant 
had not experienced paranoia since starting anti-psychotic medication.  No changes in 
mean, level or trend were observed for the VAS-P data over the course of the study. 
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3.3.4.4 Depression data 
Figure 3.30. Scores on the DASS-D for Participant 4 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = .816, p>.05) and in the clinical 
range.  Depression decreased over the control/imagery rescripting and follow-up phases 
but clinical change was not found.  
 
3.3.4.5 Social functioning data 
Figure 3.31. Scores on the TUS for Participant 4 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                Baseline            Cont/ImRs          Follow-up 
               Baseline                  Cont/ImRs      Follow-up 
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Social functioning was in the ‘social disability’ range at baseline.  There was a 
small increase over the follow-up phase.  However, this was not clinically significant.    
 
3.3.4.6 Quality of life data 
Figure 3.32. Scores on the EQ-5D-5L VAS for Participant 4 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
 Quality of life was stable over the baseline period (tau = .816, p>.05).  There 
was a small increase over the control/imagery rescripting and follow-up phases.  
However, quality of life was rated highly throughout the study and this should be 
considered.   
 
3.3.4.7 Participant summary 
 Reliable and clinical change were found for social anxiety following the 
control/imagery rescripting phase and at follow-up.  Decreases in mean and trend were 
observed for visual analogue scale data for anxiety over the imagery rescripting and 
follow-up phases.  Scores were stable over the control phase suggesting the imagery 
rescripting session had a specific effect.  All ideographic ratings decreased after 
              Baseline                Cont/ImRs    Follow-up 
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imagery rescripting and scores were low at follow-up.  Although encapsulated belief 
ratings increased at one week follow-up they decreased at one month follow-up.  No 
change was observed over the control session suggesting that it did not have an effect. 
Clinical change in psychotic symptoms was found after the control/imagery 
rescripting phase and this was maintained at one month follow-up.  However, reliable 
change was not found.  The participant did not report any paranoia throughout the 
study.  Depression decreased over the control/imagery rescripting and follow-up phases 
but this was not clinically significant.  There was a small increase in social functioning 
at follow-up, but this was not clinically significant and it remained in the ‘social 
disability’ range.  An increase in quality of life was observed over the control/imagery 
rescripting phase but this was rated high throughout the study and should be considered.           
Following the intervention, Participant 4 reported feeling less anxious about how 
she was perceived by others and more confident about being in groups.  She also 
reported feeling less guilty about not having stood up to her father to protect her 
grandmother and stated that she was feeling more optimistic about her future. 
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3.3.5 Participant 5 
 Participant 5 is a 21 year-old white British female with bipolar disorder.  She 
reported severe levels of social anxiety.  She lives with her parents and rarely leaves the 
house.  She experiences difficulties with interpersonal relationships and reported having 
no friends.  Her mood fluctuates and she has made attempts to take her own life.     
 
3.3.5.1 Social anxiety data 
Figure 3.33. Scores on the SIAS for Participant 5 
  
Figure 3.34. Scores on the VAS-A for Participant 5 
   
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                   
                                  Baseline             Cont/ImRs            Follow-up 
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Table 3.11 
Visual inspection of SIAS data displayed in Figure 3.33. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
66.5 
 
+1 
 
No trend 
 
N 
 
N 
Cont/ImRs 62.5 -9 Decrease N N 
Follow-up 46.5 -23 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.12 
Visual inspection of VAS-A data displayed in Figure 3.34. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.64 
 
-0.22 
 
Decrease 
Control 0.68 -0.10 Decrease 
Break 0.65 +0.04 Increase 
ImRs 0.42 -0.50  Decrease 
One Wk FU 0.24 +0.13 Increase 
One Mnth FU 0.20 -0.21 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Reliable and clinical change in social anxiety were observed at follow-up 
suggesting that the intervention had an effect with time.  However, despite a decreasing 
trend in scores, reliable and clinical change were not found over the control/imagery 
rescripting phase.  This suggests that other factors may have been involved in the 
change observed at follow-up.  Mean VAS-A scores decreased from imagery rescripting 
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to follow-up and there was a large shift down in scores over the imagery rescripting 
phase (compared to a small decrease in scores over the control session).  However, the 
VAS-A data were not stable over baseline (tau =-.398, p<0.01) making it difficult to 
conclude that the imagery rescripting led to the change observed. 
 
3.3.5.2 Encapsulated belief, memory and imagery data 
Figure 3.35. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 5 
  
                                          
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
All ideographic ratings reduced over the imagery rescripting session or 
following imagery rescripting.  Scores for all of the ratings were low at follow-up.  
There was a large shift down in image frequency scores between the imagery rescripting 
session and one week follow-up.  There was a small reduction in encapsulated belief, 
memory distress and imagery distress over the control session, suggesting that it might 
have had some effect.  See Appendix J for more detailed visual inspection. 
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3.3.5.3 Psychotic symptom and paranoia data 
Figure 3.36. Scores on the SSI for Participant 5  
 
Figure 3.37 Scores on the VAS-P for Participant 5 
 
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  Reliable change was 
found following the control/imagery rescripting and follow-up phases and clinical 
change was found at one month follow-up.  However, a decreasing trend over baseline 
suggests some natural improvement.  VAS-P data decreased over the imagery 
rescripting and follow-up phases.  However, data were not stable over baseline (tau = -
                   Baseline              Cont/ImRs            Follow-up 
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.477, p<.01) and a decrease over the control session suggests this had an effect.  There 
was also variation in scores across the study and this should be considered.               
 
3.3.5.4 Depression data 
Figure 3.38. Scores on the DASS-D for Participant 5 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = -.667, p>.05) and in the clinical 
range.  There was a decrease in depression over the control/imagery rescripting and 
follow-up phases and clinical change was found at one month follow-up.  
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3.3.5.5 Social functioning data 
Figure 3.39. Scores on the TUS for Participant 5 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Social functioning was in the ‘severe social disability’ range over baseline.  
Social functioning remained low and clinical change was not found.  There was a small 
increase over follow-up as the participant attended a meal with the EIP service.   
 
3.3.5.6 Quality of life data 
Figure 3.40. Scores on the EQ-5D-5L VAS for Participant 5 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
             Baseline            Cont/ImRs           Follow-up 
                 Baseline                            Cont/ImRs      Follow-up 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
109 
 
 Quality of life was stable over baseline (tau = .333, p>.05).  There was an 
increase in quality of life over the control/imagery rescripting and follow-up phases.  
However, there is an increasing trend in the data from the third baseline assessment 
until follow-up.  This suggests that other factors (e.g. natural improvement) may have 
been involved.  
 
3.3.5.7 Participant summary 
 Reliable and clinical change were found for social anxiety at follow-up 
suggesting the intervention had an effect with time.  However, reliable and clinical 
change were not found following the control/imagery rescripting phase.  This suggests 
that other factors may have been involved and this should be considered.   
Mean visual analogue scale data for anxiety decreased from imagery rescripting 
through to follow-up.  There was a greater reduction in anxiety over the imagery 
rescripting phase compared to the control phase.  However, an unstable baseline makes 
it difficult to conclude that the imagery rescripting led to the changes observed.  All 
ideographic ratings reduced over or following the imagery rescripting session and 
scores were low at follow-up.  However, small reductions in encapsulated belief and 
memory and imagery distress were observed over the control session suggesting that it 
might have had some effect.  
 Psychotic symptoms declined and reliable change was found after the 
control/imagery rescripting and follow-up phases.  Clinical change was also found at 
one month follow-up.  However, a decreasing trend over baseline suggests some natural 
improvement.  Decreases in paranoia were observed over the control and imagery 
rescripting sessions and the follow-up phase, but baseline data were unstable and there 
was variation in scores throughout the study.  Depression decreased over the 
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control/imagery rescripting phase and clinical change was found at one month follow-
up.  Social functioning remained in the ‘severe social disability’ range.  Although there 
was an increase in quality of life over the control/imagery rescripting and follow-up 
phases, an increasing trend from the third baseline assessment suggests that other 
factors (e.g. natural improvement) may be involved.  
Participant 5 reported that the intervention helped her to realise that she has a lot 
to give and that she is not disgusting.  She realised the importance of considering her 
personality more rather than focussing solely on what she looks like.  Following her 
attendance at the EIP meal she said that she was looking forward to socialising more. 
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3.3.6 Participant 6 
 Participant 6 is a 35 year-old white British male with Asperger’s syndrome and 
paranoid schizophrenia.  He has previously spent time in an acute mental health 
hospital.  He experiences high levels of social anxiety and reported difficulties in 
finding a relationship.   He lives at home with his mother and is unemployed.   
 
3.3.6.1 Social anxiety data 
Figure 3.41. Scores on the SIAS for Participant 6 
  
Figure 3.42. Scores on the VAS-A for Participant 6 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                  Baseline            Cont/ImRs           Follow-up 
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Table 3.13 
Visual inspection of SIAS data displayed in Figure 3.41. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
61.5 
 
-9 
 
Decrease 
 
N 
 
N 
Cont/ImRs 54.5 -5 Decrease N N 
Follow-up 55 +6 Increase N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table 3.14 
Visual inspection of VAS-A data displayed in Figure 3.42. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.71 
 
+0.22 
 
No trend 
Control 0.88 -0.04 No trend 
Break 0.83 -0.06 No trend 
ImRs 0.70 -0.20  Decrease 
One Wk FU 0.68 +0.16 Increase 
One Mnth FU 0.75 -0.02 No trend 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Social anxiety remained stable and reliable and clinical change were not found.  
VAS-A data were stable over baseline (tau =.282, p>.05).  There was a decreasing trend 
in VAS-A data over the imagery rescripting phase (and no trend over the control 
session) but mean scores remained high and increased at one week follow-up. 
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3.3.6.2 Encapsulated belief, memory and imagery data 
Figure 3.43. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 6 
  
                                     
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
There was a small decrease in encapsulated belief and memory and imagery 
distress following imagery rescripting.  Although there was an increase in imagery 
vividness over the imagery rescripting phase this decreased at one week follow-up.  
Imagery frequency reduced before the imagery rescripting session and remained low 
and stable.  Although there was a small reduction in imagery distress, there was little 
change in ideographic ratings over the control session suggesting that this did not have 
an effect.  Detailed visual inspection of the ratings is included in Appendix J.   
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3.3.6.3 Psychotic symptom and paranoia data 
Figure 3.44. Scores on the SSI for Participant 6  
 
Figure 3.45. Scores on the VAS-P for Participant 6 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They were stable 
over the study and reliable and clinical change were not found.  VAS-P data were stable 
over baseline (tau = .012, p>.05).  Paranoia remained high until one month follow-up 
where there was a decrease in mean score.  However, there was variation in scores 
throughout the study and this should be considered. 
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3.3.6.4 Depression data 
Figure 3.46. Scores on the DASS-D for Participant 6 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = .183, p>.05) and in the clinical 
range.  Despite a decrease over the control/imagery rescripting phase clinical change 
was not found.  There was an increase at follow-up with a return to baseline level. 
 
3.3.6.5 Social functioning data 
Figure 3.47. Scores on the TUS for Participant 6 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                         Baseline          Cont/ImRs           Follow-up 
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There was a decrease in social functioning over baseline and it was in the 
‘severe social disability’ range at the second assessment point.  There was a further 
decrease in social functioning over the control/imagery rescripting phase and this was 
stable at follow-up.  The participant completed the follow-up assessments after 
Christmas and reported taking part in less activities.  This should be considered.   
 
3.3.6.6 Quality of life data 
Figure 3.48. Scores on the EQ-5D-5L VAS for Participant 6 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Quality of life was unstable over baseline (tau = 1.00, p<.05) suggesting a 
significant change before the intervention was introduced.  There was no change in 
trend over the control/imagery rescripting phase and a decrease over follow-up.  This 
suggests that the intervention did not have a positive effect on quality of life.       
 
3.3.6.7 Participant summary 
 Social anxiety remained stable and reliable and clinical change were not found.  
There was a decrease in visual analogue scale data for anxiety over the imagery 
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rescripting phase (and no trend over the control session) but mean scores remained high 
and increased at one month follow-up.  For the ideographic ratings there was a small 
decrease in encapsulated belief and memory and imagery distress following imagery 
rescripting.  There were also decreases in imagery vividness and frequency over the 
study.  Although there was a small reduction in imagery distress, there was little change 
in ideographic ratings over the control session suggesting it had minimal effect. 
 Psychotic symptoms remained stable and reliable and clinical change were not 
found.  There was a decrease in paranoia at one month follow-up but there was variation 
in scores throughout the study making it difficult to attribute this to the intervention.  
Depression decreased over the control/imagery rescripting phase but clinical change 
was not found.  There was also an increase in scores at follow-up.  Social functioning 
decreased over the baseline and control/imagery rescripting phases and this remained 
stable and in the ‘severe social disability’ range at follow-up.  However, the follow-up 
assessments were completed after Christmas and this should be considered.  There was 
no trend in quality of life over the control/imagery rescripting phase and it decreased 
over follow-up.  This suggests the intervention did not have a positive effect on quality 
of life for this participant.  
Participant 6 reported that the intervention helped him to see that he had “over-
reacted” in the remembered event.  He found it difficult to take part, explaining that he 
did not know how to describe the event from the third person.  He also found it difficult 
to consider alternative viewpoints during the cognitive restructuring.  This may have 
been influenced by the difficulties associated with his diagnosis. 
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3.3.7 Participant 7 
 Participant 7 is a 29 year-old white British male with Asperger’s syndrome.  He 
experienced a brief psychotic episode when he was 27 years old.  He is currently 
unemployed.  He lives alone but has a long-term partner and a small number of friends.  
He reported experiencing high levels of social anxiety in public.   
 
3.3.7.1 Social anxiety data 
Figure 3.49. Scores on the SIAS for Participant 7 
  
Figure 3.50. Scores on the VAS-A for Participant 7 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                Baseline             Cont/ImRs            Follow-up 
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Table 3.15 
Visual inspection of SIAS data displayed in Figure 3.49. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
50 
 
-8 
 
Decrease 
 
N 
 
N 
Cont/ImRs 44.5 -3 No trend N N 
Follow-up 38.5 -9 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.16 
Visual inspection of VAS-A data displayed in Figure 3.50. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.59 
 
+0.05 
 
No trend 
Control 0.55 0 No trend 
Break 0.55 0 No trend 
ImRs 0.55 0  No trend 
One Wk FU 0.50 -0.10 Decrease 
One Mnth FU 0.48 +0.05 Increase 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
There was a decrease in social anxiety and reliable and clinical change were 
found at one month follow-up.  However, a decreasing trend was observed over baseline 
and no trend was observed over the control/imagery rescripting phase.  This makes it 
difficult to attribute change to the intervention and suggests that other factors might 
have been involved (e.g. natural improvement).  VAS-A data were stable over baseline 
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(tau =-.009, p>.05).  Scores remained stable until one week follow-up when there was a 
slight decrease.  
 
3.3.7.2 Encapsulated belief, memory and imagery data 
Figure 3.51. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 7 
  
                                   
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
There was a reduction in imagery frequency following imagery rescripting and 
scores were low at follow-up.  There were slight reductions in memory distress and 
imagery distress and vividness over the study.  However, imagery distress and vividness 
decreased over the control session suggesting that it might have had an effect.  The 
participant described his encapsulated belief as a “fixed firm belief” and explained that 
this could not be modified, rating it at 100 each time.  Detailed visual inspection of the 
ideographic ratings is provided in Appendix J.      
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3.3.7.3 Psychotic symptom and paranoia data 
Figure 3.52. Scores on the SSI for Participant 7  
 
Figure 3.53 Scores on the VAS-P for Participant 7 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They decreased over 
the control/imagery rescripting phase and remained stable at follow-up.  Clinical change 
was found at one week and one month follow-up.  However, reliable change was not 
observed.  VAS-P data were stable over baseline (tau = .272, p>.05) and the study. 
 
                   Baseline              Cont/ImRs            Follow-up 
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3.3.7.4 Depression data 
Figure 3.54. Scores on the DASS-D for Participant 7 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
 
Over baseline, depression was stable (tau = .333, p>.05) and in the clinical 
range.  Clinical change was observed at both follow-up time points.  However, an 
increasing trend over the follow-up phase suggests that any effect was time-limited.   
 
3.3.7.5 Social functioning data 
Figure 3.55. Scores on the TUS for Participant 7 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                   Baseline            Cont/ImRs         Follow-up 
                  Baseline                         Cont/ImRs          Follow-up 
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At the first baseline assessment, social functioning was in the ‘social disability’ 
range.  There was an increase over the baseline phase and scores remained stable but in 
the clinical range for the rest of the study.  The participant completed the one week 
follow-up assessment after Christmas and reported taking part in less activities.  This 
should be considered. 
 
3.3.7.6 Quality of life data 
Figure 3.56. Scores on the EQ-5D-5L VAS for Participant 7 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Quality of life was stable over baseline (tau = -.816, p>.05).  There was an 
increase in scores over the control/imagery rescripting phase and this remained stable at 
follow-up.  This suggests that the intervention might have had a positive effect on 
quality of life.  
 
3.3.7.7 Participant summary 
 Reliable and clinical change in social anxiety were found at one month follow-
up.  However, a decreasing trend over the baseline phase and no trend over the 
               Baseline                      Cont/ImRs         Follow-up 
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control/imagery rescripting phase makes it difficult to attribute change to the 
intervention.  Visual analogue scale data for anxiety were stable from the control to 
imagery rescripting phase.  There was a small decrease in mean scores at follow-up.  
There was a reduction in imagery frequency following imagery rescripting and follow-
up scores were low.  Small reductions in memory distress and imagery distress and 
vividness were observed over the study.  Imagery distress and vividness decreased over 
the control session suggesting that this might have had an effect.  Encapsulated belief 
ratings were stable and the participant explained that this was a “fixed firm belief” and 
could not be modified. 
 Psychotic symptoms decreased over the control/imagery rescripting phase and 
clinical change was found at one week and one month follow-up.  However, reliable 
change was not found.  Paranoia data remained stable throughout the study.  Depression 
scores decreased following the control/imagery rescripting phase and clinical change 
was observed at one week and one month follow-up.  However, an increasing trend was 
observed in depression scores over follow-up.  This suggests that the effect might have 
been time-limited.  Social functioning remained stable and in the clinical range.  There 
was an increase in quality of life scores over the control/imagery rescripting phase and 
this was maintained at follow-up.         
Participant 7 reported that he could see the benefit of the intervention and it 
helped him to think about how he appeared in the queue rather than worrying about 
what he might have looked like.  However, he explained that he found it difficult to take 
part as he could not visualise himself from an outside perspective.  This may have been 
influenced by the difficulties associated with his diagnosis.   
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3.3.8 Participant 8 
 Participant 8 is a 20 year-old white British male who developed psychosis 
following repeated drug use.  He experiences high levels of paranoia and holds concerns 
that his neighbours will break into his flat.  He continues to experience drug dependency 
and during the study he was admitted to an acute mental health ward for detoxification.  
 
3.3.8.1 Social anxiety data 
Figure 3.57. Scores on the SIAS for Participant 8 
  
Figure 3.58. Scores on the VAS-A for Participant 8 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                  Baseline             Cont/ImRs           Follow-up 
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Table 3.17 
Visual inspection of SIAS data displayed in Figure 3.57. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
59.5 
 
-3 
 
No trend 
 
N 
 
N 
Cont/ImRs 63 +10 Increase N N 
Follow-up 64.5 -7 Decrease N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table 3.18 
Visual inspection of VAS-A data displayed in Figure 3.58. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.81 
 
-0.25 
 
No trend 
Control 0.62 -0.18 Decrease 
Break 0.75 +0.44 Increase 
ImRs 0.92 -0.10  Decrease 
One Wk FU 0.79 -0.17 Decrease 
One Mnth FU 0.81 +0.21 Increase 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
There was an increase in mean social anxiety scores over the study and reliable 
and clinical change were not found.  VAS-A data were stable over baseline (tau =-.366, 
p>.05).  There was a decrease in trend over the control and imagery rescripting sessions 
suggesting that they both had an effect.  However, anxiety increased before the imagery 
rescripting phase and mean scores remained high throughout the study.   
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
127 
 
 
3.3.8.2 Encapsulated belief, memory and imagery data 
Figure 3.59. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 8 
  
                                          
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
Encapsulated belief ratings decreased over the imagery rescripting session and 
imagery frequency reduced following imagery rescripting.  However, encapsulated 
belief decreased slightly over the control session suggesting that it had an effect on 
these ratings.  There were also decreases in imagery distress and vividness following 
imagery rescripting.  However, there was variation in the ratings and with the exception 
of imagery frequency, scores were high at follow-up.   More detailed visual inspection 
of the ratings is included in Appendix J.   
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3.3.8.3 Psychotic symptom and paranoia data 
Figure 3.60. Scores on the SSI for Participant 8  
 
Figure 3.61. Scores on the VAS-P for Participant 8 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They were stable 
over the study and reliable and clinical change were not found.  VAS-P data were stable 
over baseline (tau = .029, p>.05).  There were decreases in trend over the control and 
imagery rescripting phases, with the imagery rescripting session appearing to have a 
                   Baseline             Cont/ImRs           Follow-up 
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greater effect.  However, there was variation in scores and paranoia returned to baseline 
level at follow-up.       
 
3.3.8.4 Depression data 
Figure 3.62. Scores on the DASS-D for Participant 8 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Depression was in the clinical range at baseline.  There was an increase in 
depression over the control/imagery rescripting and follow-up phases and clinical 
change was not found.  The participant was admitted to hospital before the 
control/imagery rescripting phase and had returned to his flat for the follow-up 
appointments.  It is possible that the participant’s living circumstances led to a natural 
decline in his mood and this should be considered. 
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3.3.8.5 Social functioning data 
Figure 3.63. Scores on the TUS for Participant 8 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Social functioning was in the ‘severe social disability’ range at baseline.  Scores 
remained stable and clinical change was not found.  The participant reported performing 
slightly fewer activities when he returned to his flat (one month follow-up).     
 
3.3.8.6 Quality of life data 
Figure 3.64. Scores on the EQ-5D-5L VAS for Participant 8 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                    Baseline               Cont/ImRs         Follow-up 
                        Baseline            Cont/ImRs           Follow-up 
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 There was an increase in quality of life over baseline.  The participant reported 
feeling more comfortable when the end of baseline assessment was completed as he was 
in hospital.  There was a decrease in quality of life over the follow-up phase and at this 
point the participant had returned to his flat.  This should be considered.  
 
3.3.8.7 Participant summary 
 Mean social anxiety increased and reliable and clinical change were not found.  
Although there was a decrease in visual analogue scale anxiety scores over the control 
and imagery rescripting phases, mean scores remained high.  For the ideographic 
ratings, encapsulated belief decreased over the imagery rescripting session and imagery 
frequency reduced following imagery rescripting.  There were also decreases in imagery 
distress and vividness.  However, encapsulated belief decreased over the control session 
suggesting that it had an effect.  Also, most ratings remained high at follow-up.   
Psychotic symptoms were stable and reliable and clinical change were not 
found.  There was a decrease in paranoia over the control and imagery rescripting 
phases suggesting that both had an effect.  However, this returned to baseline level at 
follow-up.  There was an increase in depression over the control/imagery rescripting 
and follow-up phases and clinical change was not found.  Social functioning remained 
in the ‘severe social disability’ range and a small decrease was observed at follow-up.  
Quality of life also decreased at follow-up.  It is possible that the participant’s level of 
depression, social functioning and quality of life were influenced by his living 
circumstances and this should be considered. 
Despite his difficulties, Participant 8 reported that he found the intervention 
useful.  He reported that it allowed him to realise that he had not wet himself in front of 
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his friends and that if he did they would be understanding.  He stated that in future he 
will feel more able to be honest with people about the way he is feeling.   
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3.3.9 Participant 9 
 Participant 9 is a 20 year-old white British male with Attention Deficit 
Hyperactivity Disorder (ADHD).  He is receiving ongoing assessment for psychotic 
symptoms.  He lives with his parents and has a girlfriend.  He experiences severe levels 
of social anxiety and rarely leaves his home, fearful that people will notice his anxiety.   
 
3.3.9.1 Social anxiety data 
Figure 3.65. Scores on the SIAS for Participant 9 
  
Figure 3.66. Scores on the VAS-A for Participant 9 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                   
                   Baseline             Cont/ImRs           Follow-up 
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Table 3.19 
Visual inspection of SIAS data displayed in Figure 3.65. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
72 
 
+14 
 
Increase 
 
N 
 
N 
Cont/ImRs 78.5 -1 No trend N N 
Follow-up 77 -2 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table 3.20 
Visual inspection of VAS-A data displayed in Figure 3.66. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.89 
 
+0.04 
 
No trend 
Control 0.75 -0.03 No trend 
Break 0.77 +0.07 Increase 
ImRs 0.78 -0.05  Decrease 
One Wk FU 0.81 +0.11 Increase 
One Mnth FU 0.83 -0.06 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
Reliable and clinical change in social anxiety were not found.  Mean scores 
increased over the control/imagery rescripting phase and remained high.  VAS-A data 
were stable over baseline (tau =-.009, p>.05).  Mean scores decreased over the control 
phase but increased over the other phases and remained high. 
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3.3.9.2 Encapsulated belief, memory and imagery data 
Figure 3.67. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 9 
  
                                          
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
Encapsulated belief remained stable until follow-up when there was a small 
decrease.  There was a large decrease in imagery frequency prior to imagery rescripting 
and this remained stable and low throughout the rest of the study.  There was variation 
in the other ratings and scores remained high at follow-up.  Decreases in imagery 
distress and vividness over the control session suggests that this had some effect.  More 
detailed visual inspection of the ideographic ratings is provided in Appendix J.   
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3.3.9.3 Psychotic symptom and paranoia data 
Figure 3.68. Scores on the SSI for Participant 9  
 
Figure 3.69. Scores on the VAS-P for Participant 9 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They remained 
stable and high and reliable and clinical change were not found.  VAS-P data were 
stable over baseline (tau = .272, p>.05).  Mean scores decreased over the control phase 
but increased over the following phases, remaining high over the course of the study.   
 
                   Baseline            Cont/ImRs           Follow-up 
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3.3.9.4 Depression data 
Figure 3.70. Scores on the DASS-D for Participant 9 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = .000, p>.05) and in the clinical 
range.  There was a small increase over the control/imagery rescripting phase and scores 
remained stable and high at follow-up.  Clinical change was not found.     
 
3.3.9.5 Social functioning data 
Figure 3.71. Scores on the TUS for Participant 9 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
                      Baseline              Cont/ImRs             Follow-up 
               Baseline                     Cont/ImRs       Follow-up 
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Social functioning was in the ‘severe social disability’ range at baseline.  Scores 
remained stable and low throughout the study and clinical change was not found.  There 
was a small increase in social functioning at follow-up and the participant reported 
going into the town centre. 
   
3.3.9.6 Quality of life data 
Figure 3.72. Scores on the EQ-5D-5L VAS for Participant 9 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
There was an increase in quality of life over each phase.  However, scores were 
not stable over baseline (tau = 1.00, p<.01) making it difficult to attribute change to the 
intervention and not to natural improvement.  This should be considered. 
 
3.3.9.7 Participant summary 
 Mean social anxiety increased over the control/imagery rescripting phase and 
reliable and clinical change were not found.  An increase in mean visual analogue scale 
data for anxiety was observed from the control phase through to follow-up and scores 
remained high.  For the ideographic ratings, there was a small decrease in encapsulated 
                    Baseline                Cont/ImRs      Follow-up 
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belief ratings at follow-up but this remained high.  Imagery frequency decreased prior to 
imagery rescripting and remained stable and low.  The other ratings varied throughout 
the study and scores were high at follow-up.  Decreases in imagery distress and 
vividness over the control session suggests that this had some effect. 
 Psychotic symptoms remained stable and high and reliable and clinical change 
were not found.  Paranoia increased from the control phase and also remained high.  
There was no clinical change in depression.  There was a small increase in depression 
over the control/imagery rescripting phase and scores remained high at follow-up.  
Social functioning remained stable and low in the ‘severe social disability’ range.  
Quality of life increased over the study but an increasing trend at baseline makes it 
difficult to attribute change to the intervention and not natural improvement. 
Participant 9 reported that the intervention helped him to think about how to 
handle difficult situations.  However, he continued to experience severe social 
disability.  He found it difficult to take part in the imagery rescripting.  He did not feel 
comfortable enough to close his eyes and asked his girlfriend to stay in the room.     
 
 
 
 
 
 
 
 
 
 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
140 
 
 
 
3.3.10 Participant 10 
 Participant 10 is a 19 year-old white British male with Emotionally Unstable 
Personality Disorder.  He experienced an acute psychotic episode when he was 17 years 
old.  He explained that social anxiety and paranoia are his main difficulties.  He has a 
girlfriend and currently lives in a supported living environment for young people.   
 
3.3.10.1 Social anxiety data 
Figure 3.73. Scores on the SIAS for Participant 10 
  
Figure 3.74. Scores on the VAS-A for Participant 10 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
                    Baseline             Cont/ImRs            Follow-up  
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Table 3.21 
Visual inspection of SIAS data displayed in Figure 3.73. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
57.5 
 
+3 
 
No trend 
 
N 
 
N 
Cont/ImRs 46.5 -25 Decrease Y Y 
Follow-up 30.5 -7 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table 3.22 
Visual inspection of VAS-A data displayed in Figure 3.74. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.59 
 
-0.46 
 
Decrease 
Control 0.21 -0.36 Decrease 
Break 0.11 +0.16 Increase 
ImRs 0.17 -0.04 No trend 
One Wk FU 0.16 +0.02 No trend 
One Mnth FU 0.10 +0.14 Decrease 
 
 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
There was a decrease in social anxiety scores over the control/imagery 
rescripting and follow-up phases and reliable and clinical change were found.  VAS-A 
data were low at one month follow-up.  There was a shift down in anxiety over the 
control phase and no trend was observed over the imagery rescripting phase.  This 
suggests that the control phase had a greater effect.  Data were not stable over baseline 
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(tau =-.317, p<.05) making it difficult to attribute change in scores to the intervention.    
However, scores appear to stabilise across the phases and this should be considered. 
 
3.3.10.2 Encapsulated belief, memory and imagery data 
Figure 3.75. Scores on the Ideographic Ratings (Wild et al., 2008) for Participant 10 
  
                                     
Note. PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; Phases between control and imagery rescripting session and imagery rescripting session 
and follow-up indicate one week breaks. 
 
There were reductions in all ideographic ratings following imagery rescripting 
and scores were low at follow-up.  Imagery frequency reduced but was stable and low 
throughout the study.  There were small reductions in memory and imagery distress and 
imagery vividness over the control session suggesting that it had some effect.  See 
Appendix J for more detailed visual inspection.   
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3.3.10.3 Psychotic symptom and paranoia data 
Figure 3.76. Scores on the SSI for Participant 10 
 
Figure 3.77. Scores on the VAS-P for Participant 10 
  
Note.                  = Mean;               = Reliable change; BL = Baseline; BL END = End of 
baseline; PRE CONT = Pre-control; POST CONT = Post-control; PRE IMRS = Pre-imagery rescripting; 
POST IMRS = Post-imagery rescripting; ONE WK FU = One week follow-up; ONE MNTH FU = One 
month follow-up; ‘Cont/ImRs’ phase includes control and imagery rescripting sessions; Phases between 
POST CONT and PRE IMRS and POST IMRS and ONE WK FU indicate one week breaks.  
 
Psychotic symptoms were in the clinical range at baseline.  They decreased over 
the study and reliable change was found at one month follow-up.  There was fluctuation 
in VAS-P data over baseline but ratings stabilised and remained low from the control 
phase.  However, the data were not stable over baseline (tau = -.370, p<.05) and there 
were small increases in paranoia over the control and imagery rescripting phases.   
                   Baseline             Cont/ImRs            Follow-up 
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3.3.10.4 Depression data 
Figure 3.78. Scores on the DASS-D for Participant 10 
 
   
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Over baseline, depression was stable (tau = -.333, p>.05) and in the clinical 
range.  There was a decrease in scores over the study but clinical change was not found. 
 
3.3.10.5 Social functioning data 
Figure 3.79. Scores for TUS for Participant 10 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
                          Baseline          Cont/ImRs           Follow-up 
              Baseline                              Cont/ImRs       Follow-up 
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Social functioning increased over baseline and was in the ‘non-clinical’ range at 
the second assessment.  There was a decrease in social functioning over the 
control/imagery rescripting phase and scores were in the clinical range at follow-up.   
 
3.3.10.6 Quality of life data 
Figure 3.80. Scores on the EQ-5D-5L VAS for Participant 10 
  
Note.            = Mean; BL = Baseline; BL END = End of baseline; ONE WEEK FU = One week 
follow-up; ONE MNTH FU = One month follow-up; ‘Cont/ImRs’ phase includes control and imagery 
rescripting sessions. 
 
Quality of life was stable over baseline (tau = .183, p>.05).  There was an 
increase in mean scores over the study and scores were high at follow-up.  However, an 
increasing trend from the second baseline assessment suggests some natural 
improvement.  
  
3.3.10.7 Participant summary 
 Reliable and clinical change in social anxiety were found following the 
control/imagery rescripting and follow-up phases.  There was a trend in visual analogue 
scale data for anxiety over baseline making it difficult to attribute change to the 
intervention.  However, scores appear to stabilise over the course of the study and 
         
                   Baseline                           Cont/ImRs      Follow-up 
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follow-up scores were low.  This suggests that the intervention might have had an 
effect.  There was a shift down in anxiety scores over the control phase and no trend 
over the imagery rescripting phase suggesting that the control session had a greater 
effect.  All ideographic ratings decreased following imagery rescripting and scores were 
low at follow-up.  There were slight reductions in memory and imagery distress and 
imagery vividness over the control session suggesting that this had an effect.   
 Psychotic symptoms decreased over the control/imagery rescripting phase and 
reliable change was found at one month follow-up.  Although paranoia stabilised from 
the control session onwards, a decreasing trend over baseline and small increases in 
scores over the control/imagery rescripting phases makes it difficult to attribute this 
change to the intervention.  Depression decreased over the study but clinical change was 
not found.  Social functioning decreased over the control/imagery rescripting phase and 
remained in the clinical range.  Quality of life increased over the control/imagery 
rescripting phase and remained stable at follow-up.  However, there was an increasing 
trend from the second baseline assessment suggesting some natural improvement.       
Participant 10 reported that he benefited from the intervention and that he had 
“not really thought about” the image and the memory since completing it.  He reported 
feeling more confident and stated that he would be able to manage the situation if he 
bumped into the ‘bully’ again.  He no longer had concerns about being assaulted.  
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3.4 Group analyses 
 In this section the data are combined and analysed in reference to each 
hypothesis.  The total number of participants achieving reliable and/or clinical change 
are presented.  Friedman’s ANOVA is used to investigate significant change in data 
across the study and Wilcoxon’s tests are used to investigate differences between the 
control and imagery rescripting sessions.  Cohen’s d repeated measures effect sizes are 
also calculated for the sample.  Due to the small sample size these statistical analyses 
are exploratory and should be interpreted with some caution.  
3.4.1 Primary hypotheses 
3.4.1.1 Hypothesis one: There will be a reduction in social anxiety scores 
following imagery rescripting, measured one month after imagery rescripting 
 Table 3.23 shows reliable and clinical change in SIAS scores and outcome for 
all participants.  Five participants (1, 4, 5, 7 & 10) ‘recovered’ (Wise, 2004).  
Participant 2 achieved reliable and clinical change at follow-up but also achieved 
reliable change at baseline.  This suggests some natural improvement and this 
participant was therefore not classified as ‘recovered’.   
Three participants (1, 4 & 10) achieved reliable and clinical change following 
control/imagery rescripting and at follow-up.  This suggests that the intervention had an 
effect.  Two participants (5 & 7) achieved reliable and clinical change at follow-up only.  
This suggests that other factors may have been involved in any identified 
improvements.  For Participant 7, a decreasing trend was observed over the baseline 
phase and no trend was observed over the control/imagery rescripting phase.  This 
suggests that there might have been some natural improvement.  However, reliable and 
clinical change were not achieved over baseline suggesting that the intervention might 
also have had an effect.  
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Table 3.23 
Reliable and clinical change and outcome on the SIAS for all participants 
 
  
 
  Reliable change 
  
 
Clinical change 
 
 
 
Outcome 
 
 
Participant 
  
 
BL 
 
 
C/I 
 
 
FU 
  
 
BL 
 
 
C/I 
 
 
FU 
 
 
(based on Wise, 
2004) 
 
 
 
 
 
1 
  
 
 
N 
 
 
 
 
 
Y 
 
 
 
 
 
Y 
 
 
 
 
 
 
N 
 
 
 
 
 
 
Y 
 
 
 
 
 
 
Y 
 
 
 
Recovered 
 
 
 
 
 
2 
  
 
 
 
 
Y 
 
 
 
 
 
N 
 
 
 
 
 
Y 
 
 
 
 
 
 
N 
 
 
 
 
 
#N 
 
 
 
 
 
Y 
 
 
 
* 
 
 
 
 
3 
  
 
 
 
N 
 
 
 
 
N 
 
 
 
 
N 
 
 
 
 
 
N 
 
 
 
 
N 
 
 
 
 
N 
 
 
Unchanged 
 
 
 
4 
 
 
 
 
N 
 
 
 
Y 
 
 
 
Y 
 
 
 
 
N 
 
 
 
Y 
 
 
 
Y 
 
 
Recovered 
 
 
 
5 
 
 
 
 
N 
 
 
 
N 
 
 
 
Y 
 
 
N 
 
 
 
N 
 
 
 
Y 
 
 
Recovered 
 
 
 
6 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
Unchanged 
 
 
 
7 
 
 
 
 
N 
 
 
 
N 
 
 
 
Y 
 
 
 
 
N 
 
 
 
N 
 
 
 
Y 
 
 
Recovered 
 
 
 
8 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
Unchanged 
 
 
 
9 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
 
 
N 
 
 
 
N 
 
 
 
N 
 
 
Unchanged 
 
 
 
10 
 
 
 
 
N 
 
 
 
Y 
 
 
 
Y 
 
 
 
 
N 
 
 
 
Y 
 
 
 
Y 
 
 
Recovered 
 
 
 
Total 
 
 
 
 
1 
 
 
 
3 
 
 
 
6 
 
 
 
 
0 
 
 
 
3 
 
 
 
6 
 
 
Recovered = 5 
 
Note. BL = Baseline phase, C/I = Control/imagery rescripting phase, FU = Follow-up phase, Y = Yes, N 
= No, * = not classified as ‘recovered’ due to reliable change over the baseline phase. 
 
Using data from the full sample, Friedman’s ANOVA revealed significant 
change in SIAS scores over the phases, 2(2) = 6.20, p = .046.  Mean scores reduced 
from 57.40 (SD = 8.00) at baseline to 48.80 (SD = 15.29) at one week follow-up and 
42.50 (SD = 17.48) at one month follow-up.  Cohen’s d effect size for the SIAS was 
0.54 following the control/imagery rescripting phase and 0.93 at one month follow-up.      
These findings suggest that, for the sample, the intervention reduced social 
anxiety and this was maintained at one month follow-up.  The SIAS was administered 
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before the control session and after the imagery rescripting session.  It is therefore not 
possible to ascertain which session had a specific effect.  As the statistical tests are 
exploratory and mean scores remained in the clinical range, the findings should be 
interpreted with caution.  They should also be considered in the context of individual 
visual inspection, which indicates that some participants did not improve.   
3.4.1.2 Hypothesis two: There will be a reduction in visual analogue scale 
ratings related to anxiety following imagery rescripting 
 Eight participants (1, 3, 4, 5, 6, 7, 8 & 10) demonstrated a reduction in anxiety 
following imagery rescripting.  Reductions in anxiety were also observed over the 
control session for four participants (3, 5, 8 & 10) suggesting that it had an effect.  Data 
for two participants (5 & 10) were not stable over baseline suggesting some natural 
improvement.  Scores for three participants (6, 7 & 8) remained high.  This suggests 
that the intervention had limited effect for these participants.   
Friedman’s ANOVA revealed no significant change in anxiety over the phases, 
2(2) = 7.44, p = .055.  Mean scores were .64 (SD = .13) at baseline, .54 (SD = .24) at 
post-control, .47 (SD = .23) at post-imagery rescripting and .43 (SD = .31) at one month 
follow-up.  Cohen’s d effect sizes were 0.49 following the control session, 0.50 
following the imagery rescripting session and 0.69 at one month follow-up. 
 Following Wild et al. (2008), mean difference scores for the control and imagery 
rescripting sessions were compared.  Mean difference for the control was .08 (SD = .12) 
and mean difference for the imagery rescripting was .12 (SD = .17).  A Wilcoxon test 
revealed no significant difference between the sessions (z = -6.52, p = .570).   
 These findings suggest that the intervention reduced anxiety in most 
participants.  In some cases anxiety reduced over the control session suggesting that it 
had an effect.  However, the statistical analyses suggest that any changes over the study 
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and any differences between the sessions was not significant.  Again, the exploratory 
nature of these tests and the results from the individual analyses should be considered. 
3.4.1.3 Hypothesis three: There will be a reduction in encapsulated belief and 
memory distress ratings related to negative imagery following imagery 
rescripting 
Nine participants (1, 2, 3, 4, 5, 6, 8, 9 & 10) demonstrated a reduction in 
encapsulated belief ratings following imagery rescripting.  However, for participants 6 
and 9, only small decreases in scores were observed.  For Participant 8, scores increased 
and remained high at follow-up.  Furthermore, four participants (1, 3, 5 & 8) 
demonstrated reductions in encapsulated belief ratings over the control session.  This 
suggests that this session had an effect for these participants. 
Friedman’s ANOVA revealed significant change in encapsulated belief ratings 
over the study phases, 2(2) = 15.89, p = <0.001.  Mean scores were 94.10 (SD = 6.37) 
at pre-control, 86.10 (SD = 14.69) at post-control, 52.70 (SD = 34.97) at post-imagery 
rescripting and 52.00 (SD = 36.09) at one month follow-up.  Cohen’s d effect sizes for 
encapsulated belief ratings were 0.68 following the control session, 1.68 following the 
imagery rescripting session and 1.52 at one month follow-up. 
A Wilcoxon test revealed a significant difference between the control and 
imagery rescripting sessions (z = -2.10, p = .039) in encapsulated belief ratings.  Mean 
difference was 8.00 (SD = 14.56) for the control session and 32.40 (SD = 30.94) for the 
imagery rescripting session.  This suggests the imagery rescripting had an effect on 
encapsulated belief but the control session did not.   
Nine participants (1, 2, 3, 4, 5, 6, 7, 9 & 10) demonstrated a reduction in 
memory distress ratings following imagery rescripting.  However, for Participant 9, a 
large increase in scores was observed at one week follow-up and this was maintained at 
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one month follow-up.  Four participants (1, 3, 5 & 10) demonstrated reduction in 
memory distress ratings over the control session.  This suggests that this session had an 
effect for these participants.      
Friedman’s ANOVA revealed a significant change in memory distress over the 
phases, 2(2) = 7.99, p = .042.  Mean scores were 72.70 (SD = 15.55) at pre-control, 
73.70 (SD = 21.81) at post-control, 59.10 (SD = 31.89) at post-imagery rescripting and 
46.60 (SD = 33.53) at one month follow-up.  Cohen’s d effect sizes for memory distress 
ratings were 0.05 following the control session, 0.41 following the imagery rescripting 
session and 1.09 at one month follow-up.  Despite the difference in effect size, a 
Wilcoxon test revealed no significant difference between the control and imagery 
rescripting sessions (z = -.712, p = .504) in memory distress ratings.   
The statistical analyses suggest that the intervention reduced encapsulated belief 
and memory distress ratings.  They also suggest that the imagery rescripting session 
(but not the control session) had an effect on encapsulated belief ratings.  However, 
some participants did not improve and some demonstrated reductions in encapsulated 
belief ratings over the control session.  The exploratory nature of the statistical testing 
should be therefore be considered.    
3.4.1.4 Hypothesis four: There will be a reduction in distress, vividness and 
frequency ratings related to negative imagery following imagery rescripting 
 Nine participants (1, 2, 3, 4, 5, 6, 7, 8 & 10) demonstrated a reduction in 
imagery distress following imagery rescripting.  However, reductions for three 
participants (6, 7 & 8) were small and this should be considered.  Also, for Participant 
8, there was an increase in scores at one month follow-up.  Eight participants (1, 2, 3, 5, 
6, 7, 9 & 10) demonstrated reductions in imagery distress over the control session.  This 
suggests that this session had an effect.   
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Friedman’s ANOVA revealed significant change in imagery distress over the 
study phases, 2(2) = 14.81, p = .001.  Mean scores were 84.40 (SD = 14.55) at pre-
control, 78.60 (SD = 18.08) at post-control, 67.60 (SD = 28.34) at post-imagery 
rescripting and 46.40 (SD = 34.80) at one month follow-up.  Cohen’s d effect sizes were 
0.29 following the control session, 0.59 following the imagery rescripting session and 
1.40 at one month follow-up.  Despite the difference in effect size, a Wilcoxon test 
revealed no significant difference between the control and imagery rescripting sessions 
(z = -.204, p = .865) in imagery distress ratings.   
 Six participants (3, 4, 5, 6, 7 & 10) demonstrated reductions in imagery 
vividness following imagery rescripting.  However, scores for Participant 3 remained 
high and did not show an overall improvement.  For Participant 6, there was a large 
increase in scores over the imagery rescripting session but this reduced at follow-up.  
Scores for Participant 7 decreased before imagery rescripting and remained stable 
throughout the study.  Reductions in imagery vividness were observed over the control 
session for four participants (1, 7, 9 & 10) suggesting that this session had an effect.     
Friedman’s ANOVA revealed no significant change in imagery vividness over 
the study phases, 2(2) = 4.46, p = .220.  Cohen’s d effect sizes were 0.02 following the 
control session, 0.59 following the imagery rescripting session and 0.79 at one month 
follow-up.  Despite the difference in effect size, a Wilcoxon test revealed no significant 
finding between difference scores for the control and imagery rescripting sessions (z = -
.459, p = .695) in imagery vividness ratings.   
 All participants demonstrated reductions in imagery frequency following 
imagery rescripting.  However, for seven participants (1, 2, 3, 4, 6, 7 & 10), scores 
remained low throughout the study.  No participants demonstrated reductions in 
imagery frequency over the control session suggesting that it did not have an effect.      
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Friedman’s ANOVA revealed significant change in imagery frequency over the 
phases, 2(2) = 19.07, p<.001.  Mean scores were 27.00 (SD = 30.09) at pre-control, 
29.60 (SD = 34.61) at post-control, 27.00 (SD = 45.12) at post-imagery rescripting and 
4.00 (SD = 7.82) at one month follow-up.  Cohen’s d effect sizes were 0.06 following 
the control session, 0.00 following the imagery rescripting session and 0.89 at one 
month follow-up.  A Wilcoxon test revealed no significant difference between the 
control and imagery rescripting sessions (z = -.412, p = .813) in imagery frequency 
ratings.   
 Overall, these findings suggest that the intervention had an effect on imagery 
distress and frequency.  Large effect sizes at one month follow-up suggests that the 
intervention may have had a greater effect with time.  Non-significant differences 
between the control and imagery rescripting sessions suggest that both had an effect.  
However, a number of participants did not demonstrate reductions in imagery distress 
and frequency over the control session and this should be considered.  
Although no significant differences were found for imagery vividness, medium 
effect sizes were found and some participants did improve.  Similarly, some participants 
did not demonstrate reductions in imagery distress and frequency.  Again, the 
exploratory nature of the statistical analyses must be taken into account. 
3.4.2 Research questions 
3.4.2.1 What is the effect of imagery rescripting on psychotic symptoms and 
paranoia in people with psychosis and social anxiety? 
 Psychotic symptoms remained stable and in the clinical range for six participants 
(1, 2, 3, 6, 8 & 9).  Two participants achieved reliable change in scores.  One participant 
(5) achieved reliable change over the control/imagery rescripting and follow-up phases 
and one participant (10) achieved reliable change over the follow-up phase.  Two 
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participants (4 & 7) achieved clinical change at one week and one month follow-up and 
one participant (5) achieved clinical change at one month follow-up.  However, a 
decreasing trend was observed for Participant 5 over baseline suggesting some natural 
improvement. 
Friedman’s ANOVA revealed significant change in psychotic symptoms over 
the phases, 2(2) = 9.39, p = .007.  Mean scores reduced from 39.50 (SD = 13.06) at 
baseline to 34.10 (SD = 14.77) at one week follow-up and 29.40 (SD = 15.39) at one 
month follow-up.  Cohen’s d effect sizes were 0.38 following the control/imagery 
rescripting phase and 0.70 at one month follow-up.  However, most participants 
remained in the clinical range.  Again, the exploratory nature of these statistical 
analyses should be considered. 
Paranoia appeared to stabilise for three participants (1, 7 & 10) over the course 
of the study.  Decreases in trend were observed for two participants (5 & 8) over the 
imagery rescripting session.  However, decreases were also observed for these 
participants over the control session suggesting that this might have had an effect.  
Paranoia remained high for three participants (3, 8 & 9).  Participant 2 experienced an 
increase in scores from the control session through to follow-up.  However, there was 
variation in this participant’s scores over the study and this should be considered.   
Friedman’s ANOVA revealed that there was no significant change in paranoia 
scores over the phases, 2(2) = 5.79, p = .122.  Mean scores were .53 (SD = .24) at 
baseline, .46 (SD = .30) at post-control, .40 (SD = .30) at one week follow-up and .44 
(SD = .40) at one month follow-up.  This indicates that for the sample, paranoia 
remained largely stable.  Cohen’s d effect sizes for the VAS-P were 0.25 following the 
control session, 0.26 following the imagery rescripting session and 0.23 at one month 
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follow-up.  A Wilcoxon test revealed no significant difference between the control and 
imagery rescripting sessions (z = -.070, p = .984) in paranoia ratings.   
The findings suggest that imagery rescripting only had an effect on psychotic 
symptoms for some participants.  A medium effect size at one month follow-up 
suggests that the intervention might have had an effect with time.  However, it is 
important to note that the statistical testing was exploratory and mean scores remained 
in the clinical range.  The group analyses indicate that there was no change in paranoia 
following imagery rescripting.  However, some participants experienced improvement 
in paranoia and some experienced deterioration.   This should be considered. 
3.4.2.2 What is the effect of imagery rescripting on depression in people with 
psychosis and social anxiety? 
Depression remained in the clinical range for eight participants (1, 2, 3, 4, 6, 8, 9 
& 10).  Participant 5 achieved clinical change at one month follow-up and Participant 7 
achieved clinical change at one week and one month follow-up.  Reliable change data 
were not available and the findings should be interpreted with caution.      
Friedman’s ANOVA revealed no significant change in depression over the study 
phases, 2(2) = 3.13, p = .233.  Mean scores were 13.30 (SD = 3.99) at baseline, 10.90 
(SD = 5.55) at one week follow-up and 11.70 (SD = 6.50) at one month follow-up.  This 
indicates that for the sample, depression remained stable.  Cohen’s d effect sizes were 
0.53 following the control/imagery rescripting phase and 0.34 at one month follow-up.   
The findings suggest that the imagery rescripting had limited effect on 
depression.  However, two participants did achieve clinical change and the exploratory 
nature of the statistical testing should be considered.   
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3.4.2.3 What is the effect of imagery rescripting on social functioning and 
quality of life in people with psychosis and social anxiety? 
No participants achieved clinical change in social functioning.  Friedman’s 
ANOVA revealed no significant change in social functioning over the phases, 2(2) = 
.684, p = .733.  Mean scores were 21.14 (SD = 15.69) at baseline, 20.26 (SD = 16.51) at 
one week follow-up and 19.91 (SD = 15.66) at one month follow-up.  This indicates 
that for the sample as a whole, social functioning remained stable and low (i.e. below 
the 30 hours per week clinical cut-off).  Cohen’s d effect sizes for the TUS were 0.05 
following the control/imagery rescripting phase and 0.08 at one month follow-up. 
Quality of life increased for seven participants (1, 3, 4, 5, 7, 9 & 10) following 
imagery rescripting.  However, two participants (1 & 4) rated highly throughout the 
study and four participants (3, 5, 9 & 10) demonstrated improvements over the baseline 
period.  This makes it difficult to attribute change to the intervention.  For two 
participants (6 & 8) scores decreased at follow-up.  This suggests that the imagery 
rescripting had limited effect on quality of life for these participants.     
Friedman’s ANOVA revealed a significant change in EQ-5D-5L VAS scores 
over the phases, 2(2) = 10.32, p = .004.  Mean scores were 54.55 (SD = 16.39) at 
baseline, 72.10 (SD = 17.51) at one week follow-up and 68.10 (SD = 24.42) at one 
month follow-up.  Cohen’s d effect sizes for the EQ-5D-5L VAS were 0.97 following 
the control/imagery rescripting phase and 0.61 at one month follow-up.   
Overall these findings suggest that imagery rescripting had a positive effect on 
quality of life.  A medium effect size at one month follow-up (compared to a large 
effect size following the control/imagery rescripting phase) might suggest that any 
effects were time-limited.  However, the exploratory nature of the analyses should be 
considered.  
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3.5 Treatment fidelity 
Analysis of the tape ratings completed by a Clinical Psychologist revealed that 
there was 98% concordance with the imagery rescripting script adapted from Wild & 
Clark (2011).  Omissions included not asking two participants (1 & 3) whether they had 
any questions before starting the imagery rescripting and not asking three participants 
(8, 9 & 10) how they felt and how the memory felt to them following the imagery 
rescripting.  The completed rating sheets are included in Appendix K.       
3.6 Chapter conclusion 
Five participants (1, 4, 5, 7 & 10) achieved reliable and clinical change in social 
anxiety at one month follow-up and were classified as ‘recovered’ (Wise, 2004).  
Reductions in visual analogue scale data for anxiety and ideographic ratings were also 
observed.  Group analyses revealed significant changes in social anxiety, encapsulated 
belief, memory and imagery distress and imagery frequency ratings.  Medium to large 
effect sizes were also found.  However, these analyses were exploratory and some 
participants did not improve.  This should be considered.   
Overall the data suggest that the imagery rescripting had no adverse effects on 
psychotic symptoms, paranoia, depression, social functioning or quality of life.  For 
psychotic symptoms, two participants (5 & 10) achieved reliable change and three 
participants (4, 5 & 7) achieved clinical change.  Reductions in paranoia data were also 
observed in some participants.  Two participants (5 & 7) achieved clinical change in 
depression.  No participants achieved clinical change in social functioning, but quality 
of life increased for some participants.  Group analyses revealed significant changes in 
psychotic symptoms and quality of life.  Medium to large effect sizes were also found.   
Non-significant differences were found between the control and imagery 
rescripting sessions for anxiety, memory and imagery distress, imagery vividness and 
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frequency and paranoia.  This suggests that both sessions had an effect.  However, some 
participants did not demonstrate change over the control session.  Again, the 
exploratory nature of the statistical analyses should be considered.   
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CHAPTER FOUR 
4. Discussion 
4.1 Overview 
 This chapter summarises the results of the study in reference to each hypothesis 
with a focus on both visual inspection and the exploratory group analyses. The results 
are discussed in relation to existing psychological literature.  Effect sizes are compared 
to those calculated using data from Wild et al. (2008) to investigate differences in 
efficacy between the studies.  The clinical implications of the findings are discussed 
with a focus on the appropriate use of imagery rescripting with people with psychosis 
and social anxiety. The strengths and limitations of the current study are highlighted and 
avenues for future research are identified. 
4.2 Summary of results 
4.2.1 Primary hypotheses 
4.2.1.1 Hypothesis one: There will be a reduction in social anxiety scores 
following imagery rescripting, measured one month after imagery rescripting 
 In support of hypothesis one, five participants (1, 4, 5, 7 & 10) achieved reliable 
and clinical change in social anxiety at one month follow-up and were classified as 
‘recovered’ (Wise, 2004).  Although reliable and clinical change were also found for 
Participant 2, reliable change was observed over the baseline phase.  This suggests some 
natural improvement and makes it difficult to attribute change to the intervention.   
Four participants (3, 6, 8 & 9) did not achieve reliable and clinical change at 
follow-up and were classified as ‘unchanged’ (Wise, 2004).  Scores for these 
participants remained largely stable and high throughout the study.  This does not 
support hypothesis one, indicating that the imagery rescripting did not always lead to a 
reduction in social anxiety, measured one month after the rescripting.   
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The group analyses revealed a significant change in social anxiety across the 
study and medium to large effect sizes were found following imagery rescripting.  
Although this offers further support for hypothesis one, mean scores remained in the 
clinical range.  This suggests that for the sample as a whole the intervention had limited 
effect.  However, the exploratory nature of these analyses should be considered.  It 
should also be noted that some participants did achieve change in social anxiety 
following imagery rescripting.  
Overall the findings offer partial support for hypothesis one, indicating that 
social anxiety reduced following imagery rescripting in some participants but not all.     
4.2.1.2 Hypothesis two: There will be a reduction in visual analogue scale 
ratings related to anxiety following imagery rescripting 
 In support of hypothesis two, eight participants (1, 3, 4, 5, 6, 7, 8 & 10) 
demonstrated a reduction in anxiety following imagery rescripting.  However, for some 
participants data were unstable over baseline (5 & 10) or only minimal changes were 
observed (6, 7 & 8).  This makes it difficult to attribute change to the intervention rather 
than other factors (e.g. natural improvement or measurement variability).  Furthermore, 
reductions in anxiety were observed for four participants (3, 5, 8 & 10) over the control 
session.  This suggests that the control session also had an effect for these participants.    
Two participants (2 & 9) did not demonstrate reduction in anxiety following 
imagery rescripting.  Instead, scores increased from the control session through to 
follow-up.  These findings do not support hypothesis two, indicating that the imagery 
rescripting did not always lead to a reduction in anxiety ratings.            
  The group analyses revealed no significant change in anxiety and medium effect 
sizes were found across the study.  Again, these findings do not support hypothesis two.  
However, the majority of participants did show some improvement in anxiety and the 
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results of these exploratory analyses should be treated with caution.   
Overall the findings offer partial support for hypothesis two, indicating that the 
imagery rescripting led to some reduction in anxiety in most participants.  Whereby 
imagery rescripting did lead to reduction in anxiety, the magnitude of change varied 
between participants, with some benefiting more than others.  However, the group 
analyses should be interpreted with caution.        
4.2.1.3 Hypothesis three: There will be a reduction in encapsulated belief and 
memory distress ratings related to negative imagery following imagery 
rescripting 
 In support of hypothesis three, nine participants (1, 2, 3, 4, 5, 6, 8, 9 & 10) 
demonstrated a reduction in encapsulated belief ratings following imagery rescripting.  
However, for three participants (6, 8 & 9) the overall change was minimal.  One 
participant (7) did not demonstrate a reduction in encapsulated belief, consistently rating 
it as ‘100’.  This does not support hypothesis three, suggesting that a reduction in 
encapsulated belief ratings was not always observed following imagery rescripting.  
Furthermore, four participants (1, 3, 5 & 8) demonstrated a reduction in encapsulated 
belief ratings over the control session, suggesting that this had an effect.   
 In further support of hypothesis three, nine participants (1, 2, 3, 4, 5, 6, 7, 9 & 
10) demonstrated reductions in memory distress ratings following imagery rescripting.  
However, for Participant 9 there was a small increase in ratings over the imagery 
rescripting phase and a large increase at follow-up.  In contrast to hypothesis three, 
Participant 8 did not demonstrate a reduction in memory distress ratings following 
imagery rescripting.  Furthermore, scores for this participant increased over the study.  
A reduction in memory distress ratings was observed for four participants (1, 3, 5 & 10) 
over the control session.  This suggests that this had an effect for these individuals. 
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 The group analyses revealed a significant difference in encapsulated belief 
ratings over the study phases.  Large effect sizes were found following imagery 
rescripting, compared to a medium effect size following the control session.  This offers 
further support for hypothesis three.  A significant difference in memory distress ratings 
was also found across the study phases.  A small effect size was found following the 
control session, a medium effect size was found following imagery rescripting and large 
effect size was found at follow-up.  Although this offers support for hypothesis three it 
is important to interpret the findings from the exploratory analyses with caution.  
However, most participants did demonstrate reduction in memory distress following 
imagery rescripting and this should be considered.   
 Overall, the findings support hypothesis three, indicating that there was a 
reduction in encapsulated belief and memory distress ratings following imagery 
rescripting in most participants.  The group analyses support this, highlighting 
significant reductions in encapsulated belief and memory distress following imagery 
rescripting.  Again, the exploratory nature of the statistics should be considered. 
4.2.1.4 Hypothesis four: There will be a reduction in distress, vividness and 
frequency ratings related to negative imagery following imagery rescripting 
 In support of hypothesis four, nine participants (1, 2, 3, 4, 5, 6, 7, 8 & 10) 
demonstrated reduction in imagery distress ratings following imagery rescripting, six 
participants (3, 4, 5, 6, 7 & 10) demonstrated reductions in imagery vividness and all 
participants demonstrated reductions in imagery frequency.  However, three participants 
(6, 7 & 8) only achieved small reductions in imagery distress.  Imagery vividness scores 
also remained high for Participant 3.  For seven participants (1, 2, 3, 4, 6, 7, & 10), 
imagery frequency was low throughout the study.  This should be considered.   
 One participant (9) did not demonstrate a reduction in imagery distress ratings 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
163 
 
following imagery rescripting.  Although there was variation in scores, four participants 
(1, 2, 8 & 9) did not show an overall reduction in imagery vividness and scores 
remained high for these participants at follow-up.  This does not support hypothesis four 
and suggests that imagery rescripting did not lead to reductions in imagery distress and 
vividness ratings in all participants.  Over the control session, a reduction in imagery 
distress ratings was observed for eight participants (1, 2, 3, 5, 6, 7, 9 & 10) and a 
reduction in imagery vividness was observed for four participants (1, 7, 9 & 10).  This 
suggests that the control session had an effect for these individuals.    
  In further support of hypothesis four, the group analyses revealed significant 
changes in imagery distress and frequency across the study.  For imagery distress, 
medium to large effect sizes were found after imagery rescripting, compared to a small 
effect size after the control session.  For imagery frequency, a large effect size was 
found at follow-up compared to small effect sizes following the control and imagery 
rescripting sessions.  This suggests a delayed effect on imagery frequency ratings.  
There was no significant change in imagery vividness over the study phases but medium 
effect sizes were found following imagery rescripting and at follow-up, compared to a 
small effect size following the control session.  These findings offer partial support for 
hypothesis four.  However, the exploratory nature of the analyses should be considered.     
Overall the findings offer partial support for hypothesis four, suggesting that 
imagery rescripting led to a reduction in imagery distress, vividness and frequency in 
most participants but not all.  This is supported by the group analyses which indicate 
significant change in imagery distress and frequency across the study phases.  Although 
the group analyses revealed a non-significant reduction in imagery vividness, some of 
the participants did improve and medium effect sizes were found following imagery 
rescripting.  This should be taken into account when interpreting the findings.      
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4.2.2 Research questions 
4.2.2.1 What is the effect of imagery rescripting for social anxiety on psychotic 
symptoms and paranoia in people with psychosis? 
Psychotic symptoms remained stable and in the clinical range for six participants 
(1, 2, 3, 6, 8 & 9) following imagery rescripting.  This suggests that the imagery 
rescripting had no effect on psychotic symptoms for these participants.  Reliable change 
was found for two participants (5 & 10) and clinical change was found for three 
participants (4, 5 & 7).  However, a decreasing trend was observed over baseline for 
Participant 5.  This suggests some natural improvement and should be considered.   
The group analyses revealed a significant reduction in psychotic symptoms over 
the study and a medium effect size was found at follow-up.  This suggests that for the 
sample the imagery rescripting had a positive effect on psychotic symptoms.  However, 
mean scores remained in the clinical range suggesting that any effect was limited.  The 
exploratory nature of the statistical analyses should also be taken into account.       
Paranoia appeared to stabilise for three participants (1, 7 & 10) suggesting that 
the imagery rescripting had a positive effect.  Improvements in paranoia were observed 
for two participants (5 & 8) over the imagery rescripting session.  However, 
improvements were also observed over the control session for these participants, 
suggesting that it had an effect.  Paranoia remained high for three participants (3, 8 & 9) 
and Participant 2 demonstrated an increase in scores from the control session through to 
follow-up.  This suggests that the imagery rescripting might have had a negative effect 
on paranoia for Participant 2.  For some participants (2, 5 & 8) there was variation in 
scores throughout the study and this should be considered.   
The group analyses revealed no significant change in paranoia and small effect 
sizes over the course of the study.  This suggests that the imagery rescripting did not 
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have an effect on paranoia.  However, it should be considered that these statistics were 
exploratory and some participants did show improvements.  
Overall, psychotic symptoms remained stable for most participants and the 
imagery rescripting only had a positive effect for some.  For paranoia, both positive and 
negative effects were observed.  Although the group analyses suggest a significant 
reduction in psychotic symptoms and no change in paranoia, they were exploratory and 
should therefore be interpreted with caution.     
4.2.2.2 What is the effect of imagery rescripting for social anxiety on depression 
in people with psychosis? 
 Clinical change in depression was observed in two participants (5 & 7) at 
follow-up suggesting that the imagery rescripting had a positive effect for these 
individuals.  Reliable change data for the DASS-D were unavailable and this should 
therefore be interpreted with caution.   
Scores for all other participants remained in the clinical range suggesting that 
the imagery rescripting had no effect for these individuals.  The group analyses revealed 
no significant change in depression over the study.  Although a medium effect size was 
found following imagery rescripting, a small effect size was found at follow-up.  
Overall the findings suggest that the imagery rescripting had limited effect on 
depression.  However, the exploratory nature of the statistics should be considered.   
4.2.2.3 What is the effect of imagery rescripting for social anxiety on social 
functioning and quality of life in people with psychosis?  
 No participants achieved clinical change in social functioning.  The group 
analyses revealed no significant change over the study phases and small effect sizes 
were found following imagery rescripting and at follow-up.  This indicates that the 
imagery rescripting had no effect on social functioning.   
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 Quality of life scores increased for seven participants (1, 3, 4, 5, 7, 9 & 10) 
following imagery rescripting.  However, increases in trend at baseline were observed 
for four participants (3, 5, 9 & 10) suggesting some natural improvement.  Also, scores 
for two participants (1 & 4) were high throughout the study.  A decrease in quality of 
life scores was observed for two participants (6 & 8) at follow-up.   
Group analyses revealed a significant change in quality of life scores over the 
study and a large effect size following imagery rescripting.  This suggests that the 
imagery rescripting had a positive effect on quality of life.  However, a medium effect 
size was found at follow-up suggesting that any effect was time-limited.  The 
exploratory nature of these statistics should also be considered in interpretation.   
4.3 Qualitative information 
 It is worth noting that all participants reported benefiting from the imagery 
rescripting in some way.  Participant 6 explained that it helped him to consider his 
actions in the remembered event but he found it difficult to describe himself in the third 
person.  Likewise, Participant 7 reported some benefit but found it difficult to visualise 
himself in the event.  Both participants had Asperger’s syndrome and their performance 
may have been influenced by the difficulties associated with their diagnosis.   
Participant 8 felt that the imagery rescripting allowed him to consider other 
perspectives, but he stopped and asked for reassurance part way through as he thought 
he had said something inappropriate.  Participant 9 felt that the imagery rescripting 
allowed him to think about how to handle difficult situations.  However, he did not want 
to close his eyes and there was background noise during the imagery rescripting.  This 
might have affected the efficacy of the intervention and should be considered. 
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4.4 Links to existing literature 
The findings will be evaluated in reference to the literature presented in the first 
chapter.  The individual and group analyses will be considered, as well as the 
encapsulated belief, memory and imagery data obtained for each participant. 
4.4.1 Imagery rescripting 
As with research investigating imagery rescripting in social phobia (e.g. Frets et 
al., 2014; Lee & Kwon, 2013; Nilsson et al., 2012; Wild et al., 2007; Wild et al., 2008) 
the group analyses found significant reductions in social anxiety following imagery 
rescripting.  In line with Wild et al. (2007, 2008), significant reductions in encapsulated 
belief, memory and imagery distress and imagery frequency ratings were also found.  
However, the individual analyses highlighted that not all participants improved on these 
measures.  Unlike Wild et al. (2007, 2008), the group analyses did not find significant 
reductions in imagery vividness.  However, some participants did improve on these 
measures and this should also be considered.  
Table 4.1 displays effect sizes for the current study and for Wild et al’s (2008) 
study.  Unfortunately Wild et al. (2008) do not provide post-control session data for 
imagery distress, vividness or frequency.  Instead, the post-control session effect sizes 
for Wild et al’s (2008) imagery ratings were calculated using pre-control and pre-
imagery rescripting session data.  This should be considered in interpretation.   
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Table 4.1  
Effect sizes for the current study and Wild et al’s (2008) study 
 
 
Current study 
  
Wild et al. (2008) 
Measure 
 
Post-
Cont 
 
Post-
IMRS 
Follow-
up 
  
Post-
Cont 
Post-
IMRS 
Follow-
up 
Social anxiety * 0.54 0.93  0.04 1.09 1.04 
Encapsulated belief 0.68 1.68 1.52  0.49 2.71 2.54 
Memory distress 0.05 0.41 1.09  0.27 2.25 1.81 
Imagery distress 0.29 0.59 1.40  0.08 * 1.17 
Imagery vividness 0.02 0.59 0.79  0.34 * 1.17 
Imagery frequency 0.06 0.00 0.89  0.23 * 0.24 
Note. Post-Cont = post-control; Post-IMRS = post-imagery rescripting; * = data were not available to 
calculate effect sizes; imagery distress, vividness and frequency data for Wild et al. (2008) calculated 
using pre-control and pre-imagery rescripting session data; follow-up for Wild et al. (2008) was one 
week, follow-up for the current study was one month. 
 
In the current study, medium to large effect sizes were found following the 
imagery rescripting session and at follow-up (with the exception of memory distress and 
imagery frequency, which yielded a medium and small effect size following the 
imagery rescripting session, respectively).  This is compared to large effect sizes in 
Wild et al’s (2008) study (with the exception of imagery frequency which yielded a 
small effect size at follow-up).  Overall these findings suggest that imagery rescripting 
is slightly less efficacious in the current study.  However, the exploratory nature of 
these calculations must be considered. 
In both studies, small effect sizes were found following the control session (with 
the exception of encapsulated belief in the current study, which yielded a medium effect 
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size).  This suggests that in both studies the imagery rescripting session had a greater 
effect than the control session.  However, the effect sizes for the current study should be 
interpreted in the context of the findings presented above, which indicate that some 
participants showed greater improvements over the control session than the imagery 
rescripting session.     
In support of Wild et al. (2008) the group analyses found a significant difference 
between the control and imagery rescripting sessions in the reduction of encapsulated 
belief ratings.  Mean difference scores were higher for the imagery rescripting session 
suggesting a greater effect.  However, four participants (1, 3, 5 & 8) achieved reductions 
in encapsulated belief over the control session.  This differs from Wild et al’s (2008) 
findings, suggesting that the control session might have had an effect for some 
participants.  The exploratory nature of the group analysis should be considered. 
The group analyses revealed no significant difference between the control and 
imagery rescripting sessions in VAS-A data or memory distress ratings.  This is 
contrary to Wild et al’s (2008) finding that there was a significant difference between 
the sessions for social anxiety and memory distress ratings.  In the current study, four 
participants (3, 5, 8 & 10) demonstrated reductions in anxiety and four participants (1, 
3, 5 & 10) demonstrated reductions in memory distress over the control session.  These 
findings suggest that the control session might have had an effect for some participants.  
Again, the exploratory nature of the group analyses should be considered. 
Even though changes were observed over the control session for some 
participants, greater improvement was often observed over the imagery rescripting 
session.  For instance, Participant 5 achieved greater improvement in anxiety, two 
participants (5 & 8) achieved greater improvement in encapsulated belief ratings and 
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three participants (1, 3 & 5) achieved greater improvement in memory distress ratings.  
This offers support for Wild et al. (2008) and should be considered.       
Wild et al. (2008) did not calculate difference scores for imagery distress, 
vividness or frequency.  In the current study, no significant differences were found 
between the control and imagery rescripting sessions for these ratings.  Eight 
participants (1, 2, 3, 5, 6, 7, 9 & 10) demonstrated reductions in imagery distress and 
four participants (1, 7, 9 & 10) demonstrated reductions in imagery vividness over the 
control session suggesting that this had an effect for these participants.   
No participants demonstrated change in imagery frequency over the control 
session.  Imagery frequency was rated for the preceding week and all participants 
duplicated their pre-control session rating at post-control.  Although no significant 
difference was found between the control and imagery rescripting sessions, scores for 
seven participants (1, 2, 3, 4, 6, 7 & 10) were low throughout the study and change was 
minimal.  This should be considered in interpretation of the group analysis.  No 
significant difference was found between the control and imagery rescripting sessions 
for paranoia.  Although paranoia decreased for two participants (5 & 8) over the 
imagery rescripting session, reductions were also observed over the control session. 
Despite the calculated differences in effect size between the control and imagery 
rescripting sessions, the findings from the current study suggest that the control session 
did have an effect for some participants.  This is contrary to data provided by Wild et al. 
(2008) that suggests it had no effect.  In the current study, exposure to the image and 
memory in the control session might have led to improvements.   
4.4.2 Theories related to imagery rescripting 
The observed change in some participants and the significant group findings can 
be explained using theoretical models of imagery rescripting.  In reference to Arntz and 
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Weertman’s (1999) work, it is possible that the final stage of the procedure allowed 
participants to introduce new information to their younger representation of self.  In 
support, emotional processing theory (Foa & Kozak, 1986) would suggest that the 
imagery rescripting encouraged exposure to the fear memory and modification of this 
using new and corrective information.  In reference to Teasdale and Barnard’s (1993) 
interacting cognitive subsystems theory, the imagery rescripting might have allowed 
information to move from the propositional (“knowing”) to the implicational (“feeling”) 
subsystem, allowing the participants’ memories to be reappraised.  
In addition, it is possible that the imagery rescripting changed the meaning of 
the chosen event through US revaluation, whereby the distressing memory represented 
the US.  This might have allowed participants to generalise to other contexts (Arntz, 
2011) and use a positive image in place of the original distressing image (Arntz, 2012).  
Finally, Brewin’s (2006) retrieval competition hypothesis would suggest that the 
imagery rescripting allowed the participants to increase the strength of their positive 
representations of self through the introduction of new information, replacing their pre-
existing negative representations.  
4.4.3 CBT for social anxiety in psychosis 
 Although the group findings suggest that imagery rescripting may be an 
effective intervention for social anxiety in people with psychosis, five out of the 10 
participants did not ‘recover’ (Wise, 2004).  This suggests that whilst effective for 
some, it may not work for all.  Nevertheless, the current study does offer some support 
for studies investigating cognitive behavioural interventions for social anxiety in people 
with psychosis (e.g. Gega et al., 2013; Good, 2002; Halperin et al., 2000; Kingsep et al., 
2003; Tully & Edwards, 2009).  Whilst they should be interpreted with caution, the 
effect sizes presented above are comparable to the medium to large effect sizes 
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calculated for some of the studies investigating the utility of CBT for social anxiety in 
people with psychosis (e.g. Gega et al., 2013; Kingsep et al., 2003).  They can also be 
compared to the effect sizes for CBT for social phobia (e.g. Gil et al., 2001).  
4.4.4 Cognitive-behavioural models 
Although the main purpose of this research is to investigate the efficacy of 
imagery rescripting for social anxiety in people with psychosis, the data obtained also 
offer support for cognitive-behavioural models.  For instance, all participants 
experienced dysfunctional beliefs about themselves, other people or the world, based on 
negative life experiences (Garety et al., 2001; Morrison, 2001).  In reference to models 
of social anxiety, the participants also appeared to experience a shift in attention 
towards themselves (Clark & Wells, 1995) and mental representations of how they 
believed they were perceived by others (Rapee & Heimberg, 1997). 
4.4.5 Models of psychosis and social anxiety 
The data obtained in the current study can be applied to models of psychosis and 
social anxiety.  In reference to Michail and Birchwood’s (2009) pathways model, 
themes of persecution from others were common in the participants’ beliefs.   Nine 
participants (1, 2, 3, 5, 6, 7, 8, 9 & 10) also experienced paranoia.  Interestingly, those 
with more severe levels of social anxiety experienced higher levels of paranoia (i.e. 6, 8 
& 9).  In addition, eight participants (1, 2, 4, 5, 6, 8, 9 & 10) ‘jumped to conclusions’ in 
their beliefs, making negative attributions about others’ behaviour (Freeman et al., 
2000).  Although this information cannot be used to draw conclusions about specific 
pathways, it does support an association between psychosis and social anxiety.   
The data also support Birchwood et al’s (2007) stigma processing model of 
psychosis and social anxiety.  Eight of the 10 participants (1, 2, 3, 4, 5, 6, 8 & 9) 
appeared to experience images concerned with others judging and rejecting them, also 
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known as an ‘other-to-self’ focus.  Of these eight participants, seven (1, 3, 4, 5, 6, 8 & 
9) appeared to focus attention on themselves and how they might appear to others (e.g. 
saying or doing something embarrassing or inappropriate), or a ‘self-to-self’ focus.   
Participant 2 experienced something slightly different with her attention focused 
on other people rather than herself (i.e. “people laughing and saying horrible things”).  
Participant 7 did not appear concerned about how others’ perceived him, focusing 
instead on feeling nervous and the situation he was in being unmanageable.  This 
participant had a diagnosis of Asperger’s syndrome and found it difficult to articulate 
why he was nervous about being in public.  This is likely to have influenced the 
information provided and should be considered.  
The data also provide support for Newman-Taylor and Stopa’s (2013) model of 
paranoia.  Excluding Participant 7, all participants experienced fear of others, self-
consciousness, perceptions of interpersonal threat or beliefs about being inadequate and 
inferior.  A perception of others as fearful was especially true for Participant 10 who 
explained that he was concerned about being approached by a ’bully’ he once knew and 
that he would be physically assaulted.  
4.4.6 Imagery 
All participants were able to describe an image that was distressing to them.  
This supports previous research suggesting that dysfunctional images are common in 
psychosis and social anxiety (e.g. Hackmann et al., 1998; Morrison et al., 2002; Schulze 
et al., 2013).  Based on data obtained during the semi-structured interview (Hackmann 
et al., 1998; Hackmann et al., 2000, as cited in Cooke, 2012), seven participants (1, 2, 3, 
6, 7, 8 & 9) held a ‘field’ perspective, two participants (5 & 10) held an observer 
perspective and one participant (4) experienced both perspectives.  This offers support 
for Lockett et al. (2012) who suggest that a ‘field’ perspective is common in psychosis.  
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Five participants (1, 3, 4, 5, 6 & 8) appeared to hold images concerned with 
social performance, whereas three participants (2, 5 & 10) had concerns that seemed to 
be related more to fear and paranoia.  Participant 9 appeared to hold concerns that were 
based in both social performance and fear and paranoia (i.e. “looking nervous in public 
and having people stare at me”).  Again, Participant 7 found it difficult to articulate his 
concerns.  Overall these findings are contrary to Lockett et al’s (2012) suggestion that 
people with psychosis and social anxiety are more likely to experience imagery related 
to fear and paranoia.  However, it must be considered that the participants are likely to 
have additional images beyond those discussed as part of the current study.   
4.5 Clinical implications 
This study offers some support for the use of imagery rescripting for social 
anxiety in people with psychosis.  Five participants ‘recovered’ and given the brief 
nature of the intervention, this is promising.  No participants achieved reliable change in 
the opposite direction and ‘deteriorated’ (Wise, 2004).  This suggests that imagery 
rescripting should not increase social anxiety in people with psychosis.  Although some 
participants did not recover, important information was gained about the suitability and 
feasibility of imagery rescripting for people with psychosis and social anxiety.   
First, it is clear that the nature of the participants’ difficulties impacted on their 
ability to benefit from the intervention.  Two of the participants (6 & 7) had diagnoses 
of Asperger’s syndrome and they found it challenging to take part in the imagery work.  
This might be expected as impairment in imagination is a core feature of the condition 
(Attwood, 2007).  These individuals could have been excluded.  However, including 
them has highlighted the need to provide time and support if using imagery rescripting 
with individuals with psychosis and comorbid autistic spectrum conditions. 
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 Of those who remained ‘unchanged’, two participants (8 & 9) experienced high 
levels of social anxiety and paranoia.  As previously noted, they found it difficult to 
fully take part in the imagery rescripting.  It is interesting to note that two participants (3 
& 6) had a diagnosis of paranoid schizophrenia.  In its current format, imagery 
rescripting may not be as effective for those with more enduring presentations.  It 
appears that the intervention was far more effective for those who had experienced a 
brief psychotic episode or psychotic symptoms associated with a mood disorder. 
 Despite this suggestion, it is important to note that the imagery rescripting did 
not exacerbate psychotic symptoms in any participants.  Furthermore, some 
participants’ psychotic symptoms improved.  Improvements in depression and quality of 
life were also observed in some participants.  This suggests that imagery rescripting 
might offer additional benefits for people with psychosis and social anxiety.  Although 
Participant 2 demonstrated an increase in paranoia following imagery rescripting, 
variation in scores was observed over the study.  Increases in paranoia were not 
observed in any other participants.   
Craig et al. (2013) note that investigations of complex interventions should be 
ethical.  With this in mind, the current study suggests that imagery rescripting is a safe 
intervention for people with psychosis and social anxiety.  None of the participants 
reported finding the intervention distressing and as noted above, the intervention did not 
exacerbate psychological symptoms.  Although Participant 8 asked to stop the 
intervention (due to concerns about having said something inappropriate), he felt able to 
continue after a short discussion.  Those participants with a diagnosis of Asperger’s 
syndrome (6 & 7) experienced difficulties in memory visualisation but this did not 
appear to have an adverse effect on their wellbeing.  The experience of these 
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participants highlights the flexibility of imagery rescripting and suggests that it can be 
used in a safe and ethical manner with those with complex and comorbid issues.  
For a small number of participants (1, 3, 4 & 8), improvements were seen in 
ideographic ratings following imagery rescripting but some of these increased at follow-
up.  This suggests that when using imagery rescripting for social anxiety in people with 
psychosis, extended intervention or ‘booster’ sessions might be necessary.  Given that a 
two session intervention had effects in this study, this could still be achieved in line 
with current service and financial restraints.     
 Despite some finding it challenging, most of the participants completed the 
imagery rescripting and reported that it was useful.  The use of an intervention that is 
able to engage individuals is worthwhile, especially in a client group where motivation 
tends to be low.  However, for those with more severe difficulties imagery rescripting 
might need to be incorporated into an extended CBT programme focused on the 
individual needs and wishes of the client.  For those with less severe presentations, 
using imagery rescripting as a stand-alone treatment might be possible.  This has the 
potential to be a short-term and cost-effective clinical tool.  
4.6 Strengths of the study 
 The use of a multiple baseline case series allowed for systematic and detailed 
investigation of change as a result of the intervention.  All participants received the 
intervention and acted as their own control, allowing effects to be attributed to the 
intervention rather than extraneous factors (Kazdin, 2010).  Randomisation, 
standardised measures and follow-up assessments were used.  With the exception of a 
small number of missing data and those participants who dropped out, all participants 
completed the measures and sessions.    
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 The inclusion of a number of assessment sessions at the beginning of the study 
allowed the Chief Investigator to build trust and rapport with the participants before 
commencing the intervention.  This was important given the nature of the client group 
and the presenting difficulties.  The use of a manualised treatment approach (taken from 
Wild & Clark, 2011) enables the study to be replicated in other settings.  A particular 
strength of this study was the investigation of treatment fidelity.  The tape ratings 
indicated that the imagery rescripting script was followed closely.   
4.7 Limitations of the study 
 4.7.1 Study design  
Kazdin (2010) notes that findings from case series designs might not be able to 
be generalised beyond the participants studied.  This study used a small sample that was 
underpowered for statistical analysis, meaning the findings should be interpreted with 
caution.  Although overall retention was good, three participants dropped out in the 
early stages of the study.  Whilst this provides useful information about the feasibility of 
investigating novel interventions in people with psychosis and social anxiety, the final 
sample may not be representative of the original population.   
In addition, the number of participants in each baseline condition was uneven, 
with three participants in the one week block, three in the two week block and four in 
the three week block.  It would have been useful to have recruited two more participants 
for the one and two week blocks, allowing more data to be obtained.  Unfortunately the 
time limits of the study did not allow for this.  The use of a multiple baseline design also 
raises ethical questions about withholding the intervention (Kazdin, 2010).  It is 
possible that those who dropped out might have stayed in the study and benefited had 
the intervention been provided sooner.  
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Participant 7 was classified as ‘recovered’ despite only achieving reliable and 
clinical change at one month follow-up.  There was also a decreasing trend over the 
baseline phase and no trend over the intervention phase.  It is possible that other factors 
were involved in this participant’s improvement and this makes it difficult to fully 
attribute change to the intervention.  Although Kazdin (2010) claims that single case 
series designs allow changes to be attributed to the intervention rather than extraneous 
factors (Kazdin, 2010), there is always potential for other factors to be involved.  This 
should be considered for all participants included in this study.  
4.7.2 Measures 
Due to budget restraints, the Chief Investigator was required to administer the 
outcome measures and the intervention.  It is possible that this led to demand 
characteristics in the participants and affected the internal validity of the study.  More 
specifically, the participants might have felt inclined to show that they were benefiting 
from the intervention and their responses may have been influenced by this.  A lack of 
assessor blinding was a common issue found in CBT for anxiety in the context of 
psychosis in the literature review presented in the first chapter.  Although the current 
study was unable to address this directly, participants were encouraged to complete the 
majority of the assessments on their own.  Unfortunately this was not possible for the 
TUS as this requires clinician administration.  It is also worth noting that many of the 
participants found it difficult to remember their activity levels when responding to the 
TUS and it is possible that the data obtained are not reliable.  
Unlike Wild et al. (2008) the current study did not take a measure of social 
anxiety immediately after the control or imagery rescripting sessions.  This makes it 
difficult to ascertain whether change occurred within these sessions or after a period of 
time (i.e. one week or one month follow-up).  Likewise, the omission of the SIAS, SSI, 
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DASS-D, TUS and EQ-5D-5L after the control session (and before the imagery 
rescripting session) did not allow the individual effect of these sessions to be measured.  
This is problematic as it is not clear how effective the imagery rescripting session was, 
or whether the control session had an effect.  Although the VAS-A was administered 
after the control and imagery rescripting sessions, use of the word ‘anxiety’ rather than 
‘social anxiety’ may mean that different concepts were being measured.  This study also 
used a different social anxiety measure to Wild et al. (2008).  Use of the same measure 
would have allowed for a more accurate comparison between the studies.  
The participants in this study were asked to complete a large quantity of 
assessments.  This might have led to practice or fatigue effects.  Although 
counterbalancing can be used to reduce such effects (Robson, 2011), this was not 
possible in the current study as the order of the control and imagery rescripting sessions 
could not be changed (Wild et al., 2008).  Also, given that the participants experienced 
high levels of social anxiety and paranoia, the responses given to the measures might 
have been influenced by individual interpretation or demand characteristics. 
4.7.3 Intervention 
Excluding Participant 4, all participants achieved control session change in at 
least one measure or ideographic rating.  No tape ratings were made of the control 
session making it difficult to see whether treatment adherence was upheld.  Wild et al. 
(2008) note that providing the control session first may allow the imagery rescripting 
session to be more effective.  Wild et al. (2007) also explain that the format of the 
imagery rescripting session does not allow for separate analysis of reliving, cognitive 
restructuring and imagery rescripting.  This applies to the current study and makes it 
difficult to ascertain how effective the different components of treatment were.   
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It is also unclear how much of the observed change was influenced by increased 
contact and rapport with the Chief Investigator.  Therapeutic improvements can often be 
seen as a result of non-specific factors such as effective alliance (Messer & Wampold, 
2002) and it is possible that this occurred.  With this in mind, it was more difficult for 
the Chief Investigator to build trust and rapport with those experiencing higher levels of 
social anxiety and paranoia or comorbid issues such as Asperger’s syndrome or drug 
abuse.  This might have influenced the results obtained and should be considered.   
The participants were aware that it was a feasibility study and their willingness 
to help might have influenced their approach.  All participants were keen to improve 
their situation or assist with the research and motivational or volunteer effects might 
have been present.  It should also be considered that the Chief Investigator’s confidence 
and skill in administering the intervention is likely to have increased as the study 
progressed.  Unfortunately, study progression was also associated with increasing 
participant complexity making it difficult to investigate this. 
4.7.4 Statistical analysis 
Despite being underpowered for statistical analysis, this study used exploratory 
non-parametric tests and repeated measures effect size calculations.  Although these 
have been interpreted with caution throughout, the lack of power limits confidence in 
the findings.  Also, due to the issues in study design, it was not possible to calculate 
statistics investigating differences between the control and imagery rescripting sessions 
for the SIAS, SSI, DASS-D, TUS and EQ-5D-5L.  It should also be considered that 
Wild et al. (2008) used parametric statistics to investigate changes over the study phases 
and differences between the control and imagery rescripting sessions.  The use of non-
parametric statistics are justified in the current study due to the small sample size.  
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However, a different approach to analysis makes it difficult to fully compare the 
findings with Wild et al’s (2008) study.  
4.8 Future research 
 Although the findings from the current study are mixed, they show some 
promise for the use of imagery rescripting in people with psychosis and social anxiety.  
Further research is therefore warranted.  Guidelines for complex interventions (Craig et 
al., 2013) note that small pilot studies offer a first step in assessing interventions for 
efficacy and feasibility.  Although they provide initial data regarding the efficacy of an 
intervention, the findings may be different when applied to larger samples or wider 
settings.  Further research might be needed to refine the design, with consideration of 
methodological issues and limitations.  This should be followed by larger scale studies 
that use randomisation (Craig et al., 2013).  This is considered in greater detail below.   
If replicating the current study, future research should plan the frequency of 
measures so that the effect of separate components of treatment (including the control 
session) can be observed.  Alternatively, future studies could utilise a between-subjects 
design with participants being randomised to a control session group or an imagery 
rescripting session group.  This would also eliminate the possibility of crossover effects 
between the two sessions (Wild et al., 2008).  In line with Wild et al. (2007) it would 
also be useful to compare those receiving reliving, cognitive restructing or imagery 
rescripting.  This would go some way to indicate which part of the imagery rescripting 
session is most effective.  Studies should also recruit larger samples with statistical 
power, allowing inferential statistics to be used with more confidence.   
Future studies should also ensure that assessments are completed by independent 
assessors blind to treatment allocation.  The control session should be rated to 
investigate potential crossover of therapeutic skills between sessions or groups.  The 
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same standarised assessments of social anxiety should be used between studies, 
allowing for more accurate comparison.  As suggested by Wild et al. (2008), the use of 
more robust measures of imagery and memory would be beneficial.  Although the 
treatment fidelity rating sheet used in this study was useful, future research could also 
look to develop its format in line with rating scales for CBT, such as the Cognitive 
Therapy Scale – Revised (CTSR; Blackburn et al., 2001).      
 Wild et al. (2007) note that imagery rescripting could be delivered in a longer 
format.  This also applies to this study, especially for those with more enduring 
difficulties that did not appear to benefit from the brief nature of the intervention.  
Future studies could compare an increasing number of imagery rescripting sessions 
between individuals or groups with different presentations.  This would allow 
conclusions to be drawn regarding optimum treatment length.   
4.9 Conclusion 
 This study offers partial support for the use of imagery rescripting for social 
anxiety in people with psychosis.  Five out of the 10 participants ‘recovered’, 
demonstrating reliable and clinical change in social anxiety post-intervention and/or at 
follow-up.  Individual and group analyses found improvements, significant reductions 
and medium to large effect sizes for anxiety and encapsulated belief and memory and 
imagery ratings.  However, improvements were not always observed and the 
exploratory group statistics should be interpreted with caution.   
Overall there was no deterioration in psychotic symptoms, paranoia, depression, 
social functioning or quality of life, and in some cases improvements were found.  
Those with less complex presentations appeared to benefit from the imagery rescripting 
most.  It might be a suitable short-term and cost-effective intervention for these 
individuals.  Those experiencing more severe and enduring psychotic disorder or 
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comorbid issues may require more time, support or comprehensive treatment.  Overall, 
the findings are promising and further research investigating imagery rescripting for 
social anxiety in the context of psychosis is warranted.  This should aim to improve on 
the current study by keeping the identified limitations in mind. 
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Appendix A – Covering letter 
 
                                    
 
A study investigating the effect of talking about images and memories of 
social events in people with psychosis and social anxiety 
 
{Insert address} 
 
 
 
 
 
Department of Psychological Sciences 
Norwich Medical School 
Norwich Research Park 
University of East Anglia 
Norwich 
NR4 7TJ 
 
{Insert date} 
 
Dear {Insert name}, 
 
Please find enclosed an information sheet about the above named study.  If you are 
interested in the study you will be asked to provide permission for me to contact you.  If 
you are happy with this a member of your care team will provide me with your contact 
details and I will call you to arrange a suitable time for us to meet.  Please feel free to 
discuss the study with a member of your care team or your family or friends.   
 
If you want to contact me directly about taking part or if you have any questions about 
the study, please do not hesitate to contact me on 07518 503098 or via 
D.Heavens@uea.ac.uk.    
 
Yours sincerely, 
 
 
Dave Heavens 
Trainee Clinical Psychologist 
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Appendix B – Participant Information Sheet 
 
                                               
Information about the research 
A study investigating the effect of talking about images and memories of 
social events in people with psychosis and social anxiety 
 
Primary researcher: Dave Heavens, Trainee Clinical Psychologist, University 
of East Anglia (UEA) 
Primary supervisor: Dr Jo Hodgekins, Clinical Psychologist and Clinical 
Lecturer, UEA 
Secondary supervisor: Dr Mike Dow, Clinical Psychologist, UEA 
Collaborator: Dr Rebecca Ison, Research Clinical Psychologist, Central 
Norfolk Early Intervention Team (CNEIT), Norfolk and Suffolk Foundation Trust 
______________________________________________________________ 
 
You are being invited to take part in a research study.  Before you decide 
whether you wish to take part, please take the time to read this information 
sheet.  If you have any questions about the research or if something is unclear, 
please speak to a member of your care team or contact me on 07518 503098.  
Please feel free to discuss the research with a family member or friend.   
 
This information sheet is split into two parts.  Part 1 tells you about the study 
and what will happen if you decide to take part.  Part 2 gives you some more 
detailed information about the study.       
 
Part 1 
 
What is the purpose of the study? 
 
I am carrying out this study as part of my assessment for the Doctorate in 
Clinical Psychology course at the UEA.  I am interested to see whether talking 
about images and memories of social events makes the images and memories 
less distressing and leads to improvements in symptoms related to social 
anxiety and psychosis.  This intervention has previously been found to be 
helpful for people with social anxiety who have not experienced an episode of 
psychosis. 
 
Why have you been invited?     
 
I am recruiting people who have experienced an episode of psychosis and who 
also experience social anxiety.  You have been contacted because a member of 
your care team feels that you might be suitable for the study.  I am hoping to 
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include 12 people in the study altogether. Unfortunately we cannot include 
everyone in this study.  People who are currently receiving treatment for social 
anxiety or people whose psychotic symptoms are making them feel quite unwell 
at the moment will not be approached to take part.   
 
If you are interested in taking part, you will have an initial meeting with the 
researcher to talk about your current worries and see whether the study is 
suitable for you.  More detail about this is provided below. 
 
Do you have to take part?   
 
You do not have to take part if you do not want to.  If after reading this sheet 
you decide that you do not want to take part in the study you do not need to do 
anything else.   
 
If you do wish to take part in the study I will ask you to read and sign a consent 
form (this is included with this information sheet).  You can keep this information 
sheet and you will be given a copy of the consent form for your records.   
 
If you change your mind about being in the research, you are free to withdraw at 
any time and you do not have to give a reason for this.  This study is not 
connected to the treatment you receive from the service or the NHS and this 
would continue as normal.  Taking part in this study will not affect the care you 
receive from the NHS either now or in the future.   
 
What will happen if you take part? 
 
If you decide to take part, you will be asked to attend seven different sessions.  
You can choose whether these sessions take place at your home or at the 
service you usually attend.   
 
The first session will involve making sure you want to take part in the study and 
if so, completing some assessments.  This will take about one hour and 10 
minutes.  I need to use these assessments to see whether you meet the study 
criteria and if you can be included.  If you do not meet the criteria then 
unfortunately I will not be able to include you in the study.  This is because the 
intervention we are testing might not be appropriate for you.  If this happens I 
will explain things to you and make sure that you have an opportunity to ask 
questions.    
 
If you can be included in the study you will be invited to a second session.  This 
will involve completing some questionnaires and ratings.  This will take about 40 
minutes.  You will then be asked to wait either 1, 2 or 3 weeks until we meet 
again.  I will randomly pick numbers from sealed envelopes (a bit like picking 
names from a hat) to see how long you will be asked to wait.  You or I will not 
be able to choose how long you will wait until the next session.  This is to make 
sure that everybody in the study is treated fairly.  If you are asked to wait for 2 
or 3 weeks then you will be asked to complete some ratings and questionnaires 
each week until we meet again.    
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The third session will involve completing some questionnaires and ratings.  This 
will take around 45 minutes.   
 
The fourth session will involve asking you about any negative images and 
memories you have of social events.  I will also ask you to complete some 
ratings.  This session will take around two hours and 10 minutes.  You can have 
breaks during this session if you want to.   
 
A week later, you will be asked to attend a fifth session where we will talk about 
any upsetting images and memories you might have about social events and try 
and make them less distressing.  I will also ask you to complete some ratings.  
This session will last around one hour and 40 minutes.  Again, you can have 
breaks if you want to.     
 
Within one week of this session you will be asked to attend the sixth session.  
This will involve completing some questionnaires and ratings and will take 
around 45 minutes.  One month after finishing the fifth session (the one where 
we will talk about images and memories and try to make them less distressing) 
you will be asked to attend the seventh and final session.  This will involve 
completing some questionnaires and ratings.  This will take around 45 minutes.   
 
I have included a table below showing you the different stages in this study.  I 
will ask your permission to tape record what we talk about in some of the 
sessions.  This will help me to check that I am doing things properly.  The tape 
recordings will be locked in a secure filing cabinet at the UEA.  The recordings 
will be erased once the study is complete.             
 
Stages involved in the study 
 
Session What will happen Approximate 
time taken 
1 Make sure you want to take part in the study and if so, 
complete assessments to see if the study is appropriate for you 
One hour and 
10 minutes 
2 Complete questionnaires and ratings about how you are 
feeling and what you do with your time 
40 minutes 
 
Wait 1, 2 or 3 weeks (decided at random) 
 
3 Complete questionnaires and ratings (as in session 2)  45 minutes 
4 Talk about images and memories of social events and 
complete ratings 
Two hours and 
10 minutes (you 
can have breaks 
if you want to) 
 
One week break 
 
5 Talk about images and memories of social events and try and 
make them less distressing.  Complete ratings. 
One hour and 
40 minutes (you 
can have breaks 
if you want to) 
6 Complete questionnaires and ratings (as in session 2) 45 minutes 
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7 Complete questionnaires and ratings (as in session 2) 45 minutes 
Total hours involved in the study Approximately 8 
hours 
 
I will also ask you if I can use your notes at the service to collect information 
about your age, ethnicity, social status and diagnoses.  All of this information 
will remain confidential (please see below for further information on this). 
 
If you decide to take part, I will let your GP know that you are doing so.  I will 
also ask for your consent for me to keep a member of your care team updated 
on your participation in the study and the things that we have talked about.  This 
is to make sure that they are kept up-to-date on how you are and what you are 
doing in the study.   
 
Will you be paid for taking part? 
 
After completion of all of the sessions you will be offered a £15 shopping 
voucher for taking part.  Unfortunately payment for travel expenses is not 
available.  However, if you prefer to carry out the sessions in your home then 
this can be arranged.   
 
What will you have to do? 
 
As mentioned, you will be asked to complete some questionnaires and ratings.  
The questionnaires will ask you about your symptoms of psychosis and how 
you find social situations.  You will also be asked whether you ever feel sad or 
depressed and what kind of things you do each day.  When completing the 
ratings you will be asked to describe how you are feeling at the time.  If you 
want more information about the questionnaires or ratings then please feel free 
to ask.   
 
I will also talk to you about any upsetting images and memories you might have 
of social events.  To help with this, I will help you to think about a time that you 
have felt anxious or worried in a social situation and ask you some questions 
about it.  I will then ask you to give me some more ratings.  For example, I will 
ask you to rate how much the pictures or memories upset or worry you and how 
often you see them in your mind.  
 
I will also talk to you about how any images and memories you have can be 
made less distressing.  To do this, I will help you to think of more positive 
images or memories or to think about the images or memories in a different 
way.  
 
Some of the questionnaires may be carried out by another researcher.  If this 
happens I will make sure that you get to meet them beforehand and you have 
the opportunity to ask them any questions you may have.  
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What are the possible disadvantages and risks of taking part? 
 
Talking about negative social events from your past may lead you to become 
upset.  If you decide to take part and this happens, please let me or a member 
of your care team know and we will do our best to help.  As explained, you can 
withdraw from the study at any point without giving a reason.    
 
If you become upset outside of the study sessions then you should call a 
member of your care team.  This will ensure that they are kept up-to-date on 
how you are and are able to provide you with the care that you need.  
 
What are the possible benefits of taking part? 
 
I hope this study will help you but I cannot promise that this will be the case.  
You may see some improvements in your symptoms of social anxiety and 
psychosis.  You may also see improvements in your mood and the number of 
activities that you are doing each day.  This is not guaranteed but I hope that 
the study will provide information on how to help people who experience 
psychosis and social anxiety. 
 
What happens when the study stops? 
 
On completion of the study, you will continue to receive care from the NHS and 
the service that you are in contact with.  Taking part in this study does not 
change this.   
 
A summary report will be given to the service and you will be able to request a 
copy of this.  This report will be about the study in general and will not include 
information about you in particular.  Once the research is complete, the 
information collected will be used to write a thesis which will be submitted to 
and marked by the UEA.  You name will not be used so those reading it will not 
be aware that you took part.        
 
What if there is a problem? 
 
Any complaint about the study or the way you have been treated or any 
possible harm that you might suffer will be addressed.  The detailed information 
about this is given in Part 2.   
 
Will taking part in the study be kept confidential? 
 
Yes.  I will follow ethical and legal practice and all information about you will be 
handled in confidence.  However, if you disclose information that suggests you 
or others are at risk we will need to share this with your case manager and your 
care team.  Further details about this are included in Part 2. 
 
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before 
making any decision. 
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Part 2 
 
What will happen to the results of the research study? 
 
The results will be used to write a thesis.  The results for the whole study will be 
summarised in a report and given to the service that you have contact with.  
Your name or any personal information about your involvement in the study will 
not be included in this.  You will be able to request a copy of this report.   
 
Once marked, the thesis will be kept in a library at the UEA so that other trainee 
clinical psychologists can access it.  It will also be held on the electronic library 
database.  The thesis will also be written up and submitted for publication in an 
academic journal.  No identifiable data (e.g. name, age) will be used in the 
thesis or any other documents. 
 
What will happen if you don’t want to carry on in the study? 
 
You have the right to withdraw from the study at any point without giving a 
reason.  If you do decide to withdraw I will ask you whether I can retain the 
information that I have already collected from you.  This is your choice and until 
the thesis is written, you can choose for all of your information to be withdrawn if 
you wish.  If you do not feel comfortable talking about withdrawing from the 
study, please ask a member of your care team to talk to me or send me a 
message on 07518 503098.    
 
What if there is a problem? 
 
If you have any concerns about the study please feel free to contact me on 
07518 503098 or via e-mail (D.Heavens@uea.ac.uk).  Alternatively, please feel 
free to contact a member of your care team who will contact me on your behalf.  
Please note that I will only be available during working hours (Monday-Friday, 
9am-5pm) and the contact details above are provided for any issues that you 
may have with your participation in the study.   
 
If you need to speak to somebody about any other issues please contact a 
member of your care team or GP.  You can also contact the Early Intervention 
team (Monday-Friday, 9am-5pm) on 01603 201400.  If you need to contact 
somebody in an emergency, please call the Crisis Resolution team on 01603 
421239.   
 
If you wish to make a complaint about the study or the way you have been 
treated, please feel free to contact the UEA Clinical Psychology Course 
Director: 
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Professor Ken Laidlaw 
Professor of Clinical Psychology/Programme Director ClinPsyD 
Department of Psychological Sciences 
Norwich Medical School 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
Tel: 01603 593600    
E-mail: K.Laidlaw@uea.ac.uk  
 
You can also contact your local Patient Advice and Liason Service (PALS): 
 
PALS Office 
Hellesdon Hospital 
Drayton High Road 
Norwich 
NR6 5BE 
 
Tel: 01603 421191   
E-mail: pals@nsft.nhs.uk 
 
Will taking part in the study be kept confidential? 
 
All of the information obtained from you during the study will remain confidential.  
Your name will not be used on questionnaires, record forms or any notes that 
are taken during the sessions.  A numbering system will be used to ensure 
anonymity (a number will be used on any documents instead of your name).  All 
documentation will be kept separate from your signed consent form.   
 
If electronic information has to be transported between locations, this will be 
done using a locked memory stick.  All information will be stored in a locked 
filing cabinet or on a password protected computer.  This also applies to any 
voice recordings that are taken.  Following study completion, the information 
collected from you will be kept for a maximum of 10 years.  After this, the 
information will be permanently destroyed.   
 
If you disclose information that makes me concerned for the safety of yourself 
or others, then I will be required to share this with your case manager and care 
team.  If you disclose any information related to a crime, I will be required to 
inform the Police.  However, any other information that you share will remain 
strictly confidential.     
 
Who is organising and funding the research?  
 
I will be organising the research with the assistance of my academic 
supervisors at the UEA.  The study collaborator will also be involved in the 
organisation of the study when required.  
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The university is funding the research.  The research is not funded by a grant.   
 
Who has reviewed the study?     
 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 
reviewed and given favourable opinion by XXXXXX Research Ethics 
Committee.  
 
Further information and contact details 
 
If you would like general information about taking part in research, please 
access the following website:  
 
www.invo.org.uk. 
 
If you would like specific information about this research, please contact me on 
07518 503098 or via e-mail (D.Heavens@uea.ac.uk).  Alternatively, you can 
contact my academic supervisor using the details overleaf. 
 
Dr Joanne Hodgekins  
Clinical Psychologist and Clinical Lecturer  
Department of Psychological Sciences  
Norwich Medical School  
Norwich Research Park  
University of East Anglia  
Norwich  
NR4 7TJ  
 
Tel: 01603 591890 
 
E-mail: J.Hodgekins@uea.ac.uk   
 
If you would like advice on whether you should participate in this study or not, 
you are advised to contact a member of your care team.  Alternatively, please 
feel free to discuss the study with family members and/or friends.   
 
Thank you for taking the time to read this information sheet. 
 
 
 
Dave Heavens 
Trainee Clinical Psychologist 
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Appendix C - Consent form 
                                              
Consent form 
A study investigating the effect of talking about pictures and memories of 
social events in people with psychosis and social anxiety 
Name of researcher: Dave Heavens, Trainee Clinical Psychologist 
Please initial the box next to each statement 
 
1. I confirm that I have read and understand the information sheet 
dated 03/11/13 (version 1.0) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and that my care and 
treatment will not be affected. 
 
3. I consent to being audio recorded for the purposes of the study and I 
am aware that all information collected from me will be stored 
securely and destroyed on completion of the research.    
 
4. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from 
regulatory authorities or from the NHS Trust, where it is relevant to 
my taking part in this research.  I give permission for this to occur. 
 
5. I understand that my GP and my care team will be informed of my 
participation in the study and I agree for them to be contacted if any 
problems arise.   
  
6. I understand that the information obtained from me will be used to  
write a thesis and may be published in a peer-reviewed journal.  I 
understand that my name will not be used on these documents.   
 
7. I agree to take part in the above study.    
            
Name of Participant  Date    Signature       
 
            
Name of Researcher  Date    Signature  
 
When completed: 1 for participant; 1 for researcher file; 1 (original) to be 
kept in clinical notes. 
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Appendix D - Measures 
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221 
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230 
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6. Ideographic ratings (Wild et al., 2008)…………………………………….... 233 
7. Schizotypal Symptoms Inventory (SSI; Hodgekins et al., 2012)…………… 235 
8. Depression Anxiety and Stress Scale – Short Version (DASS-21; Lovibond 
& Lovibond, 1995)………………………………………………………….. 
 
237 
9. Time Use Survey (Hodgekins et al., 2015; Short, 2006)……………………. 238 
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Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998) 
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Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) 
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Semi-structured interview (Hackmann et al., 1998 and Hackmann et al., 2000, as 
cited in Cooke, 2012) 
 
 
NAME:  
 
AGE:  
 
GENDER: 
 
DATE:  
 
YEARS IN EDUCATION: 
 
MEETS CRITERIA FOR SOCIAL PHOBIA ON SIAS: YES / NO 
 
EVER HAD TREATMENT FOR AN ANXIETY PROBLEM: YES / NO 
 
1. Do you ever get anxious in social situations? I wonder if you could tell me about a 
few times recently when that happened to you? 
 
 
 
2. I know that when you are anxious you probably notice a variety of things going 
through you mind. I’m particularly interested in the little pictures or images people 
get when they are nervous (give lots of reassuring and prompts here).  Have you 
ever had images like that when you are anxious either in social situations, or in 
anticipation of them? 
 
 
Always / often / sometimes / never (coded 4, 3, 2 or 1) 
 
 
3. Can you think of a time recently when you felt particularly anxious in a social 
situation? 
 
 
 
4. How anxious were you at the worst moment? (Show 0-100mm rating Scale 1 and 
enter rating in box below) 
 
 
 
 
 
 
 
5. Did you have an image or picture going through your mind at the time?   
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Yes / No 
 
Did you hear any sounds, such as a voice, in your mind at the time?   
 
Yes / No 
 
Were you aware of any smells?   
Yes / No 
 
Were you aware of any strange sensations in your body? Some people say when they 
are in a scary social situation they feel as if they are smaller than usual, or further away 
from people, or fatter than usual – were you aware of any feelings like this at the time? 
 
                                                               Yes / No 
 
6. Sometimes people get an impression of how they appear, or how others might be 
reacting, even if they are not looking at them. Did that happen to you? 
 
   Yes / No 
 
7. Please try to clearly recall the image/ impression now, with your eyes closed (allow 
about 30 seconds). Have you got it now? 
 
 
 
 
 
Thinking about the image/ impression, is your predominant impression one of viewing 
the situation as if looking out through your eyes, observing the details of what is going 
on around you, or is the predominant impression one in which you are observing 
yourself, looking at yourself from an external point of you? 
 
 
 
 
 
 
Get ratings of the extent to which the field/ observer perspective is being taken on scale 
2 – a 7 point scale ranging from -3 (completely field) to +3 (completely observer). 0 is 
seeing both perspectives equally. Enter score in box below: 
 
 
 
 
 
 
8. Can you now describe the image? What can you see? What can you hear? What can 
you smell? What can you feel? 
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If focussed on appearance probe for details of posture, clothing, facial aspects, other 
parts of the body, general appearance, any change in size (height/ weight),voice 
characteristics, pronunciation, etc… Account must be detailed enough for a film 
director to recreate the image. 
 
Write down every detail. Summarise all the client has described, in detail adding “Is 
that right?” 
 
 
 
 
 
 
 
9. Are parts of the image in your mind bigger or smaller than they would be in real 
life? Do you or other people in your image look different to how you do in real life? 
Is anything distorted in its shape or appearance? Is the perspective (how far things 
seem from each other or how big things seem in comparison to each other) how it 
would be in real life? Please look at this scale (present Scale 3, 0-100mm rating 
scale) and tell me how much you feel the image was distorted, with 0 being “Not at 
all” and 100 being “Completely distorted, things appeared completely different to 
how they would in real life”. Enter rating in box below. 
 
 
 
 
 
 
How about the things you hear in the image – do they appear louder or quieter or at all 
distorted to how they would in real life? On this scale (present Scale 3 again), with 0 
being “Not distorted at all” and 100 being “Completely distorted to how it would sound 
in real life”, how distorted would you say the sounds in your image are? Enter rating in 
box below. 
 
 
 
 
 
 
 
 
How about the smells in the image? Are they stronger or at all distorted from how you 
would experience them in real life? On this scale (present Scale 3), with 0 being 
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“Completely the same as I would smell them in real life” and 100 being “Completely 
different to how they would smell in real life”, how distorted would you say the smells 
in your image are? Enter rating in box below. 
 
 
 
 
 
 
10. Interviewer – estimate whether the image or impression had the characteristics of a 
clear visual picture 
 
Yes (code 2) / No (code 0) / Probably (code 1) 
 
11. When was the image located in time? 
 
If it reflected something that had happened in the past, ask what was happening at that 
moment/ would happen in the immediate future in that situation/ would happen in the 
far future. 
 
Did it involve just you/ others/ a mixture of the two/ no people? 
 
 
 
 
 
12. Do you frequently experience this specific image when you feel anxious in social 
situations? If not, ask if the client experiences any other images regularly when 
socially anxious. 
 
Yes / No 
 
If a different image is elicited, ask client to describe this image in as much detail as 
possible, including sights, sounds, smells, tastes, body sensations.  Remember to check 
back with the client that you have recorded this information accurately. Record below. 
 
 
 
 
 
 
 
 
13. I’m now going to ask some more questions about this image. Please recall it as 
clearly as you can. 
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How do you feel in the image (emotions)? 
 
 
 
 
 
 
What is happening in the image? 
 
 
 
 
 
 
Why is this happening? 
 
 
 
 
 
 
What has led up to this event? 
 
 
 
 
 
 
What is the worst thing about it? 
 
 
 
 
 
 
What does it mean about you? 
 
 
 
 
 
 
What does it mean about others? 
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What does it mean about the world? 
 
 
 
 
 
 
Summarise the interpersonal meaning, asking “Is that right?” and make a written 
summary. 
 
 
 
 
 
 
 
 
14. What is your earliest recollection of having the 
thoughts/sensations/emotions/experiences reflected in the image? 
 
 
 
 
 
 
 
Where were you in this earliest recollection? 
 
 
 
 
 
 
 
How old were you? 
 
 
 
 
 
 
 
What was happening in your life at the time? 
 
 
 
 
 
15. Is there a particular memory that seems to be closely linked to the image? 
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Yes / No 
 
16. If so, do you think you could evoke it with your eyes closed, just as if it was 
happening now, and describe it to me? 
 
If necessary, prompt with the following: 
 
 
 
      Can you see anything in the memory? 
 
 
 
 
 
 
      Can you hear anything (including your own voice)? 
 
 
 
 
 
 
      Any tastes or smells? 
 
 
 
 
 
 
      What sensations do you have in your body? 
 
 
 
 
 
 
Summarise below, checking with client that information is accurate: 
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17. Present Scale 4: 0-100% rating scale 
 
Can you please indicate on this scale, with 0% being “not at all” and 100% being 
“completely”, how similar the actual sensory aspects of the image are compared to those 
in the remembered event? 
 
 
 
 
 
17b. Present Scale 5: Get ratings of the extent to which the memory is focused on  
others/another person or self-focused on a 7 point scale. Enter score in box below: 
 
 
 
 
 
 
 
18. What do you feel in the remembered event? 
 
 
 
 
 
What is happening in this remembered event? 
 
 
 
 
 
What has led up to this event? 
 
 
 
 
 
What is the worst thing about it? 
 
 
 
 
 
What does it mean about you? 
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What does it mean about others? 
 
 
 
 
 
What does it mean about the world? 
 
 
 
 
 
Summarise all the meanings, asking, “Is that right?” and make a written account 
below: 
 
 
 
 
19. Present Scale 4 again. 
 
Please indicate on this scale, with 0% being “not at all similar” and 100% being 
“completely the same” how similar in terms of interpersonal meaning (what we’ve just 
been talking about) the remembered event and the image are? 
 
 
 
 
 
 
 
20. Were you anxious in social situations before this event? 
 
Yes / No 
 
21. If “yes” 
Did the event change this anxiety in any way *ie. make it better/ worse/ no different)? 
 
 
 
22. Did you experience anxiety at the time of the event? 
 
Yes / No 
 
If “no” 
Did you recall this event when your anxiety problems started? 
 
Yes / No 
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Not at all 
anxious 
A bit anxious 
Quite anxious The most anxious I have ever been 
Very anxious 
0 
25 
50 
75 
100 
Ratings for semi-structured interview (Hackmann et al., 1998 and Hackmann et 
al., 2000, as cited in Cooke, 2012) 
 
 
Scale 1 (for use with question 4) 
Ask client to mark anywhere along the line to show how anxious they were 
 
 
 
 
 
 
 
 
 
 
Scale 2 (for use with question 7) 
Ask client to choose a number to indicate the image perspective 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scale 3 (for use with question 9) 
 
Ask client to mark anywhere along the line to show how distorted from real life the 
image was 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not at all distorted 
A bit distorted 
Quite distorted Completely distorted 
Very distorted 
0 
25 
50 
75 
100 
½ through my eyes, ½ 
seeing from outside 
Slightly more 
observing 
Mostly observing 
Completely if I was seeing 
the scene from outside it 
Slightly more through 
my eyes 
Mostly through my 
eyes 
Completely through 
my eyes 
-3 -2 -1 0 +1 +2
22 
+3 
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Scale 4 (for use with questions 17 & 19) 
Ask client to mark anywhere along the line to show how similar the image and the 
remembered event are 
 
 
 
 
 
 
 
 
 
 
 
Scale 5 (for use with question 17b) 
Ask client to choose a number to indicate the focus of the memory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Completely the same Not at all similar 
A bit similar 
Quite similar 
Very similar 
0 
25 
50 
75 
100 
Completely focused on 
others/another person 
Completely focused on 
myself as if looking from 
the outside 
½ focused on others, 
½ self-focused 
Slightly more self-
focused 
Mostly self-focused 
Slightly more other 
focused 
Mostly other focused 
-3 -2 -1 0 +1 +2 +3 
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Visual analogue scale for anxiety (VAS-A) 
 
Anxiety scale 
 
 
 
 
 
 
Visual analogue scale for paranoia (VAS-P) 
 
Paranoia scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1 
Not anxious Anxious 
0 1 
Not paranoid Paranoid 
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Ideographic ratings (Wild et al., 2008) 
 
 
Scale 1 (Encapsulated belief) 
 
How much do you believe the statement we have discussed to be true? 
 
 
 
 
 
 
 
 
Scale 2 (Memory distress) 
 
How distressing is the memory we have talked about? 
 
 
 
 
 
 
 
 
 
Scale 3 (Imagery distress) 
 
How distressing is the image we have talked about? 
 
 
 
 
 
 
 
 
 
Scale 4 (Imagery vividness) 
 
How vivid is the image we have talked about? 
 
 
 
 
 
 
 
 
0 100 
Not at all Extremely 
0 100 
Not at all Extremely 
0 100 
Not at all Extremely 
0 100 
Not at all Extremely 
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(Imagery frequency) 
 
How frequently has the image occurred in the last week?  
 
(Please enter a number in the box below) 
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Schizotypal Symptoms Inventory (SSI; Hodgekins et al., 2012) 
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Depression Anxiety and Stress Scale – Short Version (DASS-21; Lovibond & 
Lovibond, 1995; DASS-D items: 3, 5, 10, 13, 16, 17 & 21) 
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Time Use Survey (Hodgekins et al., 2015; Short, 2006) 
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Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
242 
 
Appendix E 
 
Imagery Rescripting Script (adapted from Wild & Clark, 2011) 
Introduction 
Provide participant with rationale: 
“We've seen that a traumatic event led you to develop certain beliefs about yourself and 
to feel as though people will respond to you in the present in a similar way to what 
happened in the past. It is like you have been processing the present on the basis of the 
restricted information that you had in the past. At the time you were a child/younger 
person and you did not have access to current/adult information. We have seen that as 
an adult, you do not get rejected, and the world does not expect you to be perfect. 
We've seen that although the memory was painful, you were not actually rejected, 
although it very much felt like that at the time (or you were rejected on that occasion 
but are no longer rejected now).  We need to update the memory to bring in this new 
information that we have discovered. 
The way we do that is to revisit the memory again. For you to tell it in the first person 
present-tense as though you are the (Insert participant’s younger-self age)-year-old 
(Insert participant’s name) again. And then to bring in the new information as an adult. 
To see (Insert participant’s current age)-year-old (Insert participant’s name) intervening. 
This may involve talking to (Insert participant’s younger-self age)-year-old (Insert 
participant’s name) and telling him/her what you know now, you may also feel like 
intervening in another way, perhaps talking to other people in the situation. 
The aim of the procedure is to update the memory so that it is no longer an event which 
colours your present, so that you can accurately process the present as it is really 
happening. 
I may prompt you as we go along. Do you have any questions?”  
Imagery rescripting: Stage 1 
Provide participant with the following instructions: 
“When you're ready, sit comfortably, close your eyes and take yourself back. You're 
(Insert participant’s younger-self age) years old and you're…Tell me what happens, take 
me through what happens as if it's happening right now.”  
(Participant responds) 
“That's great, (Insert participant’s name), you're doing a great job. So (Insert content of 
image)…Just stay with what's happening, what happens next?” 
Ensure that participant talks through the event in as much detail as possible.  Prompt for 
further information as necessary. 
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Imagery rescripting: Stage 2 
Provide participant with the following instructions: 
“You are doing a great job, (Insert participant’s name). Now, keep your eyes closed. 
We're going to move into the next phase of this procedure. What I would like you to do 
now is to talk me through the event again, but this time I want you to tell it to me as 
though you are observing what is happening, as though you are in the room, watching 
the events unfold. So, this would mean talking me through the event in the third person. 
“I see (Insert participant’s name)…(Insert content of image).  Tell me what you see”. 
(Participant responds) 
“That's right. (Support participant’s view of situation). And what happens next? What 
do you see happening next”  
Imagery rescripting: Stage 3 
Provide participant with the following instructions: 
“Good work, (Insert participant’s name). We are almost done. Now keep your eyes 
closed. We are going to go through this one more time. This time, I want you to talk me 
through it again as if you were (Insert participant’s younger-self age)-year-old (Insert 
participant’s name) and it is happening right now. But this time, your wise (Insert 
participant’s current age)-year-old self is in the room with you. He/she has all the 
information you have learned in therapy and she can intervene if you want him/her to, 
he/she can talk to (Insert names of other people in situation) or do anything else that 
feels helpful and right in this situation. Are you ready? Okay, take me back to (Insert 
location of image), you are (Insert content of image).”  
(Participant responds) 
“That is right. What do you feel inclined to do?”  
(Participant responds) 
“So, see older (Insert participant’s name) doing this.” 
(Participant responds) 
“How does (Insert names of other people in the situation) respond?” 
(Participant responds) 
“And what happens next?” 
(Participant responds) 
“What do you feel inclined to do?” 
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(Participant responds) 
“So, see yourself saying this to (Insert names of other people in the situation)”. 
(Participant responds) 
“And how does/do (Insert names of other people in the situation) respond?” 
(Participant responds) 
“And what do you see?” 
(Participant responds) 
“Is there anything that (Insert participant’s name) needs to do or say?” 
(Participant responds) 
“Can you tell him/her in your own way?” 
(Participant responds) 
“And how does she respond?” 
(Participant responds) 
“Is there anything else that he/she needs to do or say?” 
(Participant responds) 
“Can you say that to him/her?” 
(Participant responds) 
“Is there anything else she needs to do or say?”* 
(Participant responds) 
*Continue with prompt until participant has nothing else to say 
“Okay, when you are ready, bring your attention back to this office. Take your time and 
open your eyes.  How do you feel?  How does the memory feel to you now?” 
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Appendix F – Imagery rescripting rating scale (template) 
 
Imagery rescripting rating scale                    Participant:  
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting   
Explain imagery rescripting stages (three in total)    
Explain that props and techniques can be used (e.g. cartoon characters, rewind, pause)   
Offer participant the opportunity to ask questions   
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image   
Ask participant to describe image/event as younger self   
Offer prompts to gain information about ‘what happens next’   
Inform participant that they are doing a good job   
Encourage participant to talk about the image/event in detail   
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed   
Ask participant to describe image/event as older self as observer   
Provide example of talking about the image/event in the third person   
Offer prompts to gain information about ‘what happens next’   
Inform participant that they are doing a good job   
Encourage participant to talk about the image/event in detail   
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed   
Ask participant to describe image/event as younger self with older self intervening   
Explain that information from the cognitive restructuring can be used to help   
Explain that anything else that is helpful can be used (e.g. props, techniques)   
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Ask what else they feel inclined to do (repeated as often as necessary)   
Ask how the other person responds (repeated as often as necessary)   
Offer prompts to gain information about ‘what happens next’   
Encourage participant to get older self to say or do things that their younger self requires (repeated 
as often as necessary) 
  
End of rescripting 
Encourage participant to bring attention back to the room   
Ask participant how they feel and how the memory feels to them after doing the rescripting   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
 
247 
 
Appendix G – Ethical approval documentation 
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Appendix H – GP letter 
                                          
 
A study investigating the effect of talking about pictures and memories of 
social events in people with psychosis and social anxiety 
 
 
{Insert address} 
 
Department of Psychological Sciences 
Norwich Medical School 
Norwich Research Park 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Tel: 07518 503098 
E-mail: D.Heavens@uea.ac.uk   
 
{Insert date} 
 
 
Dear Dr {Insert name}, 
 
I am writing to inform you that {Insert name} has agreed to take part in a research study 
being conducted as part fulfilment for the Doctorate in Clinical Psychology at the 
University of East Anglia.  The study is investigating whether a therapeutic intervention 
known as ‘imagery rescripting’ can be used to make pictures and memories of past 
social events less distressing in people with psychosis and social anxiety.   
 
Each participant involved in the study will be allocated to one of three conditions.  
Following the completion of some assessments, those in the first condition will be asked 
to wait one week before receiving the intervention.  Those in the second condition will 
be asked to wait for two weeks and those in the third condition will be asked to wait for 
three weeks.  All participants involved in the study will receive the intervention.  All of 
the participants will complete assessments at various stages during the study allowing 
the effect of the intervention to be observed.   
 
The intervention will be delivered over two sessions and will involve talking about 
images and memories for past social events.  The participants will be helped to view the 
images and memories discussed in a more positive way.  The time required for 
participation is approximately ten hours, divided into seven sessions over a period of 
11-13 weeks.  The assessments included in the study relate to the symptoms of social 
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anxiety, psychosis, paranoia and depression.  Measures of social functioning and quality 
of life will also be taken.   
 
If you have any concerns about {Insert name} taking part in this study or you would 
like more details, please do not hesitate to contact me using the details above.  
 
Yours sincerely, 
 
 
 
 
Dave Heavens 
Trainee Clinical Psychologist     
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Appendix I – Visual inspection for research question data 
 
Participant 1 
 
Table I1 
Visual inspection of SSI data displayed in Figure 3.4. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
35 
 
+4 
 
No trend 
 
N 
 
N 
Cont/ImRs 36 -3 No trend N N 
Follow-up 33 -3 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
  
 
Table I2 
Visual inspection of VAS-P data displayed in Figure 3.5. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.46 
 
-0.08 
 
No trend 
Control 0.34 +0.05 No trend 
Break 0.34 -0.04 No trend 
ImRs 0.31 -0.02 No trend 
One Wk FU 0.30 -0.01 No trend 
One Mnth FU 0.31 +0.04 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I3 
Visual inspection of DASS-D data displayed in Figure 3.6. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
9 
 
0 
 
No trend 
 
N 
Cont/ImRs 8 -2 Decrease N 
Follow-up 9 +3 Increase N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I4 
Visual inspection of TUS data displayed in Figure 3.7. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
40.49 
 
+4.45 
 
Increase 
 
N 
Cont/ImRs 43.42 +1.41 No trend N 
Follow-up 37.77 -12.71 Decrease N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I5 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.8. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
72 
 
-5 
 
No trend 
Cont/ImRs 77 +16 Increase 
Follow-up 85 0 No trend 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Participant 2 
 
Table I6 
Visual inspection of SSI data displayed in Figure 3.12. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
38 
 
-16 
 
Decrease 
 
N 
 
N 
Cont/ImRs 30 0 No trend N N 
Follow-up 29.5 -1 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
 
Table I7 
Visual inspection of VAS-P data displayed in Figure 3.13. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.39 
 
-0.32 
 
No trend 
Control 0.32 -0.02 No trend 
Break 0.23 -0.17 Decrease 
ImRs 0.17 +0.05 No trend 
One Wk FU 0.30 +0.22 Increase 
One Mnth FU 0.53 +0.23 Increase 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
 
 
 
 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
262 
 
Table I8 
Visual inspection of DASS-D data displayed in Figure 3.14. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
11 
 
+3 
 
No trend 
 
N 
Cont/ImRs 11 -4 Decrease N 
Follow-up 10.5 +3 Increase N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I9 
Visual inspection of TUS data displayed in Figure 3.15. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
15.89 
 
-0.81 
 
No trend 
 
N 
Cont/ImRs 14.14 -2.68 Decrease N 
Follow-up 11.05 -3.51 Decrease N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I10 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.16. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
81.25 
 
0 
 
No trend 
Cont/ImRs 80 +20 Increase 
Follow-up 87.5 -5 No trend 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Participant 3 
 
Table I11 
Visual inspection of SSI data displayed in Figure 3.20. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
29 
 
-4 
 
No trend 
 
N 
 
N 
Cont/ImRs 28 +2 No trend N N 
Follow-up 27.5 -3 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
 
Table I12 
Visual inspection of VAS-P data displayed in Figure 3.21. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.58 
 
-0.02 
 
No trend 
Control 0.78 +0.10 Increase 
Break 0.76 -0.14 Decrease 
ImRs 0.70 +0.01 No trend 
One Wk FU 0.73 +0.05 No trend 
One Mnth FU 0.75 0 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I13 
Visual inspection of DASS-D data displayed in Figure 3.22. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
8.5 
 
-1 
 
No trend 
 
N 
Cont/ImRs 8 0 No trend N 
Follow-up 10.5 +5 Increase N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I14 
Visual inspection of TUS data displayed in Figure 3.23. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
31.04 
 
-1.96 
 
No trend 
 
N 
Cont/ImRs 35.40 +10.67 Increase N 
Follow-up 40.73 0 No trend N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I15 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.24. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
59.5 
 
+9 
 
Increase 
Cont/ImRs 67 +6 Increase 
Follow-up 70 0 No trend 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Participant 4 
 
Table I16 
Visual inspection of SSI data displayed in Figure 3.28. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
21.5 
 
+5 
 
Increase 
 
N 
 
N 
Cont/ImRs 19 -10 Decrease N Y 
Follow-up 12.5 -3 No trend N Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table I17 
Visual inspection of VAS-P data displayed in Figure 3.29. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.00 
 
0 
 
No trend 
Control 0.00 0 No trend 
Break 0.00 0 No trend 
ImRs 0.00 0 No trend 
One Wk FU 0.00 0 No trend 
One Mnth FU 0.00 0 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I18 
Visual inspection of DASS-D data displayed in Figure 3.30. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
11.67 
 
+2 
 
No trend 
 
N 
Cont/ImRs 10.5 -5 Decrease N 
Follow-up 7 -2 Decrease N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I19 
Visual inspection of the TUS data displayed in Figure 3.31. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
19.58 
 
-0.38 
 
No trend 
 
N 
Cont/ImRs 20.31 +1.84 No trend N 
Follow-up 23.41 +4.35 Increase N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I20 
Visual inspection of the EQ-5D-5L VAS data displayed in Figure 3.32. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
70 
 
+15 
 
No trend 
Intervention 77.5 +5 Increase 
Follow-up 82.5 +5 Increase 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Participant 5 
 
Table I21 
Visual inspection of SSI data displayed in Figure 3.36. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
54 
 
-6 
 
Decrease 
 
N 
 
N 
Cont/ImRs 43.5 -15 Decrease Y N 
Follow-up 24 -24 Decrease Y Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
 
Table I22 
Visual inspection of VAS-P data displayed in Figure 3.37. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.55 
 
+0.04 
 
Decrease 
Control 0.63 -0.49 Decrease 
Break 0.49 +0.21 Increase 
ImRs 0.42 -0.35 Decrease 
One Wk FU 0.30 +0.12 Increase 
One Mnth FU 0.25 -0.23 Decrease 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I23 
Visual inspection of DASS-D data displayed in Figure 3.38. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
18.5 
 
-3 
 
No trend 
 
N 
Cont/ImRs 14.5 -7 Decrease N 
Follow-up 7 -8 Decrease Y 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); clinical change was calculated using the second measure in each 
phase (i.e. end of baseline, one week follow-up, one month follow-up). 
 
Table I24 
Visual inspection of TUS data displayed in Figure 3.39. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
0.34 
 
+0.67 
 
No trend 
 
N 
Cont/ImRs 0.45 +0.44 No trend N 
Follow-up 1.64 +2.81 Increase N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I25 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.40. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
30 
 
+20 
 
No trend 
Cont/ImRs 55 +20 Increase 
Follow-up 75 +20 Increase 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Table I26 
Visual inspection of SSI data displayed in Figure 3.44. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
33 
 
-2 
 
No trend 
 
N 
 
N 
Cont/ImRs 31.5 -1 No trend N N 
Follow-up 30.5 -1 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
 
Table I27 
Visual inspection of VAS-P data displayed in Figure 3.45. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.64 
 
+0.13 
 
No trend 
Control 0.85 -0.04 No trend 
Break 0.82 -0.03 No trend 
ImRs 0.83 +0.05 No trend 
One Wk FU 0.80 -0.10 No trend 
One Mnth FU 0.57 -0.37 Decrease 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I28 
Visual inspection of DASS-D data displayed in Figure 3.46. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
19 
 
+2 
 
No trend 
 
N 
Cont/ImRs 16.5 -5 Decrease N 
Follow-up 16.5 +5 Increase N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I29 
Visual inspection of TUS data displayed in Figure 3.47. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
17.81 
 
-8.76 
 
Decrease 
 
N 
Cont/ImRs 10.30 -6.27 Decrease N 
Follow-up 7.82 +1.31 No trend N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I30 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.48. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
52.5 
 
+30 
 
Increase 
Cont/ImRs 62.5 -5 No trend 
Follow-up 45 -30 Decrease 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Table I31 
Visual inspection of SSI data displayed in Figure 3.52. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
24.5 
 
-3 
 
No trend 
 
N 
 
N 
Cont/ImRs 19 -10 Decrease N Y 
Follow-up 14.5 +1 No trend N Y 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table I32 
Visual inspection of VAS-P data displayed in Figure 3.53. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.52 
 
+0.29 
 
No trend 
Control 0.50 0 No trend 
Break 0.50 0 No trend 
ImRs 0.50 0 No trend 
One Wk FU 0.50 0 No trend 
One Mnth FU 0.50 0 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I33 
Visual inspection of DASS-D data displayed in Figure 3.54. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
10 
 
+1 
 
No trend 
 
N 
Cont/ImRs 6 -8 Decrease Y 
Follow-up 3.5 +3 Increase Y 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); clinical change was calculated using the second measure in each 
phase (i.e. end of baseline, one week follow-up, one month follow-up). 
 
Table I34 
Visual inspection of TUS data displayed in Figure 3.55. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
32.18 
 
+7.52 
 
Increase 
 
N 
Cont/ImRs 34.05 -3.78 Decrease N 
Follow-up 33.59 +2.86 Increase N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I35 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.56. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
38.33 
 
-5 
 
No trend 
Cont/ImRs 55 +40 Increase 
Follow-up 72.5 -5 No trend 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Table I36 
Visual inspection of SSI data displayed in Figure 3.60. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
57.5 
 
-3 
 
No trend 
 
N 
 
N 
Cont/ImRs 59 +6 Increase N N 
Follow-up 59 -6 Decrease N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I37 
Visual inspection of VAS-P data displayed in Figure 3.61. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.78 
 
-0.09 
 
No trend 
Control 0.62 -0.22 Decrease 
Break 0.76 +0.49 Increase 
ImRs 0.67 -0.66 Decrease 
One Wk FU 0.55 +0.41 Increase 
One Mnth FU 0.76 +0.01 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I38 
Visual inspection of DASS-D data displayed in Figure 3.62. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
13.5 
 
-1 
 
No trend 
 
N 
Cont/ImRs 15.5 +5 Increase N 
Follow-up 19 +2 Increase N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I39 
Visual inspection of TUS data displayed in Figure 3.63. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
8.66 
 
-1.54 
 
No trend 
 
N 
Cont/ImRs 8.78 +1.77 No trend N 
Follow-up 7.41 -4.51 Decrease N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I40 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.64. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
57.5 
 
+75 
 
Increase 
Cont/ImRs 71 -8 Decrease 
Follow-up 48.5 -37 Decrease 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Table I41 
Visual inspection of SSI data displayed in Figure 3.68. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
50.5 
 
+13 
 
Increase 
 
N 
 
N 
Cont/ImRs 54 -6 Decrease N N 
Follow-up 52 +2 No trend N N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); the reliable change threshold was calculated from the mean baseline score 
for Cont/ImRs and follow-up; clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I42 
Visual inspection of VAS-P data displayed in Figure 3.69. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.91 
 
+0.03 
 
No trend 
Control 0.80 -0.02 No trend 
Break 0.82 +0.05 Increase 
ImRs 0.84 -0.01 No trend 
One Wk FU 0.88 +0.09 Increase 
One Mnth FU 0.91 -0.03 Decrease 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I43 
Visual inspection of DASS-D data displayed in Figure 3.70. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
18.33 
 
0 
 
No trend 
 
N 
Cont/ImRs 19.5 +3 Increase N 
Follow-up 21 0 No trend N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I44 
Visual inspection of TUS data displayed in Figure 3.71. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
0.50 
 
0 
 
No trend 
 
N 
Cont/ImRs 0.50 0 No trend N 
Follow-up 1.44 +1.87 Increase N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up).   
 
Table I45 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.72. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
27 
 
+4 
 
Increase 
Cont/ImRs 31.5 +5 Increase 
Follow-up 39.5 +9 Increase 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Table I46 
Visual inspection of SSI data displayed in Figure 3.76. 
 
 
 
Mean 
 
Level 
 
Trend 
 
Reliable 
change 
 
Clinical 
change 
 
Baseline 
 
52 
 
-8 
 
Increase 
 
N 
 
N 
Cont/ImRs 48 -16 Decrease N N 
Follow-up 35.5 -9 Decrease Y N 
 
Note. ‘Cont/ImRs’ phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); the reliable change threshold was calculated from the mean 
baseline score for Cont/ImRs and follow-up; clinical change was calculated using the second measure in 
each phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
 
Table I47 
Visual inspection of VAS-P data displayed in Figure 3.77. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
0.46 
 
-0.72 
 
Decrease 
Control 0.05 +0.04 No trend 
Break 0.07 -0.01 No trend 
ImRs 0.08 +0.03 No trend 
One Wk FU 0.05 -0.09 Decrease 
One Mnth FU 0.02 +0.03 No trend 
 
 
Note. ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth FU = One 
month follow-up; + or – indicates the direction of the change.   
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Table I48 
Visual inspection of DASS-D data displayed in Figure 3.78. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
16.5 
 
-7 
 
No trend 
 
N 
Cont/ImRs 10.5 +1 No trend N 
Follow-up 5.9 -3 Decrease N 
 
Note. Cont/ImRs phase includes both control and imagery rescripting sessions; + or – indicates the 
direction of change; N (No); clinical change was calculated using the second measure in each phase (i.e. 
end of baseline, one week follow-up, one month follow-up). 
 
Table I49 
Visual inspection of TUS data displayed in Figure 3.79. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Clinical change 
 
Baseline 
 
44.94 
 
+17.42 
 
Increase 
 
Y 
Cont/ImRs 43.84 -19.62 Decrease N 
Follow-up 36.03 +3.99 Increase N 
 
Note. Cont/ImRs phase includes both the control and imagery rescripting sessions; + or – indicates the 
direction of change; Y (Yes), N (No); clinical change was calculated using the second measure in each 
phase (i.e. end of baseline, one week follow-up, one month follow-up).   
 
Table I50 
Visual inspection of EQ-5D-5L-VAS data displayed in Figure 3.80. 
 
Phase 
 
Mean 
 
Level 
 
Trend 
 
Baseline 
 
61.25 
 
0 
 
No trend 
Cont/ImRs 82.5 +25 Increase 
Follow-up 95.5 +1 No trend 
 
Note. Cont/ImRs phase includes control and imagery rescripting sessions; + or – indicates the direction of 
change. 
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Appendix J - Visual inspection for ideographic ratings 
 
Participant 1 
 
Table J1 
Visual inspection of the ideographic ratings data displayed in Figure 3.3. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
75.5 
 
52.5 
 
53.5 
 
66 
 
4 
 Break 49 39 37 69.5 2.5 
 ImRs 27 24 18.5 71 1 
 One Wk FU 15 20 15.5 73.5 0.5 
 One Mnth FU 26 17.5 12 70 0 
       
Level Control -37 -11 -9 -4 0 
 Break -16 -16 -24 +11 -3 
 ImRs -28 -14 -13 -8 0 
 One Wk FU +4 +6 +5 +13 -1 
 One Mnth FU +18 -11 -12 -20 0 
       
Trend Control Dec Dec Dec NT NT 
 Break Dec Dec Dec Inc Dec 
 ImRs Dec Dec Dec Dec NT 
 One Wk FU Inc Inc Inc Inc Dec 
 One Mnth FU Inc Dec Dec Dec NT 
       
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J2 
Visual inspection of the ideographic ratings data displayed in Figure 3.11. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
84 
 
95 
 
88 
 
60 
 
4 
 Break 83 86 87 66 3 
 ImRs 73 83 90 78 1 
 One Wk FU 63 79 81 76 3 
 One Mnth FU 52 65 69 66 3 
       
Level Control 0 +3 -4 +2 0 
 Break -3 -20 +2 +9 -3 
 ImRs -16 +13 +3 +15 0 
 One Wk FU -4 -21 -20 -19 +3 
 One Mnth FU -18 -7 -4 -1 +2 
       
Trend Control NT Inc Dec Inc NT 
 Break NT Dec Inc Inc Dec 
 ImRs Dec Inc Inc Inc NT 
 One Wk FU Dec Dec Dec Dec Inc 
 One Mnth FU Dec Dec Dec NT Dec 
 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J3 
Visual inspection of the ideographic ratings data displayed in Figure 3.19. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
79 
 
69.5 
 
71.5 
 
43 
 
2 
 Break 68 63.5 71.5 57 2 
 ImRs 57 57 55 58.5 2 
 One Wk FU 45 43 39.5 46 2 
 One Mnth FU 40.5 39 38 45.5 1.5 
       
Level Control -30 -19 -3 +10 0 
 Break +8 +7 +3 +18 0 
 ImRs -30 -20 -36 -15 0 
 One Wk FU +6 -8 +5 -10 0 
 One Mnth FU -15 0 -8 +9 -1 
       
Trend Control Dec Dec NT Inc NT 
 Break Inc Inc NT Inc NT 
 ImRs Dec Dec Dec Dec NT 
 One Wk FU Inc Dec Inc Dec NT 
 One Mnth FU Dec NT Dec Inc Dec 
 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J4 
Visual inspection of the ideographic ratings data displayed in Figure 3.27. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
100 
 
100 
 
100 
 
50 
 
15.5 
 Break 100 100 100 64 11.5 
 ImRs 54.5 100 100 61 7.5 
 One Wk FU 43 77 76.5 32 6 
 One Mnth FU 51 29 28.5 13.5 2 
       
Level Control 0 0 0 -2 +1 
 Break 0 0 0 +30 -9 
 ImRs -91 0 0 -36 +1 
 One Wk FU +68 -46 -47 -22 -4 
 One Mnth FU -52 -50 -49 -15 -4 
       
Trend Control NT NT NT NT NT 
 Break NT NT NT Inc Dec 
 ImRs Dec NT NT Dec NT 
 One Wk FU Inc Dec  Dec Dec Dec 
 One Mnth FU Dec Dec Dec Dec Dec 
 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J5 
Visual inspection of the ideographic ratings data displayed in Figure 3.35. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
95.5 
 
61 
 
95 
 
92 
 
80 
 Break 93 63.5 95 100 115 
 ImRs 70 47 82.5 91.5 140 
 One Wk FU 41 23.5 60.5 62.5 85 
 One Mnth FU 24 24.5 41 25.5 15 
       
Level Control -9 -12 -10 +16 +20 
 Break +4 -17 +10 0 +50 
 ImRs -30 -50 -35 -17 0 
 One Wk FU -8 +3 -9 -41 -110 
 One Mnth FU -26 -1 -30 -33 -30 
       
Trend Control Dec Dec Dec Inc Inc 
 Break Inc Inc Inc NT Inc 
 ImRs Dec Dec Dec Dec NT 
 One Wk FU Dec NT Dec Dec Dec 
 One Mnth FU Dec NT Dec Dec Dec 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
 
 
 
 
 
 
 
 
 
 
 
 
Imagery rescripting for social anxiety in psychosis                                          D. Heavens 
284 
 
Participant 6 
 
Table J6 
Visual inspection of the ideographic ratings data displayed in Figure 3.43. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
87 
 
83.5 
 
86.5 
 
45.5 
 
21 
 Break 87 76.5 86 29.5 12.5 
 ImRs 86.5 68 83.5 46 5 
 One Wk FU 84 69.5 77 45.5 5 
 One Mnth FU 78.5 59 74 17.5 4 
       
Level Control +4 +13 -3 +1 0 
 Break -4 -27 +2 -33 -17 
 ImRs +3 +10 -7 +66 +2 
 One Wk FU -8 -7 -6 -67 -2 
 One Mnth FU +3 -14 0 +11 0 
       
Trend Control NT Inc NT NT NT 
 Break NT Dec NT Dec Dec 
 ImRs NT Inc Dec Inc NT 
 One Wk FU Dec Dec Dec Dec NT 
 One Mnth FU Dec Dec NT Inc NT 
 
 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J7 
Visual inspection of the ideographic ratings data displayed in Figure 3.51. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
100 
 
80 
 
57.5 
 
75 
 
12 
 Break 100 75 55 60 18 
 ImRs 100 65 60 50 24 
 One Wk FU 100 60 55 50 13.5 
 One Mnth FU 100 55 50 50 1.5 
       
Level Control 0 +20 -15 -10 0 
 Break 0 -30 +10 -20 +12 
 ImRs 0 +10 0 0 0 
 One Wk FU 0 -20 -10 0 -21 
 One Mnth FU 0 -10 0 0 -3 
       
Trend Control NT Inc Dec Dec NT 
 Break NT Dec Inc Dec Inc 
 ImRs NT Inc NT NT NT 
 One Wk FU NT Dec Dec NT Dec 
 One Mnth FU NT Inc NT NT Dec 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J8 
Visual inspection of the ideographic ratings data displayed in Figure 3.59. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
93.5 
 
84 
 
97.5 
 
63.5 
 
49 
 Break 93.5 93.5 99.5 74 59.5 
 ImRs 77.5 94 99 76 71 
 One Wk FU 75 96 85.5 63.5 46 
 One Mnth FU 96 97 82.5 65.5 22.5 
       
Level Control -13 +20 +5 +13 0 
 Break +13 -1 -1 +8 +21 
 ImRs -45 +2 0 -4 +2 
 One Wk FU +40 +2 -27 -21 -52 
 One Mnth FU +2 0 +21 +25 +5 
       
Trend Control Dec Inc Inc Inc NT 
 Break Inc NT NT Inc Inc 
 ImRs Dec NT NT Dec NT 
 One Wk FU Inc NT Dec Dec Dec 
 One Mnth FU NT NT Inc Inc Inc  
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Table J9 
Visual inspection of the ideographic ratings data displayed in Figure 3.67. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
97.5 
 
51 
 
78.5 
 
49.5 
 
87.5 
 Break 99 29.5 40.5 68.5 49.5 
 ImRs 98.5 12.5 43.5 90.5 10 
 One Wk FU 98.5 53 85 89 8.5 
 One Mnth FU 95.5 89.5 93 87.5 7 
       
Level Control +3 +2 -9 -17 +5 
 Break 0 -45 -67 +55 -81 
 ImRs -1 +11 +73 -11 +2 
 One Wk FU +1 +70 +10 +8 -5 
 One Mnth FU -7 +3 +6 -11 +2 
       
Trend Control Inc Inc Dec Dec Inc 
 Break NT Dec Dec Inc Dec 
 ImRs NT Inc Inc Dec NT 
 One Wk FU NT Inc Inc Inc Dec 
 One Mnth FU Dec Inc Inc Dec NT 
 
 
 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Participant 10 
 
Table J10 
Visual inspection of the ideographic ratings data displayed in Figure 3.75. 
 
Inspection 
 
 
Time point 
 
EB 
 
MD 
 
ID 
 
IV 
 
IF 
 
Mean 
 
Control 
 
89 
 
56 
 
87 
 
65.5 
 
8 
 Break 84 52.5 83.5 74 5.5 
 ImRs 45 56 68.5 83.5 4 
 One Wk FU 17.5 39.5 45 57 3.5 
 One Mnth FU 15 12.5 26.5 16 1 
       
Level Control +2 -6 -10 -5 0 
 Break -12 -1 +3 +22 -5 
 ImRs -66 +8 -33 -3 +2 
 One Wk FU +11 -41 -14 -50 -3 
 One Mnth FU -16 -13 -23 -32 -2 
       
Trend Control NT Dec Dec Dec NT 
 Break Dec NT Inc Inc Dec 
 ImRs Dec Inc Dec NT Inc 
 One Wk FU Inc Dec Dec Dec Dec 
 One Mnth FU Dec Dec Dec Dec Dec 
 
 
 
 
 
 
 
Note. EB = Encapsulated belief; MD = Memory distress; ID = Imagery distress; IV = Imagery vividness; 
IF = Imagery frequency; Control = Control session; Break = Break between control and imagery 
rescripting session; ImRs = Imagery rescripting session; One Wk FU = One week follow-up; One Mnth 
FU = One month follow-up; - sign indicates shift down in scores, + sign indicates shift up in scores; Dec 
= Decrease in trend, Inc = Increase in trend; NT = No trend. 
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Appendix K - Imagery rescripting rating sheets (completed) 
Imagery rescripting rating scale                        Participant: 1 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes  
Explain imagery rescripting stages (three in total)  Yes Had already cognitively restructured the memory? 
Unclear when the cognitive restructuring happened 
but incorporated well into the session 
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes Done really nicely and in keeping with clients 
understanding and experience 
Offer participant the opportunity to ask questions No  
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes This enabled the client to open up emotionally 
Inform participant that they are doing a good job Yes Not very frequently but some encouragement given 
Encourage participant to talk about the image/event in detail Yes Got 5 senses and smells of cigarettes, bodily 
sensations 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes This happens frequently through stage 2 
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes Lots of thoughts, feelings and ideas but did not 
restructure at this point?? 
Guide participant in talking about image as younger self with older self intervening 
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Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self intervening Yes  
Explain that information from the cognitive restructuring can be used to help Yes This was done well incorporating positive beliefs 
about self-image and also helpful information 
about how she shouldn’t be behaving the way she 
was and how he can stand up to people and this is 
ok. Really well executed!! 
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes This enabled him to feel more hopeful and think 
about being and feeling more sure and confident 
Ask how the other person responds (repeated as often as necessary) Yes Asked frequently and appropriately 
Offer prompts to gain information about ‘what happens next’ Yes This again allowed client to expand more 
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes Offered guidance on anything else you would like 
him to say and do really sensitively 
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes Gained more control over the memory and felt 
better, “that situation was the exception rather than 
the rule!!” 
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Imagery rescripting rating scale                        Participant: 2 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes Very clearly explained 
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes  
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes Prompted client to remain in 1st person but she 
struggled to do this and struggled to stay in the 
memory. However, therapist persisted and client was 
able to access thoughts, feelings well in the session 
Offer prompts to gain information about ‘what happens next’ Yes Used feelings in body and senses to support client to 
access memory deeply 
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  Used senses to help participant to access feelings in 
the memory 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes Lots of detail encouraged to be given and this was 
very positive and in line with social anxiety 
expectations 
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes “You are doing a really good job of describing this” 
Encourage participant to talk about the image/event in detail Yes Lots of “anything else” to elicit further detail 
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Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes Did well at this but again struggled to remain in the 
first person and again therapist very sensitively 
persisted 
Ask participant to describe image/event as younger self with older self 
intervening 
Yes Although it was not clear that older self was present 
throughout the memory. It took a while for the older 
self to be incorporated 
Explain that information from the cognitive restructuring can be used to help Yes  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes Able to coach younger self saying “keep calm and 
carry on”. Lovely therapeutic moment 
Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes Lots of supportive self statements and actions to 
manage with the situation better and advice from older 
self-elicited well 
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes  
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Imagery rescripting rating scale                                Participant: 3 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes Very clearly explained 
Explain imagery rescripting stages (three in total)  Yes Very quiet responses from participant. Unsure how 
much the participant was just agreeing 
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions No No chance to ask questions given. Client very quiet 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  Used senses to help participant and encouraged client 
to go into more detail 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes Client easily adapts to observer perspective.  Therapist 
appropriately encouraging 
Provide example of talking about the image/event in the third person Yes Uses the clients own example 
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes Lots of lovely encouragement from therapist 
Encourage participant to talk about the image/event in detail Yes Lots of detail brought out, more so than in first person 
perspective. This enables the client to link with the 
strong emotions of sadness and loneliness that had not 
previously been discussed. Participant did not make 
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any changes as the adult self/observer 
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self 
intervening 
Yes  
Explain that information from the cognitive restructuring can be used to help Yes Did not use much info from restructuring although 
having hugs and reminders seemed supportive  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes This was done lots although she did not take 
opportunities to make changes. With encouragement 
form the therapist the participant started to develop 
more helpful thoughts, e.g. they’re not talking about 
you 
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes This stage enabled participant to feel more confident 
in the memory 
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes  
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Imagery rescripting rating scale                                Participant: 4 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes Very clear 
Explain imagery rescripting stages (three in total) Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes  
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes Not speaking in present tense but past tense. Therapist 
goes with this and also does not use present tense. 
However, this did not seem to cause any difficulties 
with emotional engagement with the exercise 
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  Therapist engages participant in thoughts, feelings, 
and 5 senses successfully 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes Quickly participant gets into observer image but does 
not choose to anything differently 
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
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Ask participant to describe image/event as younger self with older self 
intervening 
Yes Participant initially struggled to do this but therapist 
encouraged her to stick with it in a very gentle and 
empathetic way 
Explain that information from the cognitive restructuring can be used to help Yes  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes This was done very well and in a very sensitive way. 
The client described feeling very alone and distressed 
by the memory.  The therapist appropriately 
encouraged participant to make changes 
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes  
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes  
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Imagery rescripting rating scale                                Participant: 5 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes Described very clearly 
Explain imagery rescripting stages (three in total)  Yes Well described using the script, although sounded 
more relaxed than with previous participants 
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes No questions asked by participant 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes Described the scene well. Not talking in the present 
tense but this did not affect her ability to engage in the 
therapeutic task 
Offer prompts to gain information about ‘what happens next’ Yes Used the ability to pause the scene well 
Inform participant that they are doing a good job Yes The therapeutic interaction enabled the client to get 
into the scene and express more physical and 
emotional reactions, e.g. “my body is going to 
implode into itself 
Encourage participant to talk about the image/event in detail Yes   
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes The therapist’s responses enabled participant to 
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express her greatest fears around believing that older 
people are judging her in the memory and described 
the impact of the panic attack in more detail 
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self 
intervening 
Yes  
Explain that information from the cognitive restructuring can be used to help Yes Used a lot of the restructuring and this sounded very 
empowering for the participant 
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes Imagines chairs etc. in the scene 
Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes Uses older self well, including reassurance around the 
panic attack. Able to introduce the positive aspects of 
self, including kindness and generosity 
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes It was not as bad as the participant was expecting it to 
be 
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Imagery rescripting rating scale                                Participant: 6 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes  
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes Participant expresses a number of concerns about 
having to imagine what is going to happen. 
Difficulties imaging self. Therapist explains not to 
worry about this and takes control in a very gentle 
way. Participant struggled to take in all the 
information 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes The participant struggled to speak in the present tense 
and spoke in a disjointed way with gaps in the 
memory 
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  The participant struggled to explain how he was 
feeling in the present tense and kept going back and 
forth but with encouragement from the therapist he 
was able to engage in the exercise 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes Participant does this well and the therapist is skilled at 
encouraging this 
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Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self 
intervening 
Yes Able to do this with scaffolding and support from 
therapist 
Explain that information from the cognitive restructuring can be used to help Yes Uses this. Although participant struggles with the 
imaginative process and keeps coming away from the 
imagery or digressing 
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes  
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes  
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Imagery rescripting rating scale                                Participant: 7 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes  
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes Participant had a number of questions and talked these 
through with the therapist 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes   
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self 
intervening 
Yes  
Explain that information from the cognitive restructuring can be used to help Yes  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
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Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes  
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
Yes  
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Imagery rescripting rating scale                                Participant: 8 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes Used script 
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, pause) Yes  
Offer participant the opportunity to ask questions Yes No questions asked but client clarified what had 
been said 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes   
Ask participant to describe image/event as younger self Yes Well described, client chose to work with a 
memory that involved drug taking, although 
appeared to recall it well in detail 
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes Talked and sounded anxious and paranoid talking 
about needing the toilet and catastrophic thoughts 
about being unable to control his bladder. The 
participant asked for the Dictaphone to be 
switched off, possibly due to paranoia around 
drug taking etc. although this is not clear on the 
tape 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
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Encourage participant to talk about the image/event in detail Yes Mentioned a lot of his thoughts and feelings 
about using MDMA and worries about it that he 
did not know at the time 
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self intervening Yes  
Explain that information from the cognitive restructuring can be used to help Yes Uses information lots from his adult knowledge, 
which reassures his younger self 
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes Lots of helpful reassurance from older self and 
also supporting younger self to think more 
positively about himself 
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
No 
 
Not on tape recording 
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Imagery rescripting rating scale                                Participant: 9 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes  
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, 
pause) 
Yes  
Offer participant the opportunity to ask questions Yes Participant asked questions freely throughout the 
discussion, appear to be fairly literal/concrete in his 
language 
Asked participant to imagine therapist is an alien but 
it was unclear what prompted this. There was also 
someone else in the room, presumably to support the 
participant but unclear what her role was and what 
impact this may have had on the intervention 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes The supportive person in the room added into the 
memory at two points, again unclear what impact this 
might have had on the intervention, as she was also 
there when the event memory had occurred and 
added in her perspective 
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes Lots of detail about thoughts and feelings and body 
sensations elicited 
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes Someone sounded like they were clearing up in the 
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background, unclear what impact again that this 
might have had on the intervention 
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes Again participant had someone else in the room with 
him and they were talking as he was describing the 
memory 
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self 
intervening 
Yes  
Explain that information from the cognitive restructuring can be used to help Yes  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes  
End of rescripting 
Encourage participant to bring attention back to the room Yes  
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
No Not on the tape 
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Imagery rescripting rating scale                              Participant: 10 
 
Introduction to rescripting Achieved Comments 
Provide introduction to imagery rescripting Yes  
Explain imagery rescripting stages (three in total)  Yes  
Explain that props and techniques can be used (e.g. cartoon characters, rewind, pause) Yes  
Offer participant the opportunity to ask questions Yes Asked questions appropriately during the 
discussion 
Guide participant in talking about image as younger self 
Encourage participant to close eyes and revisit the image Yes  
Ask participant to describe image/event as younger self Yes  
Offer prompts to gain information about ‘what happens next’ Yes Lots of thoughts and feelings elicited 
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes  
Guide participant in talking about image as older self as observer 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as older self as observer Yes  
Provide example of talking about the image/event in the third person Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Inform participant that they are doing a good job Yes  
Encourage participant to talk about the image/event in detail Yes Again lots of details about thoughts and 
feelings elicited when thinking about the 
bullying 
Guide participant in talking about image as younger self with older self intervening 
Encourage participant to keep their eyes closed Yes  
Ask participant to describe image/event as younger self with older self intervening Yes  
Explain that information from the cognitive restructuring can be used to help Yes  
Explain that anything else that is helpful can be used (e.g. props, techniques) Yes  
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Ask what else they feel inclined to do (repeated as often as necessary) Yes  
Ask how the other person responds (repeated as often as necessary) Yes  
Offer prompts to gain information about ‘what happens next’ Yes  
Encourage participant to get older self to say or do things that their younger self 
requires (repeated as often as necessary) 
Yes  
End of rescripting 
Encourage participant to bring attention back to the room Yes No preparation for coming out of memory, e.g. 
become aware of the sounds around us etc. 
Ask participant how they feel and how the memory feels to them after doing the 
rescripting 
No Not on the tape 
 
